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Abstract
Refractive error is a significant cause of vision impairment both through the limited access to
correction in some areas and the associated ocular diseases for which refractive errors are risk
factors. Having timely, regular access to population level estimates of refractive error and vision
impairment is necessary to adequately plan public health resources and resource appropriate
interventions. A lack of access to current and regularly updated refractive error and vision
impairment prevalence data has been identified as a significant limitation in predicting future
population trends with many countries lacking any prevalence data or available data being outdated.
This project addresses this gap by utilising the untapped potential of Big Data in the form of
spectacle lens sales data and optometric electronic medical record data and assesses the potential
of these data sources as a public health tool. Chapter 5 contains a review of the application of Big
Data and Artificial Intelligence to the field of eyecare and describes the revolutionary potential these
new technologies may hold. Chapter 6 describes the data used in this project and the steps taken to
acquire and clean the data. Chapter 7 and 8 compare the prevalence of refractive error found using
spectacle lens sales data and optometric electronic medical record data to a large population survey
of refractive error and demonstrate that with careful analysis an accurate estimation of population
distribution of refractive error can be obtained from both types of data. Chapter 8 also estimates the
likely level of vision impairment by age 75 given the distribution of myopia in the spectacle lens sales
data. Chapter 9 analyses visual acuity data within the optometric electronic medical records which
allowed the optimum recall interval and visual acuity threshold for driving licence renewal to be
determined. Chapter 10 provides a summary and conclusion on the work, and contains
recommendations for future research.
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1 Introduction
1.1 Background
In 1999 the World Health Organisation (WHO) launched “VISION 2020 – The Right to Sight” initiative
in order to eliminate avoidable blindness.1 As part of this initiative refractive error was identified as a
priority condition.2 In the intervening years, it has become apparent that of all refractive errors,
myopia is the most concerning as the prevalence has increased dramatically and is projected to
continue on this trajectory.3 This may result in an increasing number of individuals affected by vision
impairment both due to uncorrected myopia and the complications of myopia.4 One of the
recognised barriers to establishing the extent of these problems is the significant lack of population
level prevalence data for both refractive error and vision impairment.3,5
Accurate and current prevalence data for refractive error and vision is needed to allow policy makers
and relevant stake holders determine the need for public health interventions and to ensure the
necessary level of support is in place for those effected. Beyond merely establishing the extent of
the problem however there is an ongoing need for this data to assess the impact of any
interventions that are put in place. Current population level data on refractive error and vision is also
needed to ensure evidence-based decisions can be made by policy makers with regards to any vision
standards that may be applied to the public.
In recent years there has been an explosion in the volume of digital data created on a daily basis6
with the healthcare domain seeing a particularly large increase in data being generated.7 In this new
era of “Big Data”, insight to some research questions that previously were difficult or impossible to
answer, is now achievable. It may now be possible to bridge the gap that is present in refractive
error and vision data using these new techniques.
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1.2 Research Aims and Objectives
It has been established that myopia prevalence is increasing dramatically8,9 and is projected to
continue to increase over the coming years.3 A lack of current refractive error prevalence data has
been identified as a potential limitation in these predictions3 and also presents a barrier to assessing
the efficacy of possible interventions at a population level. The lack of data is likely as a result of the
prohibitive cost and significant amount of time required to conduct a typical epidemiological study
of refractive error. Therefore, the primary aim of this research was to examine and validate
alternative data sources and methods to determine the distribution of refractive error and vision
across the general population and validate these results against pre-existing research. Secondary
aims were to use these results to estimate the vision impairment due to myopia in a population and
demonstrate how these data sources and methods can be used as a basis for public health policy.
To achieve these aims a large database of refractive error and vision data was created from
spectacle lens sales data and optometric electronic medical record (EMR) data. The prevalence of
refractive error is reported and detailed comparison of these results with typical epidemiological
studies of refractive error is undertaken. Deriving a relationship between age and prescribed reading
addition allowed an estimated age for the spectacle lens data to be calculated. This facilitated a
comparison of both the spectacle lens data and EMR data across age groups with published data on
refractive error prevalence.
In order to validate the use of spectacle lens sales data as a source of refractive error
epidemiological data, a novel methodology was investigated which established the range of
refractive errors over which spectacle lens sales data can be used to estimate the distribution of
refractive error in a population. Having established this range, the potential level of vision
impairment due to myopia is reported across the range of myopic refractive errors.
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To further demonstrate how this form of data can be used as the basis for public health policy,
evidence-based recommendations for standardised driver vision screening were developed.
Determining the variation in visual acuity with age within the population of the EMR data allowed
the maximum length of time that could pass between vision screenings for an individual to still pass
the driving visual acuity standard to be calculated. The influence of varying the visual acuity standard
for driving on the number of individuals expected to meet the standard was also determined.
The long-term aim of this project is to continue data collection creating the most comprehensive,
current and easily accessible database on refractive error and vision available. This will provide a
foundation upon which public health policy in eyecare can be developed and also allow monitoring
of the impact of these policies over time.
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2 Refractive Error
2.1 Introduction
Refractive error is a condition in which the eye fails to create a sharp image at the retina resulting in
a degradation of visual acuity. Generally, refractive error can be considered as one of four distinct
types with all individuals experiencing 1 or more refractive errors over the course of their life.
Myopia (short-sightedness) causes difficulty with viewing distant objects and is usually caused by an
eye whose axial length has grown too long (Figure 2.1). Hyperopia (long-sightedness) causes
difficulty with viewing near objects and possibly distant objects depending on the degree of
hyperopia and age of the individual. Hyperopia is usually caused by an eye whose AL is too short
(Figure 2.1). Presbyopia causes difficulty with viewing near objects in older individuals as they lose
the ability to accommodate. Astigmatism is caused by a variation in curvature of the cornea or
crystalline lens which causes an object to have two points of focus.
Typically, in high income countries, refractive error can be easily addressed by the provision of an
optical appliance such as spectacles or contact lenses or through surgical techniques such as laserassisted in situ keratomileusis (LASIK). Unfortunately, despite the ease with which refractive error
can be corrected, it is still the leading cause of moderate to severe vision impairment in older adults
and second most common cause of blindness in older adults globally.10
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Figure 2.1: Comparison of axial length in emmetropia, myopia and hyperopia showing a long axial
length in myopia and a short axial length in hyperopia.. Reproduced from Schachar.11

2.2 Emmetropisation
To understand why refractive error develops, it is necessary to consider how refraction changes in
infancy and young childhood through the process of emmetropisation. At birth refractive error is
approximately normally distributed within the population.12 If this situation was to remain
unchanged the number of individuals effected by refractive error would be considerably higher than
that observed in most studies of refractive error (Figure 2.2). In early childhood, the process by
which refractive error reduces in most children is referred to as emmetropisation. The mean
refractive error in infants is hyperopic and there is significant variability as seen by relatively large
standard deviations.13 Over the first year of life, there is a shift to less hyperopic refractive errors
with a significant reduction in the variability of refractive errors.12 This occurs due to a combination
of changes in the power of the refractive surfaces of the eye i.e., the cornea and the crystalline lens
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and an increase in the axial length of the eye.13 At a population level, these changes have the effect
of altering the distribution of refractive error away from a normal distribution towards a
leptokurtotic distribution (Figure 2.2). This distribution is positively skewed as opposed to the
negatively skewed distributions seen in adults but otherwise is more closely aligned to the
distributions observed in adults than the approximately normal distribution found at birth.
The majority of the emmetropisation process has occurred within the first year of life13 with the
process finishing by approximately age 6 with low rates of refractive error in most populations by this
age.12 At this point the persistence of refractive error is likely due to a failure in the emmetropisation
process, a large initial refractive error at birth which failed to sufficiently emmetropise or a
combination of both. Given the significant number people requiring refractive error correction by
adulthood other processes appear to be involved in the development of refractive error.

Figure 2.2: Comparison of a normal distribution of spherical equivalent (dashed line) to the
distribution of spherical equivalent observed in adults participating in the Gutenberg Health
Survey14
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2.3 Myopia
Myopia occurs when there is an imbalance between the refracting surfaces of the eye (the cornea
and the crystalline lens) and the axial length of the eye that results in light focusing before it reaches
the retina. Although any component of the optical system of the eye can be responsible for myopia,
increased axial length is by far the most common cause of myopia.15–17 Average values of axial length
are considered to be approximately 23.5 mm with men usually having a slightly larger axial length
than women.17 High myopia is usually associated with axial lengths greater than 26 mm with axial
length rising to above 30 mm in cases of very high myopia.16
The aetiology of myopia and increasing axial length is complex and not fully understood. There are
several mechanisms suggested with both environmental and genetic causes proposed. There is
significant debate over the degree to which recognised environmental and genetic risk factors
contribute to myopia development although most authors agree both contribute to some extent.18,19
The following sections describe the current thinking in the mechanics of how myopia develops and
the risk factors for myopia.

2.3.1 Scleral Remodelling
The exact biological mechanism by which the axial length of the eye increases in myopia is not fully
described. The increase in axial length is usually as a result of a lengthening of the vitreous chamber
during myopia development (Figure 2.3).20 In myopia this change in vitreous chamber size usually
results in a prolate ocular shape with the change in vitreous chamber occurring primarily through
elongation along the visual axis.21 This is supported by animal studies which also demonstrate
prolate shapes in myopic chick eyes.21 Changes in the biomechanical structure of the sclera is the
prevailing theory as to how axial length elongation occurs.22 There is evidence that the sclera is less
31

rigid in myopic eyes than emmetropic or hyperopic eyes with the sclera being least rigid in the most
myopic eyes.23 The sclera has also been observed to be thinner in myopic eyes24,25 with the greatest
degree of thinning happening in the most myopic eyes. This thinning appears to occur as a result of
the thinning of collagen fibre bundles and reduced collagen fibre diameters.22 There is also evidence
from animal studies that demonstrate scleral glycosaminoglycan synthesis is reduced when myopia
is developing.26

Figure 2.3: Lengthening of the vitreous chamber is the primary cause of myopia development.
Higher levels of myopia usually have greater vitreous elongation. Adapted from Baird et al. 27

Although there appears to be strong evidence that the observed changes in the scleral structure are
responsible for the increase in axial length observed in myopia, several authors22,28 have emphasised
that this evidence is primarily based on eyes that have been examined after enucleation which has
occurred in many cases after the death of the patient. This is likely to have been some time after
myopia developed and the changes in scleral structure may actually be in response to the increased
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axial length associated with myopia as opposed to having been responsible for the increased axial
length.22,28
The exact method by which the sclera is stimulated to grow and cause increased axial length in
myopia is poorly understood. Flitcroft explored the most likely causes of eye growth in a detailed
summary of the current research.29 There is evidence in both animal and human studies that the
retina plays a role in controlling eye growth. Flitcroft suggests the more myopic and skewed
distribution of refractive error apparent in those with a retinal dystrophy may be evidence of a
failure in the process of emmetropisation due to the retina’s dysfunction in controlling eye growth.29
There is also evidence that peripheral retinal defocus may be a key instigator of myopic eye growth
with several studies in both animals30,31 and humans32–34 finding off-axis hyperopia may signal for an
increase in eye growth (Figure 2.4). Interestingly, this seems to be a local effect with several animal
studies that used a lens or diffuser to affect only half the visual field demonstrating increased scleral
growth only in the affected part of the eye.35,36 The pathway by which the retina signals for increased
scleral growth is also not fully understood although retinoic acid and dopamine may play a role.29

Figure 2.4: Representation of hyperopic and myopic defocus in an eye. In a myopic eye, the relative
peripheral hyperopic defocus causes peripheral light to focus behind the retina is thought to drive
axial elongation. Reproduced from https://www.cvs.rochester.edu/yoonlab/research/mpc.html
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2.3.2 Education & Near Work
There appears to be a significant link between education and myopia. Studies have found evidence
for education as a risk factor for myopia development in populations of both adults and children.
Mirshahi et al37 found a significant effect of number of years spent in education and the risk of
becoming myopic in a German adult population. The authors observed a prevalence of myopia of
60.3% in those that had completed at least 13 years of education in comparison to a prevalence of
26.9% in those that had never finished secondary education. This study had a significant strength in
that they were able to control for 45 myopia-associated single nucleotide polymorphisms. They
observed weak genetic effects in the likelihood of myopia development however these were much
smaller than the effect of education.
Williams et al also observed significantly higher prevalence of myopia in those with higher education
in an adult European population.38 Myopia prevalence was 36.6% in those completing higher
education compared to 25.4% in those completing primary education only. As the authors were
comparing participants from different countries with different educational systems, a simplification
in the definition of primary (leaving education before 16 years of age), secondary (leaving education
up to 19 years of age) and higher education was necessary (leaving education at or after 20 years of
age). As the participants were from different generations, this simplification may overlook some
variance in education attainment. The authors also used a lower definition for myopia (≤ -0.75 D SE)
then the more common definition (≤ -0.50 D SE) used by Mirshahi et al.37 Regardless of the
differences between these two studies, both show strong evidence for a higher prevalence of
myopia in adults that have spent more years in education.
Studies in children have also observed links between education and myopia development. Saw et
al39 observed higher levels of academic performance in Asian children with myopia a finding that was
also observed in a cohort of predominately Caucasian children.40 Establishing that education
specifically is the primary driver of myopia development is difficult due to the number of possible
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confounding causes of myopia development. Most education systems involve time spent indoors
with periods of near work (Figure 2.5), both of which have been identified as risk factors for myopia
development.41,42

Figure 2.5: A typical educational environment involves time spent indoors with periods of near
work. Reproduced from https://www.irishtimes.com/news/education/middle-class-childrenoutperform-others-before-starting-school-1.3512956

The effect of near work on myopia in children is unclear with conflicting results observed. Myopic
children have been observed to spend more time on near work activities in both Asian and
Caucasian populations,43,44 however other studies have found that varying amounts of time spent on
near work had no association with myopia prevalence in some populations of children.45 Some
authors have also examined the effect of near work on the development of myopia. Hepsen et al46
studied both refractive and biometric changes in two groups of Turkish male students under
different educational systems. Children engaged in more near work and study were observed to
have more myopic progression and an increase in axial length over a three-year period. Saw et al47
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observed no association between time spent on near work and myopic progression in group of
myopic children. A recent meta-analysis on the effect of near work on myopia found that more
hours of near work might increase myopia prevalence although “more longitudinal and randomized
controlled trials should be performed to confirm whether near work is a risk factor for the
development of myopia”.41 Developing such a trial would however present significant challenges,
not the least of which would be the ethical issues raised by preventing children doing near work.
The conflicting results obtained when assessing the impact of near work on myopia may lead to the
conclusion that near work itself is not a risk factor for myopia development and progression but
rather the type and intensity of near work with some suggestion that prolonged periods studying
small text can drive myopia development.48 Morgan and Rose identified the use of after school
tutorials in many East Asian countries as possibly being related to the very high levels of myopia
found in older adolescents in those countries.49 The authors observed that in many East Asian
countries there is significant emphasis placed on educational performance with some children taking
part in after school tutorials while in primary school. There is less use of after school tutorials in
countries with a lower prevalence of myopia49 where children may spend more time outdoors.50 The
conclusion of Morgan and Rose are somewhat supported by evidence from Israel. Male UltraOrthodox Jewish communities have been observed to have very high levels of myopia, similar to
those found in East Asian young adults.48,51,52 Male students from these communities can spend up
to 16 hours per day reading and discussing religious texts48 which may explain the higher level of
myopia even when compared to female students from the same community.48,51 These findings are
supported by evidence from studies of immigrant communities. These studies have found children
from countries with typically low prevalence of myopia that have emigrated to countries with higher
prevalence are more likely to become myopic, particularly if they emigrated at a younger age and
were thus exposed to a different educational environment from a younger age.53
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Despite the evidence supporting education as a risk factor for developing myopia, it is not possible
to conclusively determine what environmental aspect of education is resulting in a higher prevalence
of myopia due to the difficulty in controlling for confounders. Some areas with very high myopia
prevalence have introduced modifications to the school day in an effort to reduce the risk of
developing myopia with most increasing mandatory time spent outdoors for school children.54,55

2.3.3 Time Spent Outdoors
Over the last decade, there has been significant research on the protective role time spent outdoors
may have with regards to the development or progression of myopia.56,57 A meta-analysis observed a
small but significant protective effect of increasing time spent outdoors in developing myopia.56 The
authors found a 2% reduction in odds of myopia for each additional hour spent outdoors per week.
There is also good evidence from three RCT studies in both Taiwan58 and China59,60 that increasing
time spent outdoors reduces the risk of developing myopia. All three studies used a similar design
with children some schools assigned provided with additional time spent outdoors while those in the
control arm of the study continued with the normal school day. In all cases incident myopia was
reduced in the intervention schools with the reduction ranging from 4.8%59 to 9.2%.58 A recent large
scale cohort study from Taiwan supports these findings.54 The authors reported a 2.34% annual
reduction in prevalence of presumed myopia among school children following a government
initiative to encourage 2 hours of outdoor activity per day. There are some limitations with this
finding as reduced visual acuity (VA) was measured as a surrogate for refractive error with the
authors assuming a child with reduced VA suffered with myopia. The authors were also not able to
ensure the protocol was followed precisely in each school or control for other risk factors such as
parental myopia. Nevertheless, in a country with such high levels of myopia,9 this simple
intervention has shown promising results.
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The protective effect time spent outdoors has on myopia progression for those already myopic is
less clear. Two Taiwanese studies found conflicting results with a 2013 study finding no difference in
myopia progression between school children encouraged to spend recess outdoors and those
allowed to have recess in the classroom.58 A 2018 study by the same authors did observe a
difference in myopia progression between students spending time outdoors and those spending less
time outdoors (0.57 D vs 0.79D) over the course of a year.55 The authors point to the students
assessed being younger in the later study and concerns about compliance in the initial study as a
possible explanation for the discrepancy in the results. Two studies from China also observed lower
rates of myopia progression (0.17 D reduction after 1 year60 and 0.17 D reduction after 3 years59) in
children encouraged to participate in more outdoor activities. A meta-analysis including some of the
above studies observed no significant protective effect of increasing time spent outdoors on myopia
progression.61 As the overall level of reduction of myopia progression is less than would be typically
achieved using other myopia control strategies such as atropine or orthokeratology contact lenses,
increased time outdoors is recommended as an adjunct therapy for those already myopic.55,62–64
The exact mechanism by which increased time outdoors may be protective against both developing
myopia and progressing myopia is poorly understood and requires further research. There are
numerous theories proposed with varying degrees of evidence to support each (Figure 2.6). An initial
theory proposed that physical activity was protective against the development and progression of
myopia.42,65 These studies did not adequately differentiate between physical activity that took place
either outdoors or indoors and hence did not control for time spent outdoors. Rose et al45 found
outdoor activity was similarly related to reduced development of myopia but observed no
relationship between indoor sport participation and lower prevalence of myopia. These findings are
supported by a recent longitudinal study which found no association between physical activity and
myopia.66
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Figure 2.6: Spending more time outdoors may reduce risk of myopia via multiple means including
less hyperopic defocus, bright luminance and different chromatic composition of the light.
Reproduced from Lingham et al.67

A simple explanation by which time outdoors could be protective against myopia development is
that children that spend more time outdoors are spending less time partaking in activities that are
thought to be myopiagenic such as near work.41 This does not seem to be case as it has been found
that time spent outdoors and time spent reading in children are not correlated.42,45 This lack of
correlation with near work only extends to reading and it is unknown if it also extends to near work
using electronic devices however a recent meta-analysis of the limited data available found no
association between screen use and myopia.68 It should be noted this lack of correlation is from
countries that do not typically have the intensive educational practices that have been observed in
countries with very high levels of childhood myopia.49 It may not be the case that time spent on near
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work and time spent outdoors are not correlated in countries with these type of educational
practices.
Serum vitamin D levels have also been suggested to be related to myopia and a possible mechanism
by which increased time outdoors may reduce the risk of myopia development.69,70 It is theorised the
relationship between myopia and vitamin D occurs in one of two ways. Vitamin D is either directly
protective against myopia development, which can explain the protective nature of time spent
outdoors due to the increase in vitamin D production, or increased vitamin D is merely present due
to spending more time outdoors and is not related to myopia development or progression.71 A
recent meta-analysis confirmed the finding that reduced serum vitamin D levels were associated
with an increased risk of being myopic.72 The authors controlled for time spent outdoors and still
found an increased risk of myopia with lower serum vitamin D levels however they expressed
concern that time spent outdoors was self-reported by the subjects which led the authors to have
less confidence in the result. They felt lower serum vitamin D was in reality just a bio-marker for less
time spent outdoors and not actually responsible for the development of myopia. The conclusion
that low serum vitamin D is a bio-marker for less time spent outdoors rather than pathognomonic
for myopia is supported by a recent study assessing the relationship between genetic variants known
to affect vitamin D serum concentration and refractive error.73
In an outdoor environment, there is typically less dioptric variation as most objects are at a distance
which results in relatively uniform dioptric values.29 Figure 2.7 demonstrates the dioptric variation
that can occur with both indoor and outdoor environments. As a result of the reduced dioptric
variation, there is minimal peripheral retinal defocus which has been found to be a driver for myopia
development.32–34 This is one possible explanation as to why increased time outdoors can result in
lower prevalence of myopia without any significant evidence to the contrary.
Higher levels of illuminance have also been suggested as a possible explanation as to the protective
effect time spent outdoors has on developing myopia. The level of illuminance outside can be orders
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of magnitude higher than those found indoors. It has been found that longer periods in higher levels
of illuminance can be protective against developing myopia.55,74 The type of light exposure may also
play role in myopia development. Several animal studies have observed increased levels of myopia in
animals exposed to red light when compared to controls exposed to white light.75,76 Increased levels
of hyperopia were observed in animals exposed to blue/violet light indicating this type of light may
be protective against myopia development.75,76 It should be noted there are conflicting results in this
area with some animal species finding the opposite effect of increasing myopia with blue light
exposure.77 Adjusting the lighting to be of a higher illuminance and more towards the blue end of
the spectrum may be an alternative in schools that have difficulty increasing the number of hours
spent outdoors for their students. This however is a less desirable strategy than spending time
outdoors for several reasons. The added public health benefit of increased activity outdoors for
children cannot be understated given concerns over increasing levels of childhood obesity and
diabetes in some countries.78 There is also a risk that increased use of blue blocking lenses in
spectacles and contact lenses could render this benefit minimal in those children already using a
refractive error correction.79
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Figure 2.7: Dioptric error maps taking into account of the accommodation response and the point
of fixation for both an indoor and outdoor scene showing greater hyperopic defocus for the indoor
scene. Reproduced from Flitcroft.29

2.3.4 Parental Myopia
The risk of a child developing myopia when one or both parents is myopic is not fully understood. A
recent meta-analysis of the risk of developing myopia in the presence of parental myopia observed
varying odds ratios depending on the underlying study design.80 Taking the results at their most
conservative, the authors observed odds of developing myopia of 1.44 when one parent is myopic
and 1.85 when both parents are myopic. The majority of studies used in this meta-analysis
demonstrated increased odds of myopia with either one or both parents being myopic. It should be
noted there was a wide range of results with higher odds typically found in studies with worse
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design and lower statistical power such as the case control design used by Konstantopoulos,
Yadegarfar and Elgohary.81
All studies of the risk of myopia associated with parental myopia are subject to a significant
confounder in that children share their environment with their parents. This makes it difficult to
establish if the true risk factor is having parents with myopia or living in an environment that may
induce myopia. It has been established that education is a risk factor for myopia.37,38 In the field of
family psychology, a significant link has been observed between the level of education of parents
and their expectation of academic achievement in their children.82 This results in parents making
changes to the home environment in an effort to support their children’s academic achievement.82
This may include the increased use of after school tuition which was noted to be used to a much
greater extent in countries with very high levels of myopia49 or encouragement of more time spent
on near work.83 It has been observed in one study of the risks associated with myopia development
that parents did not influence the near work environment of their children40 however this was based
on self-reported time spent on near work which has only been found to have fair reliablity.84
Comparing studies with findings on the effect of parental myopia is difficult for several reasons
which mainly relate to the design of each study. Some studies determine parental myopia using
refraction85,86 while others ask parents to self-identify as myopic through the use of a
questionnaire83,87–92 with an obvious potential risk of misclassification by using a questionnaire. Xiang
et al90 investigated this misclassification risk by performing refraction on a subgroup of parents after
they had completed their questionnaire. They found a sensitivity of 0.83 and specificity of 0.79
which they determined was sufficient to deem the questionnaire results accurate. The most
common misclassification error was that myopic parents did not realise that they were myopic.
Many studies use a varying definition of myopia and most do not identify the degree of parental
myopia but merely whether a parent is myopic. The variable definitions of myopia used make direct
comparison between studies difficult. Using threshold values of myopia closer to emmetropia can
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induce a classification error,93 particularly when there is uncertainty about the measure of refractive
error as there is in the case of self-reporting of myopia status. Simply identifying parents in a binary
fashion as myopic or non-myopic leads to a lack of nuance when describing the results in many of
these studies and leads to further questions. Do highly myopic parents have highly myopic children?
In families with both parents being myopic, if one is highly myopic does this increase the odds of
myopia in children compared to families with both parents having low myopia? Is there a greater
effect of paternal or maternal myopia? A recent study85 assessed the refractive status of both
parents and their children to determine the risk of myopia based on the level of parental myopia.
They identified that the risk of myopia was dose dependent with children of parents with higher
myopia more likely to be myopic. When both parents had high myopia, this led to the highest risk of
developing myopia. If either parent had low to moderate myopia, this reduced the risk of developing
myopia when compared to children with both parents having high myopia. When the authors
controlled for possible confounders such as near work and time spent outdoors, it was found the
odds of myopia development reduced for children whose parents had low to moderate myopia but
increased for children whose parents were highly myopic. The authors suggest this may indicate that
high myopia has greater degree of heritability while low to moderate myopia may be more
influenced by environmental conditions.
The age of the children assessed is also significant. An individual’s highest absolute level of myopia
has typically been reached by the late teenage years or in early adulthood.94 Many studies of
parental myopia assess children of relatively young age87,90,92 before the maximal level of myopia will
have been reached. This may induce a misclassification error as some non-myopic children may
become myopic in the ensuing years. This may cause a misclassification error in two opposing ways.
Firstly, if the children of myopic parents have not yet become myopic when the study is conducted
this will have the effect of reducing the apparent effect of parental myopia. Secondly, if the children
of non-myopic parents develop myopia after the study has been conducted this will have the effect
of increasing the apparent effect of parental myopia. There is some evidence for the former as
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French et al88 assessed risk factors for myopia in both younger and older children. They observed
parental myopia was significant in the younger age group but was not significant in the older age
group. This may imply that some of the younger participants would have become myopic later and
thereby reduce the apparent effect of parental myopia or it may point to increased hereditary in
younger onset myopia and increased environmental effect in older onset myopia.
The study location can also contribute to some uncertainty with regards to results. Studies carried
out in locations with very high myopia prevalence among both parents and children may find a
relationship merely because such a high number of individuals are myopic. Several studies carried
out in East Asia have observed a significant effect of parental myopia on the risk of developing
myopia in children however relatively few children in some of these studies had no myopic
parents86,87 with one study having as few as 20% of included children with no myopic parents.92

2.3.5 Genetic Studies of Myopia
It has been recognised for a long time that myopia is to some extent a heritable condition.95 Twin
studies have been used to estimate the relative contribution of both genetics and the environment
to myopia development. This usually involves comparing monozygotic (identical) twins to dizygotic
(fraternal) twins. If a condition is entirely genetic monozygotic twins would have a correlation of 1.0
as they have identical genetics while dizygotic twins would have a correlation of 0.5 as they share
half their genetics. If the environment shared by the twins were the only source for the condition
then both sets of twins would have a correlation 1.0.96 In reality most complex conditions such as
myopia are a combination of both genetics and the environment. Twin studies have estimated the
heritability of myopia as being from approximately 60% up to as high as 98%.95,97–99 These findings
are somewhat supported by findings that axial length and corneal curvature are also heritable with
twin studies showing heritability of both being approximately 60-90%.100–102
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As a result of increased computing power and reduced costs for genotyping, the number of genetic
studies of myopia has grown significantly over the last decade.103 Prior to 2009, no genes had been
identified for non-syndromic myopia. Within 10 years over 200 gene loci had been identified as a
result of increased use of genome-wide association studies (GWAS).103–105 Despite this work, the
largest such study can only explain 7.8% of the heritability of myopia.103 This heritability gap is a
common feature of GWAS106 and may reduce with larger sample studies although not being able to
account for gene-environment effects or rare gene variants may always be a limitation preventing
full mapping of the heritability of myopia.103,106
Some effort has been made to determine the interaction between genetic risk of myopia and
environment. Verhoeven et al107 determined the genetic risk of 2 large cohorts of Europeans for
myopia based on the findings of the Consortium on Refractive Error and Myopia (CREAM).104 They
also assessed the educational level and refractive error of the participants and found a significant
synergistic effect between high genetic risk of myopia and high educational attainment. The odds
ratio (OR) for myopia was higher with both high genetic risk (OR: 7.2) and higher educational
attainment (OR: 6.1) but was substantially higher when a participant had both high genetic risk and
higher educational attainment (OR: 51.3) implying the environment associated with higher
educational attainment may up-regulate genes conveying a risk of myopia.

2.4 Hyperopia
In many respects hyperopia is a refractive error which is opposite to myopia. Hyperopia occurs when
light focuses behind the retina (Figure 2.1). Much like myopia this occurs as a result of an imbalance
between the refracting surfaces of the eye and the axial length. In hyperopia the failure to focus light
at the retina occurs due to having too short an axial length,108 refracting surfaces with flatter radii of
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curvature108,109 or a combination of both. It is has been observed that having too short an axial
length is the most common cause of hyperopia.108,109
When compared to myopia there is significantly less research carried out in the field of hyperopia.
There are several likely reasons for this lack of research. Firstly, myopia is easier to detect without
the use of cycloplegia, even if imperfectly, particularly in children.110 This occurs due to the masking
of hyperopia by the accommodative system which results in less obvious symptoms. Having less
obvious symptoms can also result in the perception that hyperopia has less impact on some aspects
of life such as childhood learning which may also explain the lack of research. The impact of
uncorrected myopia on childhood learning has been established as significant111 however the effect
of hyperopia is less clear although some research indicates it also has a significant effect.112,113
Another reason for the greater volume of research in myopia is likely due to the significant increases
in myopia prevalence3 and associated pathology114 over the last number years which have given
researchers more impetus to understand and manage myopia and its associated complications.
Refractive error is approximately normally distributed at birth12 although the distribution is not
centred at 0 dioptres (D) spherical equivalent refraction (SER) but centred at a low hyperopic
refraction which has been found to be in the range of approximately +2 to +4 D SER (Figure
2.8).13,115–118 The level of hyperopia present at birth appears to be related to birth weight or weeks of
gestation with lower levels of hyperopia observed in those children born at earlier weeks of
gestation and with lower birth weights.117,119 Several studies13,116,118 on new-borns have
demonstrated that hyperopia reduces through the process of emmetropisation with a low
prevalence of significant hyperopia by age 6 (Figure 2.9).12 Flitcroft describes the persistence of
hyperopia beyond this stage as a failure of the process of emmetropisation, an initial refractive error
at birth too great to sufficiently emmetropise or a combination of both.12
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Figure 2.8: An approximately normal distribution of refractive error centred at +2.00 D SER in 3month-old babies. This is the typical distribution of refractive error found in young children.
Reproduced from Flitcroft.12

Figure 2.9: As children age the distribution of refractive error becomes more leptokurtotic and less
hyperopic. This is seen by the high peak of the distribution and reducing frequency of hyperopia in
children by 3 years of age. Reproduced from Flitcroft.12

Unlike myopia, there have been no environmental risk factors identified which seem to increase the
risk of hyperopia development. Age has however been associated with increasing hyperopia.120–122
Longitudinal studies have observed mean refractive errors increasing in the hyperopic direction in
populations aged approximately 50 to 70 years old with the trend reversing in those older than
70.120,121 There are several mechanisms proposed by which eyes become more relatively hyperopic
with age. The loss of accommodation with age and hence the manifestation of latent hyperopia is
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often considered to be the primary cause of hyperopia due to aging amongst clinicians however
Hashemi et al122 demonstrated that there was very little difference between the longitudinal change
of manifest and cycloplegic refractions of their study participants. This indicates the loss of
accommodation is unlikely to be the main driver of increasing hyperopia with age. It is also
suggested that changes in the parameters of the crystalline lens are responsible for increasing
hyperopia with age.122 Given most hyperopia occurs due to a reduced axial length, it may be
anticipated that axial length might reduce with age and be the cause for increasing hyperopia.
Gudmundsdottir et al121 did observe a reduced axial length in older cohorts but no longitudinal data
on axial length was available so this finding may have been a cohort effect and not truly the cause of
the increasing hyperopia. Given the significant increases in myopia prevalence in recent decades, it
also needs to be acknowledged that the apparent increase in hyperopia with age may just be a
cohort affect and what is being observed is merely generational differences in refractive error
prevalence. This is an area that requires further research to truly establish the if there is a
mechanism which drives an age-related change in refractive error or if this is merely a cohort effect.

2.5 Astigmatism
Astigmatism is a refractive error caused by a variation in the refractive power of the eye along
different meridians. This variation can occur due to a difference in the curvature of the anterior
cornea, posterior cornea, anterior crystalline lens or posterior crystalline lens (Figure 2.10).
Astigmatism can also occur as a result of the decentration or tilting of the crystalline lens or a
combination of any of these factors.123 Astigmatism is usually considered as with-the-rule (WTR),
having the strongest power orientated approximately vertically or as against-the-rule (ATR), having
the strongest power orientated approximately horizontally.123 Astigmatism that with the strongest
power orientated neither vertically or horizontally is referred to as oblique (Figure 2.11).
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Figure 2.10: Astigmatism occurs when two principal points of focus occur due to a difference in the
curvature of the anterior cornea, posterior cornea, anterior crystalline lens or posterior crystalline
lens. Reproduced from www.mayoclinic.org.

Figure 2.11: Corneal topography illustrating with the rule astigmatism (image 1), against the rule
astigmatism (image 2) and oblique astigmatism (image 3). Reproduced from
www.optometricmanagement.com/issues/2009/february-2009/perfect-the-football-fit

At birth, higher levels of astigmatism have been found with mean values of approximately 6 DC124
which would be considered very high in an adult population.125 These high values of astigmatism are
related to the very steep corneas present in infants.124 As the cornea flattens in the first 6 to 12
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months of life a form of emmetropisation takes place that results in a significant reduction in the
level of astigmatism present in most infants.124,126
Astigmatism also changes with increasing age.125 Low levels of astigmatism are quite common in
young adult populations.123,125 In later life there is an increase in astigmatism that also changes from
the WTR type more commonly found in younger populations to ATR.125 This change in orientation of
astigmatism is thought to be due to increased lid laxity. It is theorised the lids may be one of the
causative factors for astigmatism with the pressure exerted by the lids on the cornea influencing
both the orientation127 and severity of the astigmatism.128 As the lids become less tight with age, this
results in decreasing WTR astigmatism and increasing ATR astigmatism.125
There is some suggestion that the magnitude129 and type130,131 of astigmatism is associated with
higher spherical refractive error although there are conflicting results with some studies observing
no association.132 Conflicting results have also been found with regards to the genetics of
astigmatism. Twin studies of astigmatism have reported results with evidence both for97 and
against133 a genetic component to astigmatism.
There is still a significant degree of uncertainty surrounding the potential causes of astigmatism with
both environmental and genetic causes implicated.123 There has been significantly less research
carried out in the area of astigmatism when compared to myopia and further studies will be
required to ascertain the mechanism behind astigmatism development and any potential modifiable
risk factors.

2.6 Presbyopia
Presbyopia is a universal condition which will affect all people living to an older age. Despite the
universality of this condition, there is a lack of agreement on the definition of presbyopia which may
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be due to an incomplete understanding of the aetiology of presbyopia. Wolffshon and Davies134
address this point in a recent review of presbyopia and propose the following definition:
“presbyopia occurs when the physiologically normal age-related reduction in the eyes focusing range
reaches a point, when optimally corrected for distance vision, that the clarity of vision at near is
insufficient to satisfy an individual’s requirements”
In a young eye the process of accommodation allows a dynamic range of focussing power which
enables a seamless adjustment from distance to near viewing. Although there is some debate over
the exact mechanism of accommodation,135 the Helmholtz theory is the most widely supported.134
This theory describes accommodation occurring as a result of ciliary body muscle contraction which
leads to relaxation of the zonules and the decrease in the radius of curvature of both the anterior
and posterior surface of the crystalline lens.136 The most commonly accepted physiological cause for
presbyopia is an increase in the rigidity of the crystalline lens resulting in a reduction of
accommodation (Figure 2.12).137,138
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Figure 2.12: Presbyopia is thought to occur due to increased rigidity of the crystalline lens causing
a reduction of accommodation. This reduction in accommodation results in the inability to focus
the image of a near object on the retina. Reproduced from https://www.newsmedical.net/health/Presbyopia-Age-Related-Farsightedness.aspx

Presbyopia is typically considered to commence at approximately age 40 although there is significant
variation between individuals139,140 and taken from a purely mechanistic standpoint, there is
evidence of reduced accommodation after the first decade of life.141 The variation in age of onset of
presbyopia has been attributed to several causes. Distance refractive error has been observed to
affect accommodation with myopes found to have higher accommodation which can delay the onset
of presbyopia.142,143 Some natural variation in accommodative ability between individuals may result
in the symptoms of presbyopia manifesting earlier in some individuals.144 Climate and geographic
location have also been implicated in developing presbyopia symptoms at a younger age with higher
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ambient temperature and locations closer to the equator both implicated in an earlier onset of
symptoms.139,145 Female sex has also been identified as resulting in the onset of symptoms at an
earlier age.146,147 It has been suggested this may be as a result of women typically having shorter
arms and therefore a closer near point of focus which requires a higher accommodative ability.146
Ethnicity has also been investigated with Caucasians typically found to experience presbyopia
symptoms at an older age.148–150
It should be noted that there is significant interplay between all of these risk factors for earlier onset
of presbyopia symptoms and it has been argued that there is an inherent risk of bias in most of these
studies due to confounding factors.149 One significant confounder in many of these risk factor is the
presence of myopia. The presence of myopia can negate the symptoms of presbyopia as many
myopic individuals have good near vision despite their age-related loss of accommodation. As
previously established education is strongly associated with myopia.37,38 Historically, high levels of
education have typically been found in males in Western countries. These are countries which are
not close to the equator and are largely Caucasian in ethnicity. This may imply that geographic
location, ambient temperature, ethnicity and female sex are in reality surrogates for lower
educational attainment and a corresponding lower level of myopia prevalence. Regardless of the
exact age at which the symptoms of presbyopia become manifest, this is a universal condition in
older eyes.134

2.7 Summary
Refractive error is a normal state for the eye after birth. By age 6 the process of emmetropisation
should result in the majority of children having minimal refractive error. The development of
refractive error beyond this age is usually in the myopic direction. Much research has been carried
out into the cause of myopia development with both environmental and genetic risk factors
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identified. Education involving long periods indoors and intensive study would appear to be the one
of the primary drivers of myopia development. Hyperopia after the age of 6 in children seems to be
a failure of the process of emmetropisation. High levels of astigmatism are also found at birth with a
similar reduction in the early years of life as is observed with hyperopia. Relatively little research has
been carried out on the development of hyperopia and astigmatism beyond young childhood
although both appear to be affected by aging. Presbyopia is a universal condition in older life
although earlier development of symptoms may be influenced by several factors such as sex,
ethnicity and climate.
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3 Prevalence of Refractive Error
3.1 Introduction
Establishing the prevalence of refractive error is crucial to ensure adequate public health planning
can take place. This information is required to facilitate adequate correction of refractive error and
plan for possible additional care needed due to the complications of refractive error. There is also a
need to predict the likely changes in refractive error prevalence and put in place appropriate plans
to prevent or mitigate against any consequences due to population level changes in refractive error
distribution. This chapter explores some of the difficulties in determining refractive error prevalence
and the current estimates of refractive error prevalence.

3.2 Interpreting Refractive Error Prevalence Studies
Several difficulties exist when comparing and contrasting published epidemiological studies of
refractive error. There is a significant lack of consistency in the reporting of results with variety in the
definition of refractive error, the use of cycloplegia and the method of refraction. The lack of
consistency with regards to defining the refractive error of interest is one of the most considerable
barriers to making comparisons. Most studies of refractive error define the refractive error based on
the SER with common definitions of myopia being ≤ -0.25 D,151 ≤ -0.50 D,152,153 < -0.50 D,14,120 ≤ -0.75
D,154,155 < -0.75 D,156,157 ≤ -1.00 D158,159 and < -1.00 D.156,160 There is even less consistency in hyperopia
with definitions ranging from ≥ +0.50 D152 to > +3.00 D.158 As refractive error is usually found to have
a leptokurtotic distribution centred at approximately zero refractive error, changing the definition of
a refractive error can have a significant impact on the reported prevalence. This problem is
described by the example in Figure 4.1 which represents the distribution of refractive error taken
from a large EMR database. The figure demonstrates the typical leptokurtotic distribution of
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refractive error in a population. The dashed lines represent two possible definitions for myopia; ≤ 0.50 D (dashed red line) and ≤ -1.00 D (dashed blue line). The crude prevalence of myopia changes in
this dataset from 33.9% using a definition of ≤ -0.50 D to 26.4% using a definition of ≤ -1.00 D. Apart
from making epidemiological studies of refractive error difficult to compare, varying the definitions
of myopia and hyperopia can alter the apparent effect of associated risk factors.60,161

Figure 3.1: The effect of changing the refractive error definition. In this distribution of spherical
equivalent refraction (SER) the crude prevalence of myopia changes from 33.9% using a definition
of ≤ -0.50 D (dashed red line) to 26.4% using a definition of ≤ -1.00 D (dashed blue line)

The problem of establishing a consistent definition is even more difficult to overcome with
astigmatism as this refractive error contains two components; the cylindrical power and axis. The
definitions for power usually vary from ≤ -0.50 cylindrical dioptres (DC) to ≤ -1.00 DC14,154,158 with the
axis type usually described as being WTR, ATR or oblique if described at all.125,162 The difficulty in
defining presbyopia is explored by Wolffsohn and Davies in their comprehensive review of the
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condition.134 Having a definition purely focussed on near vision impairment would include many
young individuals however presbyopia is an inherently age related condition. Some authors have
used an objective definition of requiring an optical correction of ≥ +1.00 D added to the distance
correction to achieve near vision of N8 however this does not account for low myopes that can read
N8 with no correction in place but still suffer from the loss of accommodation that causes
presbyopia.163 It should be noted however that both in terms of effect on the individual and at a
population level, having difficulty seeing at near distances is the most significant issue whether this
has been caused by presbyopia in an older person or hyperopia in young person.
Some of these issues have been recognised within the research community with a recent consensus
paper from the International Myopia Institute (IMI) attempting to resolve the definition of myopia.93
The authors suggest a definition of ≤ -0.50 D SER as this is the most widely used definition of myopia
in published literature. The authors acknowledge this threshold is not without limitations and
suggest a higher threshold may be more appropriate for intervention trials to avoid false positive
and false negative associations. They also suggest a higher threshold may be appropriate if there is a
risk of misclassification as may be the case if cycloplegia is not used in younger individuals.
Cycloplegia involves the use of drugs such as tropicamide or cyclopentolate to paralyse the
accommodative system. An active accommodation system can significantly affect the results of
refraction, particularly in children. Both myopic and hyperopic children’s refractions have been
found to be more hyperopic when using cycloplegia with the magnitude of effect more pronounced
for higher levels of hyperopia and at younger ages.164 Most significantly, there is a real risk of
misclassifying children as myopic when performing non-cycloplegic refraction as it has been found
that up to 34% of children found to be myopic when assessed with non-cycloplegic auto-refraction
are found to be emmetropic or hyperopic following cycloplegia.164 Consensus has not yet been
reached on the need for cycloplegia in adults.165–167 The difference between non-cycloplegic and
cycloplegic refractions appears to diminish with age.166 Some authors have found a difference in
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young adults that could result in a misclassification error166,167 while others have not.165 This
difference has not been found in older adults that have started to experience the effects of
presbyopia so cycloplegia is not necessary in this group166 however the exact age between young
adulthood and commencement of presbyopia at which cycloplegia is no longer necessary has not
been established.
The pharmaceutical agent used to obtain a cycloplegic effect recommended by the IMI is 2 drops of
1% tropicamide separated by 5 minutes with the refraction measurement taking place 30 minutes
after the first drop is instilled. This recommendation is consistent with the published findings
comparing pharmaceutical agents for cycloplegia. A recent meta-analysis found no statistically
significant different in the results of cycloplegic refraction using either 1% tropicamide or 1%
cyclopentolate.168 The authors did observe a statistically significant difference for young children and
in hyperopes with more hyperopic refractions found in the presence of 1% cyclopentolate however
despite reaching statistical significance, the differences were still minimal (0.25 D, CI: 0.10 D, 0.40 D)
and unlikely to cause a misclassification error. As 1% tropicamide reaches its maximal effect in a
quicker time and causes less side effects, this is the most commonly used and recommended agent
for studies of refractive error.169
The method by which the refraction has been determined also needs to be considered when
comparing epidemiological studies of refractive error. Refraction techniques for most studies use
either an objective or subjective technique. Objective techniques primarily involve the use of
autorefraction while subjective techniques comprise either a full subjective refraction or
retinoscopy. The IMI recommends the use of objective techniques in myopia control studies as they
are more repeatable and subject to less practitioner bias than subjective techniques.169 They also
recommend the use of an open-field autorefractor (Figure 3.2) to reduce the likelihood of
instrument accommodation and instrument myopia.169 Although subjective refraction is less
repeatable than objective techniques the intra and inter examiner repeatability is within ± 0.50 D in
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the presence of cycloplegia170 which is approximately 0.25 D worse than the intra and inter examiner
repeatability of autorefraction.171 This difference is significant for studies examining the
effectiveness of a myopia control technique which usually report change of the order of under 1.00
D per year,172 however for an appropriately powered epidemiological study of refractive error this
difference is unlikely to result in a significant level of misclassification.

Figure 3.2: An example of an open-field autorefractor, the device recommended by the
International Myopia Institute (IMI) to determine refractive error in epidemiological and
interventional studies of myopia.169 Reproduced from Bradley et al.173

The changes that occur in refractive error due to age can also make prevalence figures hard to
interpret. In general, most children are born hyperopic becoming less hyperopic over the first
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months and years of life.12 If myopia develops, this usually occurs with increased axial elongation
during the teenage years resulting in the maximal level of myopia being reached by early
adulthood.174 There appears to be a tendency for most people to become increasingly hyperopic
with increasing age122 until later life when an increase in myopia can be observed as a consequence
of the development of nuclear sclerotic cataracts.175 Figure 3.3 demonstrates these changes by
showing the mean refractive error at 5-year age groups for a large EMR database. A significant
caveat when considering these changes with age is the potential for a cohort effect. There are no
longitudinal studies of refractive error over a long period of time that adequately control for a
cohort effect so these perceived changes in refractive error may just be changes occurring due to
population level changes in refractive error prevalence. This is a particular risk when considering
populations that have a significant change in refractive error prevalence over a short period of time
such as several Asian countries.3 Nevertheless, these potential changes in refractive error over the
life course mean that refractive error prevalence studies need to adequately describe the
participants’ age to allow appropriate comparisons. This is particularly the case for children where
significant changes in refractive error can occur in a relatively short period of time.
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Figure 3.3: The mean spherical equivalent refraction (SER) for 5-year age groups in a large (n =
649,486) cross sectional electronic medical records (EMR) database.

3.3 Prevalence of Refractive Error in Adults
3.3.1 Myopia
When comparing epidemiological studies of myopia, there are obvious geographic trends (Figure
3.4). East Asia has been found to have a significantly higher prevalence of myopia than any other
geographic location.3 Many studies of refractive error in this area have observed prevalence rates
over 40%176–178 with some even exceeding 50%179,180 (Table 3.1). The Beijing Eye Study found a
myopia (<-0.50 D SER) prevalence of 22.9% among 3,251 participants aged over 40 years181 with a
prevalence of 2.6% of high myopia (<-6.00 D SER). This study used a combination of non-cycloplegic
auto-refractor and subjective refraction to assess refractive error but did not assess refractive error
in anyone found to have unaided visual acuity of logMAR 0.0 or better which may have led to an
underestimation of myopia prevalence. Much higher rates of myopia have been observed in other
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urbanised parts of East Asia. The Korea National Health and Nutrition Examination Survey
(KNHANES) found a prevalence of myopia (<-0.50 D SER) of 48.1% in 33,355 participants aged 20
years old and older. They assessed refractive error using non-cycloplegic auto-refractor. Similarly
high rates of myopia have been observed in Indonesia,176 Myanmar180 and Japan177 with a recent
study in Japan179 observing a prevalence rate of 50.0% in adults aged 34 – 80. The very high
prevalence of myopia observed in some Asian countries has not been seen in all Asian countries.
Bangladesh,182 India183,184 and Iran185 have all reported lower prevalence rates (Table 3.1).
Unsurprisingly, countries with higher rates of myopia also tend to have higher rates of high myopia
with several East Asian countries having rates in excess of 5%179,180,186 although the use of various
definitions of high myopia make direct comparisons difficult.
The prevalence of myopia is not typically found to be as high outside Asia. After Asia, the highest
prevalence of myopia is usually found in Western countries (Table 3.1). The European Eye
Epidemiology Consortium (E3) has produced the largest estimate of refractive error prevalence in
Europe154. Fifteen different studies on refractive error were combined to produce an agestandardised prevalence of myopia in Europe of 30.6% using a definition of myopia as < -0.50 D SER.
Refractive error was measured without cycloplegia either by auto-refractor or subjective refraction
in all included studies. High myopia was observed in 2.7% of all participants with higher levels in
younger age groups. The UK Biobank has recruited 502,682 participants aged from 40 to 69 years old
to study health and disease159. Refractive error was assessed in 107,452 participants using noncycloplegic auto-refractor making this one of the largest studies of refractive error in Europe. Myopia
(≤ -0.50 D SER) was observed in 33.5% of participants while high myopia (≤ -6.00 D SER) was found in
4.0% of participants. In the United States the National Health and Nutrition Examination Survey
(NHANES) found a prevalence of myopia (≤ -0.50 D SER) of 44.7% in adults over the age of 20 years
old which reduced to 20.5% in adults over the age of 60 years old158 which is similar to the rates
found in European populations. The Blue Mountains Eye Study showed much lower prevalence of
myopia than has been observed in other Western populations187. Refractive error data was collected
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from 3,174 Australians aged from 49 to 97 by either subjective refraction or lensometry. The
prevalence of myopia was found to be 14.4% overall.

Figure 3.4: Current and projected myopia prevalence in adults around the world. Highest rates are
observed in East Asia. Data taken from Holden et al.3 Reproduced from
https://retinatoday.com/articles/2019-sept/myopia-a-global-epidemic

The prevalence of myopia varies across South America reflecting the different backgrounds and
environments of its inhabitants. Myopia (< -0.99 D SER) levels of approximately 7.5% have been
found after non-cycloplegic auto-refraction in 1,261 Venezuelan inhabitants of both rural and urban
backgrounds188. Lower levels of myopia (≤ -0.50 D SER) of 4.7% and 5.5% were observed in two
communities in Ecuador189. The lower rates of myopia found in Ecuador may be as the result of using
cycloplegic retinoscopy as the method to assess refractive error. Another factor may be the
difference in age cohorts with the groups in Ecuador limited to between 18 and 45 while in
Venezuela the age ranged from 0 to over 55. Higher levels of myopia (≤ -0.50 D SER) have been
observed in some South American communities with a prevalence of 14.4% observed in Columbia190
and 29.2% found in office workers in Argentina.191
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There is relatively little information available on the prevalence of myopia in Africa. Several studies
detail the rates of uncorrected refractive error but do not go into detail as to the nature of the
refractive error.192,193 Some studies do provide information on refractive error status in adults such
as a Nigerian study that found myopia (< -0.50 D SER) was observed in 16.2% and high myopia (< 5.00 D SER) was observed in 2.1% of adults over 40 when assessed with either non-cycloplegic autorefractor or subjective refraction194. Comparable results were found in Durban, South Africa with a
prevalence of myopia (< -0.50 D SER) of 11.4% for a similarly aged group of adults.195
When comparing the above prevalence studies, it is important to consider the make-up of the study
population. Table 3.1 lists a number of studies reporting myopia prevalence with similar age profiles
however many studies do not provide detailed breakdowns of the participants by age. As myopia is
has usually reached its maximum prevalence in the second to third decade,154,158,179 studies having
more or less younger participants will be biased towards having a higher or lower prevalence rate.
The environment of the study participants also needs to be considered. It has been consistently
found that urban lifestyles tend to result in a higher prevalence of myopia160,196 likely due to
experiencing many of the risk factors described in chapter 2. Many of the studies with the lowest
prevalence of myopia usually take place in rural environments with low levels of educational
attainment189,195 while the highest prevalence is usually found in highly urbanised environments with
high levels of educational attainment.178,179
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Table 3.1: Prevalence of myopia and high myopia in adults around the world.
Author (year)

Country

Sample
Size

Age

Cycloplegia

Myopia
Definition

Myopia
Prevalence

High Myopia
Definition

High Myopia
Prevalence

No

Refraction
Method
Africa
Objective

Ezelum
(2011)194
Mashige
(2016)195

Nigeria

13599

40+

< -0.50 D

16.2%

< -5.00 D

2.1%

South Africa

1939

35 – 90

No

Objective

< -0.50 D

11.4%

NR

NR

≤ -0.50 D
≤ -0.50 D
≤ -0.50 D

48.5%
30.0%
30.2%

≤ -6.00 D
< -6.00 D
< -6.00 D

0.6%
3.1%
1.9%

Saw (2002)
Tan (2011)197
Hashemi
(2012)185
Nakao (2020)179
Wong (2000)186
Bourne
(2004)182
Xu (2005)181
Sawada
(2008)177
Gupta (2008)180
Liang (2009)198
Krishnaiah
(2009)184
Nangia (2010)183
Kim (2013)178
Yoo (2013)199

Indonesia
Singapore
Iran

1043
1835
4864

21+
55+
40 – 64

No
No
Yes

Asia
Objective
Objective
Subjective

Japan
Singapore
Bangladesh

9850
1113
11189

34 – 80
40 – 79
30+

No
No
No

Objective
Subjective
Objective

≤ -0.50 D
< -0.50 D
< -0.50 D

50.0%
35.0%
22.1%

≤ -6.00 D
< -5.00 D
< -5.00 D

7.9%
6.9%
1.8%

China
Japan

4319
3021

40+
40+

No
No

Subjective
Objective

< -0.50 D
< -0.50 D

22.9%
41.8%

< -6.00 D
< -6.00 D

2.6%
5.5%

Myanmar
China
India

2076
6491
3642

40+
30+
40 – 95

No
No
No

Objective
Subjective
Subjective

< -0.50 D
< -0.50 D
< -0.50 D

51.0%
21.8%
36.5%

< -6.00 D
< -5.00 D
< -5.00 D

6.5%
1.7%
4.8%

India
South Korea
South Korea

4619
23392
1532

30+
20+
40+

No
No
No

< -0.50 D
< -0.50 D
< -0.50 D

17.0%
48.1%
20.5%

< -6.00 D
< -6.00 D
< -6.00 D

0.9%
4.0%
1.0%

Vitale (2008)158
Antón (2009)152
Nowak (2018)200

USA
Spain
Poland

12010
417
998

20+
40 – 79
35 – 97

No
No
No

Subjective
Objective
Objective
Western Countries
Objective
Subjective
Subjective

≤ -0.50 D
≤ -0.50 D
≤ -0.50 D

44.7%
25.4%
24.1%

≤ -5.00 D
≤ -5.00 D
NR

6.5%
3.5%
NR

176
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Sherwin
(2012)201
Cumberland
(2015)159
Wang (1994)202
Attebo (1999)203
Hendricks
(2009)204
Wolfram
(2014)14
Varma (2017)205

UK

4428

48 – 89

No

Objective

≤ -0.50 D

27.8%

NR

NR

UK

107452

40 – 69

No

Objective

≤ -0.50 D

33.5%

≤ -6.00 D

4.0%

USA
Australia
Netherlands

4275
3654
444

43 – 84
49 – 97
17 – 60

No
No
No

Objective
Subjective
Objective

< -0.50 D
< -0.50 D
< -0.50 D

26.2%
15.5%
29.7%

NR
≤ -4.00 D
≤ -5.00 D

NR
3.0%
4.3%

Germany

13959

35 – 74

No

Objective

< -0.50 D

35.1%

≤ -6.00 D

3.5%

USA

4582

50+

35.1%

≤ -5.00 D

7.4%

1283

18 – 45

No
Objective
< -0.50 D
Central and South America
Yes
Subjective
≤ -0.50 D

4.7%/5.5%

NR

NR

1518

25 – 65

No

Subjective

≤ -0.50 D

29.2%

≤ -6.00 D

1.6%

3608

35 – 55

No

Subjective

≤ -0.50 D

14.4%

NR

NR

Jiménez
Ecuador
(2004)189
Cortinez
Argentina
191
(2008)
Galvis (2018)190 Columbia
NR = Not reported.
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3.3.2 Hyperopia
The prevalence of hyperopia in adults tends to follow an oppoesed trend as that described for
myopia. The highest prevalence of hyperopia is found in regions with a low prevalence of myopia
(Table 3.2). Although relatively few assessments of refractive error in adults have taken place in
Africa, those that have, indicate a high prevalence of hyperopia with one Nigerian study finding over
50% of adults aged 40 and older to be hyperopic.194 Similar results have been found in Central and
South America which also typically have lower rates of myopia when compared internationally.190
Western countries typically have a lower prevalence of hyperopia with the E3 observing a rate of
hyperopia (≥ +1.00 D SER) of 25.23% in adults aged 25 – 89.154 The prevalence of hyperopia in
Australian adults is high at over 50% when compared to other Western countries although this study
used an older age group and lower definition of hyperopia (> +0.50 D SER) which may contribute to
some of the difference observed.203 A study with a similar age profile in the UK observed a similar
prevalence of hyperopia of 49.4%.201 This highlights the need to consider the age of participants
when considering hyperopia prevalence in much the same way as is required when considering
studies of myopia prevalence. As hyperopia increases with age (Figure 3.2), studies using older
participants are likely to find higher rates of hyperopia. This point is further highlighted when
comparing two studies of refractive error conducted over the same time period in South Korea. Yoo
et al observed a prevalence rate of 41.8% in adults aged 40 and over.199 Kim et al observed a
prevalence rate of 24.2% in adults aged over 20 but they also reported rates for adults aged 40 and
over and found a prevalence of 34.8% which is much closer to the finding the by Yoo et al.178,199 The
remaining difference may be accounted for by the differing environments of the participants with
Yoo et al’s study focusing on rural inhabitants199 although as described in chapter 3.2, there is a
significant risk of a cohort effect when comparing refractive error prevalence across generations
which may also explain this variance. In general, East Asia tends to have the lowest rates of
hyperopia (Table 4.2) with a prevalence as low as 13.9% in Indonesia.176
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3.3.3 Astigmatism
The prevalence of astigmatism in adults follows less obvious trends than myopia or hyperopia. High
prevalence of astigmatism was found in countries in all geographical regions with participants living
in various environments (Table 3.2). High levels of astigmatism were reported in Japan,177 South
Korea,199 Spain152 and Nigeria194 while low levels were observed in Ecuador189 and Poland.200
The most consistent explanation for higher levels of astigmatism in a population is older age. Many
studies reported a relationship between increasing astigmatism and increasing age.177,194,199,200,203
This relationship was consistent across studies with both high and low overall prevalence of
astigmatism. This likely indicates a significant level of variation in astigmatism prevalence between
studies is due to the age of the study participants. This cannot completely explain the variance
however as different prevalence rates of astigmatism have been found even in similarly aged
populations.182,200
Some authors have suggested that higher refractive error results in higher levels of astigmatism203
and thus countries with high prevalence of myopia or hyperopia will also have high levels of
astigmatism. There have been conflicting reports on this relationship with some authors finding no
relationship between refractive error and astigmatism.177 Another possible explanation for the
differences observed is suggested by Bourne et al.182 In this study the authors observed a higher rate
of astigmatism in those with cataract. It may be the case that areas reporting higher levels of
astigmatism in older participants may also be areas with worse access to cataract surgery and the
high astigmatism prevalence may indicate a higher prevalence of cataract in the elderly in these
countries.
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Table 3.2: Prevalence of hyperopia and astigmatism in adults around the world.
Author (year)

Country

Sample
Size

Age

Cycloplegia

Ezelum
(2011)194
Mashige
(2016)195

Nigeria

13599

40+

No

35 – 90

No

South Africa 1939

Refraction
Method
Africa
Objective

Hyperopia Hyperopia
Definition Prevalence

Astigmatism
Definition

Astigmatism
Prevalence

> +0.50 D

50.7%

> 0.50 D

63.5%

Objective

> +0.50 D

37.7%

≥ 0.50 D

25.7%

≥ +0.50 D
> +0.50 D
> +0.50 D

13.9%
28.4%
20.6%

≥ 0.50 D
> 0.50 D
> 0.50 D

44.3%
43.9%
32.4%

Saw (2002)
Wong (2000)186
Bourne
(2004)182
Xu (2005)181
Sawada
(2008)177
Liang (2009)198
Krishnaiah
(2009)184
Nangia (2010)183
Hashemi
(2012)185,206
Kim (2013)178
Yoo (2013)199
Tan (2011)197
Gupta (2008)180

Indonesia
Singapore
Bangladesh

1043
1113
11189

21+
40 – 79
30+

No
No
No

Asia
Objective
Subjective
Objective

China
Japan

4319
3021

40+
40+

No
No

Subjective
Objective

> +0.50 D
> +0.50 D

20.0%
27.9%

NR
> 0.50 D

NR
54.0%

China
India

6491
3642

30+
40 – 95

No
No

Subjective
Subjective

> +0.50 D
> +0.50 D

22.0%
18.1%

> 0.50 D
> 0.50 D

28.0%
38.2%

India
Iran

4619
4864/5020

30+
40 – 64

No
Yes

Subjective
Subjective

> +0.50 D
> +0.50 D

18.0%
35.6%

NR
> 0.50 D

NR
49.1%

South Korea
South Korea
Singapore
Myanmar

23392
1532
1835
2076

20+
40+
55+
40+

No
No
No
No

> +0.50 D
> +0.50 D
≥ +1.00 D
> +1.00 D

24.2%
41.8%
41.5%
15.0%

> 1.00 D
> 0.50 D
≥ 1.00 D
> 1.00 D

28.3%
63.7%
43.5%
30.6%

Antón (2009)152
Sherwin
(2012)201
Nowak (2018)200

Spain
UK

417
4428

40 – 79
48 – 89

Objective
Objective
Objective
Objective
Western Countries
No
Subjective
No
Objective

≥ +0.50 D
≥ +0.50 D

43.6%
49.4%

> 0.50 D
NR

53.5%
NR

Poland

998

35 – 97

No

≥ +0.50 D

37.5%

≥ 0.50 D

10.8%

176

Subjective
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Wang (1994)202
Attebo (1999)203
Hendricks
(2009)204
Varma (2017)205
Wolfram
(2014)14
Cumberland
(2015)159
Vitale (2008)158

USA
4275
Australia
3654
Netherlands 444

43 – 84
49 – 97
17 – 60

No
No
No

Objective
Subjective
Objective

> +0.50 D
> +0.50 D
> +0.50 D

49.0%
56.6%
9.9%

NR
≥ 0.75 D
> 0.50 D

NR
37.0%
23.6%

USA
Germany

4582
13959

50+
35 – 74

No
No

Objective
Objective

> +0.50 D
> +0.50 D

40.2%
31.8%

> 0.50 D
> 0.50 D

45.6%
32.3%

UK

107452

40 – 69

No

Objective

≥ +1.00 D

27.6%

NR

NR

USA

12010

20+

≥ +3.00 D

3.6%

≥ 1.00 D

36.2%

1518

25 – 65

No
Objective
Central and South America
No
Subjective

≥ +0.50 D

18.1%

NR

NR

3608
1283

35 – 55
18 – 45

No
Yes

≥ +0.50 D
≥ +1.00 D

42.1%
16.1%/11.5%

NR
≥ 0.50 D

NR
9.9%/7.7%

Cortinez
Argentina
191
(2008)
Galvis (2018)190 Columbia
Jiménez
Ecuador
189
(2004)
NR = not reported.

Subjective
Subjective

71

3.3.4 Presbyopia
The ambiguity with regards to the definition of presbyopia makes reporting on the prevalence of
presbyopia difficult. Taken from a purely mechanistic view point, presbyopia can be considered the
loss of accommodative ability through aging in which case every person that lives long enough will
eventually be affected by presbyopia.134 This should mean that prevalence rates should reach 100%
past a certain age however most studies of presbyopia prevalence are more concerned with finding
those affected by correctable near vision impairment and establishing the number of people that are
uncorrected or undercorrected.207 If this is used as the basis for defining presbyopia, many myopic
individuals will not suffer from near vision impairment when they have no correction in place and
therefore prevalence rates will not reach 100% and may be much lower in countries with a high
prevalence of myopia. There are also relatively few studies describing the prevalence of presbyopia,
in a 2008 meta-analysis only 4 studies were found that met the inclusion criteria.163 This metaanalysis was repeated in 2018 when more studies had been carried out however there were still only
25 prevalence studies which primarily consisted of studies performed in Africa and Asia.207
The current estimated number of people effected by presbyopia is approximately 1.8 billion which is
projected to rise to 2.1 billion by the year 2030.207 This prevalence rate is expected to reduce after
the year 2030 due to the compensatory effect caused by the projected increase in myopia.3 Most
significantly there are estimated to be 826 million (95% CI: 686 – 960 million) people affected by
near vision impairment due to uncorrected and undercorrected presbyopia (Figure 3.5).207 Bourne et
al recently estimated near vision impairment due to uncorrected and under corrected presbyopia
was lower at 510 million (95% CI: 371 – 667 million) people using a different methodology.5 Although
there is disagreement between these two studies, the confidence intervals are quite close so the
true number of people affected by near vision impairment can likely be estimated as lying between
the two values.
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Figure 3.5: Map showing the prevalence of vision impairment resulting from uncorrected
presbyopia. The highest prevalence is found in Africa and East Asia while lowest prevalence is
observed in Western countries. Reproduced from Fricke et al.207

73

3.4 Refractive Error Prevalence in Children
Many of the difficulties in comparing refractive error prevalence studies in adults are also present in
studies of children. This is often magnified due to the significant changes in refractive error that can
take place over relatively short periods of time in children.208 The Refractive Error Studies in

Children (RESC) suggested a uniform methodology and reporting structure to allow a better
estimation of global prevalence of refractive error and vision impairment in children.209 This
resulted in a series of studies in a variety of locations which were directly comparable .210–214
Several other studies of refractive error in children such as the Northern Ireland Childhood Errors of
Refraction (NICER) study215 and the Ireland Eye Study (IES)216 have also adopted the same reporting
methodology allowing for straightforward comparison however studies using the RESC protocol are
not available in all locations and in particular are less commonly performed for older children (Table
3.5 and 3.8).
The primary strength of the RESC methodology is the uniformity of reporting and the use of
cycloplegic autorefraction as the method of determining refractive error. One of the weaknesses is
that, the protocol does not require investigation of refractive error if a child has VA better than
0.625 decimal209 although many authors using this methodology carried out refractive error
assessment in all children regardless of VA.216,217 For those authors that did not assess refractive
error in children with VA better than 0.625 decimal, this will likely result in an underreporting of low
levels of myopia.218 The use of consistent definitions for refractive errors is another strength of the
RESC methodology although there was some variation in the definitions used for astigmatism with
investigators using either ≥ 0.75 DC210,212,214 or ≥ 1.00 DC.216,218
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3.4.1 Myopia
Myopia prevalence in children follows similar trends as those seen in adults. The highest prevalence
rates are typically seen in East Asia in urban settings208,219 with the lowest rates observed in Africa
and rural settings (Figure 3.6).220,221 The most significant difference when considering refractive error
prevalence in children as opposed to adults, is the rapid changes in refractive error that can occur
over a relatively short period of time.222 This necessitates grouping children in relatively small age
cohorts to facilitate appropriate comparison.

Figure 3.6: The rate of myopia seen in children based on recent studies. Myopia less than 25%
reported in blue, myopia less than 45% reported in green and myopia greater than or equal to 45%
reported in red. Adapted from https://myopiainstitute.org/myopia/

For young children under the age of 11, there is a greater level of homogeneity observed in myopia
prevalence. This is particularly the case for younger children aged approximately 6 years old (Table
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3.3). It is uncommon to observe myopia prevalence above 10% in this age group. One of the highest
levels of myopia observed in the approximately 6-year-old age group was 10% in a group of children
in Malaysia.214 The authors noted that the prevalence varied by ethnicity with prevalence in Chinese
children being higher at 20.9%. This level of myopia prevalence at this age has not been found in
other studies of Chinese children which are typically under 10%.210,223,224 The lowest prevalence rates
of myopia of less than 1% at this age have been observed in Australia225, Brazil218 and Ghana.226 Rates
were similarly low in this age cohort in other Western populations215,216 apart from those reported in
the Aston Eye Study (AES) which observed a prevalence of 9.4% however this study was more
ethnically diverse, including a significant cohort of Asian children, which may explain the variation.224
Myopia prevalence has been found in all locations to consistently increase as children reach the
teenage years (Figure 3.7) however the most dramatic changes are typically seen in East Asia (Table
3.4). Two Chinese studies found a prevalence of approximately 50% by age 10 – 11 in an urban
setting213,223 with relatively high prevalence of 38.8% also found in a rural setting in China.210 The
prevalence found by the mid teenage years was not as high in some other Asian countries with
prevalence’s of 10.8% and 32.5% in India212 and Malaysia214 by age 15 respectively. In Western
countries the prevalence of myopia by the early teenage years has also risen but is typically lower
than that found in Asia, usually below 20%.215,216 As with younger children, Africa, Australia and
South America usually have the lowest prevalence rates which are at or below 10% by age
15.211,217,225,226
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Figure 3.7: The prevalence of myopia in among older teenagers is extremely high in some east
Asian countries as indicated by the almost universal need for correction in this group of male
teenage students. Reproduced from Dolgin.227

There is less consistency in the reporting of myopia prevalence among older teenagers and young
adults. Studies using the RESC methodology have not to date recruited children older than
16.210,213,214,216,217,225 Most studies of myopia prevalence in older children still make use of the most
common definition of myopia of ≤ -0.50 D SER however the method of refraction used and use of
cycloplegia is inconsistent (Table 3.5). In this age group the rates of myopia increase dramatically in
East Asia (Figure 3.7) with a prevalence above 90% reported in both China208 and South Korea.219 The
study by Wang et al208 did not use cycloplegia so this very high prevalence may overstate the true
prevalence however the study by Jung et al219 found a prevalence of 96.5% using cycloplegia and a
more conservative definition of myopia of < -0.50 D SER making a misclassification error unlikely.
The very high prevalence (over 20%) of high myopia found in both studies is of most concern (see
chapter 4.4.3).208,219 Elsewhere the rates of myopia in this age cohort are more variable with rates in
Western countries varying from 13.4% in Norway228 to 59.0% in the USA.229 The study conducted in
Norway used cycloplegia with autorefraction and a definition of ≤ -0.50 D SER while the study in the
USA used non-cycloplegic subjective refraction with a definition of ≤ -1.00 D SER. The very high rate
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observed in the USA may be due to referral bias as this was a retrospective study using EMRs of
those accessing eyecare through a private health insurance plan. This may underrepresent the
number of emmetropic and hyperopic children in this age group as they are less likely to be
symptomatic and access care. A Polish study using a similar methodology to the study conducted in
Norway observed a myopia rate of 32.6% however the sample sizes for both studies were relatively
small. In Africa, the prevalence of myopia in this age group remained low with two studies finding
very similar rates of 4.6% and 4.3% in Rwanda220 and Ghana226 respectively. The only study of this
age cohort in central and South America reported a myopia prevalence of 15.5%, however, the
unusual definitions used for refractive error (myopia ≤ -0.10 D SER) make these results hard to
interpret.230
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Table 3.3: Prevalence of myopia and high myopia in young children (6 – 10 years old) around the world.
Author (year)

Country

Sample
Size

Age

Cycloplegia

Naidoo (2003)217

South Africa

OvenseriOgbomo (2010)226

Ghana

458
551
231
254

6
10
5–7
8 – 10

210

Zhao (2000)
Murthy (2002)212

China
India

He (2004)213

China

Goh (2005)214

Malaysia

Ma (2016)223

China

O’Donoghue
(2010)215
Logan (2011)224
French (2012)225
Harrington
(2019)216

1152
494
590
295
415
590
589
1230
962

5–7
6
10
6
10
7
10
6
10

Myopia
Definition

Myopia
Prevalence

High Myopia
Definition

High Myopia
Prevalence

Yes

Refraction
Method
Africa
Objective

≤ -0.50 D

NR

NR

Yes

Objective

≤ -0.50 D

4.6%
1.9%
0.9%
8.3%

NR

NR

Yes
Yes

Asia
Objective
Objective

≤ -0.50 D
≤ -0.50 D

NR
NR

NR
NR

Yes

Objective

≤ -0.50 D

NR

NR

Yes

Objective

≤ -0.50 D

NR

NR

Yes

Subjective

≤ -0.50 D

1.2%
5.9%
7.0%
5.9%
30.1%
10.0%
16.2%
5.2%
52.2%

≤ -6.00 D

0.0%
1.0%

≤ -0.50 D

2.8%

NR

NR

≤ -0.50 D
≤ -0.50 D
≤ -0.50 D

9.4%
0.7%
3.3%

NR
NR
NR

NR
NR
NR

3.5%
0.8%*

NR
NR

NR
NR

UK

392

6–7

Western Countries
Yes
Objective

UK
Australia
Ireland

359
1105
733

6–7
6–7
6–7

Yes
Yes
Yes

Objective
Objective
Objective

Central and South America
Maul (2000)211
Chile
1675
5–7
Yes
Objective
≤ -0.50 D
Moraes Ibrahim
Brazil
246
10
Yes
Subjective
≤ -0.50 D
(2013)218
NR = not reported. *Refractive error was not assessed in children with VA ≥ 0.625 decimal.
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Table 3.4: Prevalence of myopia and high myopia in children (11 – 15 years old) around the world.
Author (year)

Country

Sample
Size

Age

Cycloplegia

Naidoo (2003)217

South Africa

OvenseriOgbomo (2010)226

Ghana

476
326
253
203

11
15
11 – 13
14 – 16

210

Zhao (2000)
Murthy (2002)212

China
India

He (2004)213

China

Goh (2005)214

Malaysia

Rim (2016)156
O’Donoghue
(2010)215
Logan (2011)224
French (2012)225
Harrington
(2019)216
211

Myopia
Definition

Myopia
Prevalence

High Myopia
Definition

High Myopia
Prevalence

Yes

Refraction
Method
Africa
Objective

≤ -0.50 D

NR

NR

Yes

Objective

≤ -0.50 D

4.4%
9.6%
9.1%
8.9%

NR

NR

Yes
Yes

Asia
Objective
Objective

≤ -0.50 D
≤ -0.50 D

NR
NR

NR
NR

Yes

Objective

≤ -0.50 D

NR

NR

Yes

Objective

≤ -0.50 D

NR

NR

< -0.75 D

38.8%
9.7%
10.8%
49.7%
78.4%
22.6%
32.5%
73.0%

< -6.00 D

9.3%

≤ -0.50 D

15.0%

NR

NR

≤ -0.50 D
≤ -0.50 D
≤ -0.50 D

29.4%
4.6%
19.9%

NR
NR
NR

NR
NR
NR

South Korea

905
528
381
427
376
701
693
7486+

14 – 15
11
15
11
15
11
15
12 – 18

UK

661

12 – 13

Objective
Western Countries
Yes
Objective

UK
Australia
Ireland

296
1406
901

12 – 13
12 – 13
12 – 13

Yes
Yes
Yes

No

Objective
Objective
Objective

Central and South America
Yes
Objective
≤ -0.50 D
Yes
Subjective
≤ -0.50 D

Maul (2000)
Chile
1675
14 – 15
12.5%
NR
NR
Moraes Ibrahim
Brazil
340
12
2.9%**
NR
NR
218
(2013)
175
15
3.4%**
*Astigmatism prevalence for entire study population, not reported in age groups. **Refractive error was not assessed in children with VA ≥ 0.625 decimal.
+
Sample size for ages 5 – 19. NR = not reported.
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Table 3.5: Prevalence of myopia and high myopia in older children (16 years old and over) around the world.
Author (year)

Country

Sample
Size

Age

Cycloplegia

Semanyenzi
(2015)220
Mehari (2013)221

Rwanda

300

17 – 20

Yes

Ghana

814

16 – 18

No

Wang (2020)208

China

370

18

No

Jung (2012)219
South Korea
231
Quek (2004)
Singapore
Hashemi (2014)232 Iran

23616
453
434+

19
15+
18

Yes
No
No

Hagen (2018)228
Shapira (2019)233
Czepita (2006)234
Theophanous
(2018)229

439
104689
187
2849

16 – 19
16 – 19
18
17 – 19

Norway
Israel
Poland
USA

Refraction
Method
Africa
Objective

Myopia
Definition

Myopia
Prevalence

High Myopia
Definition

High Myopia
Prevalence

≤ -0.50 D

4.6%

≤ -6.00 D

0.5%

Subjective
Asia
Objective

≤ -0.50 D

4.3%

NR

NR

≤ -0.50 D

92.7%

≤ -6.00 D

26.0%

Objective
Objective
Subjective
Western Countries
Yes
Objective
No
Objective
Yes
Subjective
No
Subjective

< -0.50 D
≤ -0.50 D
≤ -0.50 D

96.5%
74.2%
37.1%

≤ -6.00 D
≤ -6.00 D
≤ -6.00 D

21.6%
6.8%
0.5%*

≤ -0.50 D
≤ -0.50 D
≤ -0.50 D
≤ -1.00 D

13.4%
23.3%
32.6%
59.0%

≤ -6.00 D
≤ -6.00 D
NR
≤ -6.00 D

0.5%
1.7%
NR
4.9%

Central and South America
Yes
Subjective
≤ -0.10 D

15.5%

NR

NR

De Amorim
Brazil
1024
16 – 20
Garcia (2005)230
*High myopia prevalence for entire study population. +Sample size for ages 14 – 18. NR = not reported.
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3.4.2 Hyperopia
Hyperopia prevalence in children has been found to be highest at younger ages and usually reduces
as the prevalence of myopia increases with increasing age. The RESC used a definition for hyperopia
of ≥ +2.00 D SER.209 When compared to adult studies this is an unusually high definition for
hyperopia however this was likely chosen as the effects of accommodation in childhood mean a
child with a refraction below +2.00 D SER is likely to be asymptomatic. The screening strategy
employed by the RESC209 and many other studies of refractive error in children contains a significant
limitation. Children first had their visual acuity screened and if it was found to be 0.625 decimal or
better, they were deemed to be emmetropic with no full refractive error examination. This is
particularly problematic for hyperopic children as many hyperopic children can appear to have good
distance visual acuity due to the compensatory effect of their accommodation.
The highest prevalence of hyperopia (≥ +2.00 D) in young children (6 – 10 years old) has been
observed in Europe with two studies finding rates above 25%.215,216 A similar rate has been found in
Chile211 although most other countries with prevalence data for young children report rates of
approximately 10% or less (Table 3.6). Having higher rates of hyperopia in young children does not
necessarily imply the rates of myopia will be lower as the children age. Naidoo et al217 found a
hyperopia prevalence of 4.6% in South Africa in 6-year-olds which was much lower than the 25.0%
observed in 6 – 7-year-olds by Harrington et al216 in Ireland however by age 12 – 13 the myopia
prevalence observed by Harrington et al216 was 19.9% while Naidoo et al217 only observed 9.6%
myopia prevalence by age 15.
In young teenage children the rates of hyperopia are reduced to below 10% (Table 3.7) with the
lowest rates observed in East Asian populations.210,213,214 The low rate of hyperopia observed in these
populations is likely a consequence of the increasing levels of myopia that become apparent at this
age. This trend of reducing hyperopia prevalence continues in older children (Table 3.8) however
these studies are more difficult to compare as most authors use a lower definition of hyperopia of ≥
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+0.50 D SER. There are also relatively few studies reporting on the prevalence of hyperopic refractive
error in older teenagers. The highest levels of hyperopia were observed in Norway228 and Brazil230
however the low threshold for hyperopia selected in both studies is the most likely cause for these
high prevalence values. The Norwegian study228 also reported a prevalence of 6.4% at a threshold of
≥ +2.00 D SER which is still higher than that found in other studies but not as significantly different.

3.4.3 Astigmatism
Establishing trends in astigmatism prevalence in children is more difficult than for myopia and
hyperopia. This is primarily due to how astigmatism is reported in the literature. The RESC
recommended astigmatism was defined as ≥ 0.75 DC209 however not all authors have used this
definition instead using ≥ 1.00 DC.216,225 More significantly, most studies using the RESC protocol did
not report astigmatism prevalence for each age group but instead reported the prevalence for the
entire cohort of children making any age-related patterns difficult to elicit. There are also no obvious
geographical trends (Table 3.6 – 3.8) with both high and low prevalence of astigmatism reported in
Asia210,213 and elsewhere.211,215 In China, a higher prevalence of astigmatism was found in children
living in an urban environment than those living in a rural environment.210,213 This may offer an
explanation as to the various prevalence values observed in different studies however these two
studies also had significantly different rates of myopia with much higher levels of myopia observed
in the urban setting.210,213 It has been suggested that astigmatism may be associated with having a
refractive error123 in which case the higher prevalence of myopia may be the true reason for the
difference in astigmatism prevalence found in these two studies.
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Table 3.6: Prevalence of hyperopia and astigmatism in young children (6 – 10 years old) around the world.
Author (year)

Country

Sample
Size

Age

Cycloplegia

Naidoo (2003)217

South Africa
Ghana

6
10
5–7
8 – 10

Yes

OvenseriOgbomo (2010)226

458
551
231
254

210

Zhao (2000)
Murthy (2002)212

China
India

He (2004)213

China

Goh (2005)214

Malaysia

Ma (2016)223

China

O’Donoghue
(2010)215
Logan (2011)224
French (2012)225
Harrington
(2019)216

1152
494
590
295
415
590
589
1230
962

5–7
6
10
6
10
7
10
6
10

Refraction
Method
Africa
Objective

Hyperopia Hyperopia
Definition Prevalence

Astigmatism
Definition

Astigmatism
Prevalence

≥ +2.00 D

4.6%
1.9%
0.9%
8.3%

≥ 0.75 D

14.6%*

≥ 0.75 D

13.0%
14.2%

8.5%
13.0%
5.3%
10.7%
4.6%
5.0%
1.4%
87.3%
30.5%

≥ 0.75 D
≥ 0.75 D

9.5%*
14.6%*

≥ 0.75 D

42.8%*

≥ 0.75 D

20.3%*

≥ 1.00 D

21.6%
24.1%

Yes

Objective

≥ +2.00 D

Yes
Yes

Asia
Objective
Objective

≥ +2.00 D
≥ +2.00 D

Yes

Objective

≥ +2.00 D

Yes

Objective

≥ +2.00 D

Yes

Subjective

≥ +0.50 D

≥ +2.00 D

26.0%

NR

24.3%

≥ +2.00 D
≥ +2.00 D
≥ +2.00 D

12.3%
12.0%
25.0%

NR
≥ 1.00 D
≥ 1.00 D

NR
3.8%
19.2%

UK

392

6–7

Western Countries
Yes
Objective

UK
Australia
Ireland

1105
733

6–7
6–7
6–7

Yes
Yes
Yes

Objective
Objective
Objective

Central and South America
Maul (2000)211
Chile
1675
5–7
Yes
Objective
≥ +2.00 D 21.6%
≥ 0.75 D
26.7%*
Moraes Ibrahim
Brazil
246
10
Yes
Subjective
≥ +2.00 D 1.63%**
≥ 1.00 D
1.45%
(2013)218
*Astigmatism prevalence for entire study population, not reported in age groups. **Refractive error was not assessed in children with VA ≥ 0.625 decimal.
NR = not reported.
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Table 3.7: Prevalence of hyperopia and astigmatism in young children (11 – 15 years old) around the world.
Author (year)

Country

Sample
Size

Age

Cycloplegia

Naidoo (2003)217

South Africa
Ghana

11
15
11 – 13
14 – 16

Yes

OvenseriOgbomo (2010)226

476
326
253
203

210

Zhao (2000)
Murthy (2002)212

China
India

He (2004)213

China

Goh (2005)214

Malaysia

Rim (2016)156
O’Donoghue
(2010)215
Logan (2011)224
French (2012)225
Harrington
(2019)216
211

Refraction
Method
Africa
Objective

Hyperopia Hyperopia
Definition Prevalence

Astigmatism
Definition

Astigmatism
Prevalence

≥ +2.00 D

3.2%
0.7%
1.6%
3.0%

≥ 0.75 D

14.6%*

≥ 0.75 D

13.0%
16.7%

≥ 0.75 D
≥ 0.75 D

9.5%*
14.6%*

≥ 0.75 D

42.8%*

≥ 0.75 D

20.3%*

≥ 1.00 D

34.0%

Yes

Objective

≥ +2.00 D

Yes
Yes

Asia
Objective
Objective

≥ +2.00 D
≥ +2.00 D

Yes

Objective

≥ +2.00 D

Yes

Objective

≥ +2.00 D
> +0.50 D

1.1%
5.0%
3.9%
3.5%
0.5%
0.9%
0.9%
2.6%

≥ +2.00 D

11.8%

NR

24.3%

≥ +2.00 D
≥ +2.00 D
≥ +2.00 D

5.4%
4.4%
8.9%

NR
≥ 1.00 D
≥ 1.00 D

NR
3.8%
15.9%

South Korea

905
528
381
427
376
701
693
7486+

14 – 15
11
15
11
15
11
15
12 – 18

UK

392

12 – 13

Objective
Western Countries
Yes
Objective

UK
Australia
Ireland

296
1105
733

12 – 13
12 – 13
12 – 13

Yes
Yes
Yes

No

Objective
Objective
Objective

Central and South America
Yes
Objective
Yes
Subjective

Maul (2000)
Chile
1675
5–7
≥ +2.00 D 7.5%
≥ 0.75 D
26.7%*
Moraes Ibrahim
Brazil
340
12
≥ +2.00 D 0.8%**
≥ 1.00 D
1.45%*
218
(2013)
175
15
1.12%**
*Astigmatism prevalence for entire study population, not reported in age groups. **Refractive error was not assessed in children with VA ≥ 0.625 decimal.
+
Sample size for ages 5 – 19. NR = not reported.
85

Table 3.8: Prevalence of hyperopia and astigmatism in older children (16 years old and over) around the world.
Author (year)

Country

Sample
Size

Age

Cycloplegia

Semanyenzi
(2015)220
Mehari (2013)221

Rwanda

300

17 – 20

Yes

Ghana

814

16 – 18

No

Quek (2004)231
Singapore
Hashemi (2014)232 Iran

453
434+

15+
18

Hagen (2018)228
Czepita (2006)234

439
187

16 – 19
18

Norway
Poland

Refraction
Method
Africa
Objective

Subjective
Asia
No
Objective
No
Subjective
Western Countries
Yes
Objective
Yes
Subjective
Central and South America
Yes
Subjective

Hyperopia Hyperopia
Definition Prevalence

Astigmatism
Definition

Astigmatism
Prevalence

≥ +0.50 D

4.3%*

≥ 0.50 D

2.2%

≥ +2.00 D

0.3%

≥ 0.50 D

2.17%**

≥ +0.50 D
≥ +0.50 D

1.8%
22.6%

≥ 0.50 D
> 0.50 D

60.3%
27.4%

≥ +0.50 D
≥ +1.00 D

55.4%
3.2%

≥ 1.00 D
NR

8.9%
NR

De Amorim
Brazil
1024
16 – 20
≥ +0.10 D 67.8%
≥ 0.10 D
4.0%
Garcia (2005)230
*Hyperopia prevalence for entire study population, not reported in age groups. ** Astigmatism prevalence for entire study population, not reported in age
groups +Sample size for ages 14 – 18. NR = not reported.
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3.5 Evidence for Increasing Myopia
The evidence above indicates the high levels of myopia present in some locations and also appears
to indicate an increased prevalence of myopia in younger generations. Some studies have specifically
looked at changes in myopia prevalence that have occurred over longer periods of time within
certain populations.
Comparison of the results from the 1999-2004 National Health and Nutrition Examination Survey
NHANES with those from 1971-1972 demonstrated a significant increase in the prevalence of
myopia8 in participants aged 12 to 54 in the United States. Overall myopia prevalence increased
from 25.0% to 41.6%. All levels of myopia increased over time with severe myopia (≤ -7.9 D SER)
increasing from 0.2% to 1.6%. A similar time span was assessed in Australian Aboriginal
communities.235 In 1977 161 adults aged 20 to 30 had their refractive error measured by cycloplegic
subjective refraction with a mean refraction of +0.54 D SER. 128 adults of the same age range were
assessed in 2000 and observed to have mean refraction of -0.55 D SER. In 2000 refractive error was
assessed by non-cycloplegic auto-refractor. The authors validated the use of non-cycloplegic autorefractor as showing excellent agreement against cycloplegic subjective refraction but this may have
induced a bias for increased myopia.
Bar Dayan et al236 documented an increase of myopia (≤ -0.50 D SER) in 919,929 young adults (16 to
22) attending for military service in the Israeli army. They observed a change in myopia prevalence
from 20.3% to 28.3% from 1990 to 2002. This was based on non-cycloplegic subjective refraction.
A slightly younger age group (18.46 ± 0.69 years) was assessed over a 15-year period by Chen et al in
China.237 43,858 third-year high school students were assessed with non-cycloplegic autorefraction
to determine refractive error. The prevalence of myopia (≤ -0.50 D SER) was found to increase from
79.5% to 87.7% between the years 2001 and 2015. They observed significant increases in moderate
myopia (38.8% to 45.7%) and high myopia (7.9% to 16.6%) levels.
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Another East Asian study238 assessed the refractive error difference between parents and their
children in an attempt to determine change in myopia (≤ -0.50 D SER) prevalence over time.
Refractive error was determined by cycloplegic auto-refactor in children and non-cycloplegic autorefractor or self-reporting in adults. Children at younger ages were found to be more hyperopic than
their parents but by age 16 to 17.9 years 70% of children were more myopic than their parents. The
overall estimation indicated the children would eventually be approximately -1.94 D SER more
myopic than their parents at age 18.
In Taiwan a study examined children aged 7, 12, 15 and 16 to 18 in 8 different years between 1983
and 2016.9 They observed an increase in the prevalence of myopia (≤ -0.25 D SER) across all age
categories over the time span with the prevalence of myopia in children aged 7 increasing from 5.8%
to 25.4% and the prevalence in those aged 16 to 18 increasing from 74% to 90%. There were also
significant increases in the rate of high myopia (< -6.00 D SER) with highest rates seen in those aged
16 to 18 (17% to 24%).

3.6 Future Predictions
Given the apparent increasing myopia prevalence over the last number of decades several authors
have attempted to predict the future prevalence of myopia. Holden et al.3 conducted the largest
such study and based their predications on a meta-analysis of 145 epidemiological studies of
refractive error. The authors predicted a global prevalence of myopia of 49.8% by 2050 with the
highest prevalence in high income Asian countries at 66.4% and the lowest in East Africa at 22.7%
(Figure 3.8). Of most concern the authors predict the global prevalence of high myopia will reach
9.8% by 2050. The authors noted several limitations in their predictions including the relative lack of
data available in some regions. Similar projections have been made for Chinese239 and Indian240
children. Dong et al239 based their predictions on 22 studies of refractive error in Chinese children
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and predicted by 2050 84.3% of Chinese children aged 3 – 18 years would myopic. This is higher than
that predicted by Holden et al3 however their results did not apply specifically to children. Priscilla
and Verkicharla240 used a similar methodology to predict the prevalence of myopia in Indian children
by 2050. They based their prediction on a meta-analysis of 8 studies of refractive error. By the 2050
the authors predict 48.2% of Indian children living in urban settings would be myopic. This is less
than the 53.0% predicted by Holden et al. and Priscilla and Verkicharla240 suggest the true difference
may be even larger as their prediction does not include adults and those living in rural settings that
are less likely to be myopic. This variation may be due to the authors using a different statistical
model to Holden et al3 as the data available could not facilitate a similar analysis.

Figure 3.8: Estimated increase in myopia based on analysis by Holden et al.3
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3.7 Summary
There are several challenges in establishing the current worldwide prevalence of refractive error
however the evidence available indicates some patterns. Myopia is a refractive error of significant
concern as the prevalence of myopia has increased significantly in recent decades and is projected to
continue to increase over the coming decades if interventions do take place. This is particularly the
case in some parts of Asia where myopia prevalence has reached extreme levels. As the prevalence
of high myopia increases in tandem with the increases found in myopia in general, the risk of
uncorrectable vision loss due to the complications of myopia (see chapter 4) may increase
significantly in the coming years. Fewer epidemiological studies of hyperopia and astigmatism have
taken place but current evidence indicates the prevalence of hyperopia is reducing as the prevalence
of myopia is increasing while the only obvious trend in astigmatism is that the prevalence increases
with increasing age. The prevalence of presbyopia is difficult to establish due to a lack of studies and
an inconsistent definition for presbyopia. The primary concern with presbyopia is the level of
undercorrection of presbyopia resulting in near vision impairment which has been estimated to
effect in excess of 500 million people currently.
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4 Vision Impairment
4.1 Introduction
The WHO defines vision impairment using categories ranging from mild vision impairment to
blind.241 This is done using the level of presenting visual acuity according to table 1.

Table 4.1: Classification of severity of vision impairment based on visual acuity in the better eye.
Adapted from the World Health Report on Vision.241
Category
Mild vision impairment
Moderate vision impairment
Severe vision impairment
Blindness
Near vision impairment

Visual Acuity in the Better Eye
Worse than:
6/12 (0.5)
6/18 (0.33)
6/60 (0.1)
3/60 (0.05)
N6 or M 0.8 at 40 cm

Equal to or better than:
6/18 (0.33)
6/60 (0.1)
3/60 (0.05)

Classically, vision impairment was not considered based on presenting visual acuity but rather based
on best corrected visual acuity.241 Both methods of defining vision impairment have advantages and
disadvantages. By measuring vision impairment based on presenting visual acuity, the number of
people within a population that require eye care is determined as many of these individuals can
achieve normal vision with interventions such as refractive error correction or cataract surgery. This
is particularly useful in countries with poor access to eyecare. Measuring vision impairment based on
best corrected visual acuity more accurately reflects the number of individuals within a population
that have uncorrectable vision impairment and allows better resource and support planning for
those affected.
Vision impairment may also be defined according to the level visual field restriction, with a visual
field less than 20 degrees in the better eye representing vision impairment and a visual field less
than 10 degrees representing blindness.242
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Vision impairment has a significant impact on both the individual and society. Many studies have
examined the impact of vision impairment on various aspects of an affected individuals quality of life
(QoL).243 A recent review article demonstrated a consistent reduction of QoL in those with vision
impairment.243 It has also been found that QoL measures reduce with worse levels of vision
impairment regardless of how long the vision impairment is present.244 It should be noted however
that even mild levels of vision impairment are associated with a reduction in QoL.245 The most
consistently reported individual impact of vision impairment is on leisure and work, social
interactions, household and personal care, mobility and the emotional reaction to vision
loss.244,246,247 There are also several reports on the potential health impacts of vision impairment. An
association with an increased risk of falls and vision impairment has been found in both an Asian245
and a North American248 population. There are mixed reports on the association of vision
impairment and depression symptoms. Some investigators have observed an association between
symptoms of depression and vision impairment249,250 while others have found no association.251,252
Frank et al249 suggest that the strongest relationship is found with self-reported vision impairment as
opposed to measures of VA which may explain the variation in results. A recent meta-analysis
reported on the association between vision impairment and mortality finding an increased risk of
mortality in those with vision impairment with the risk of mortality increasing as the level of vision
impairment increased.253
Apart from the individual impact, vision impairment has significant societal impacts. There are
significant economic costs associated with vision impairment and blindness with a conservative
analysis estimating the global cost of loss of productivity due to undercorrected refractive error at
$121 billion in 2007.254 These estimates have increased in the intervening years with undercorrected
myopia alone accounting for $244 billion in lost productivity in 2015.4 In the Republic of Ireland, the
estimated direct cost of vision impairment and blindness to the healthcare system in 2020 was €137
million.255 Additional direct costs in the form of lost productivity, informal care and welfare costs
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amounted to €312 million giving a total cost to the economy in 2020 of €449 million.255 When adding
the indirect cost of disability adjusted life years (DALYs), a measure combing years of life lost due to
earlier death and years lost due to disability, the economic cost rises to over €2 billion.255

4.2 Causes of Vision Impairment
The vision loss expert group (VLEG) provides an estimation of the global burden of vision impairment
and blindness (Figure 4.1).5 They estimated that in 2020 the leading cause of blindness globally was
cataract followed by glaucoma with cataract accounting for over 50% of all cases of blindness.256
Cataract was the second leading cause of moderate to severe vision impairment (MSVI) after
undercorrected refractive error and together they accounted for 75% of all cases of MSVI.256 The
overall global prevalence of vision impairment has increased from 3.92% in 2010 to 4.34% in 2020
and it is predicted that by 2050 895 million people will have some level of distance vision
impairment.5 Since 2010 there was found to be no change in the overall crude prevalence of total
vision impairment in older adults however the overall crude prevalence of blindness had decreased
by 14.4% while MSVI had slightly increased by 1.6%. 256
There was some variation noted with significant differences in the causes of vision impairment and
blindness in different geographic regions. Typically, in higher income regions such as Western
Europe, cataract and undercorrected refractive error did not represent as many cases of blindness
although they still contributed significantly as a cause of vision impairment.10,256 Other causes of
blindness such as age related macular degeneration and glaucoma were more common in higher
income regions, likely due to the older populations within these regions.10,256
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Figure 4.1: Geographic variation in vision impairment with highest number of people affected by
vision loss found in East and South Asia. Reproduced from the Vision Loss Expert Group Atlas.5,256
Available at https://www.iapb.org/learn/vision-atlas/

4.3 Vision Impairment in Ireland
4.3.1 Vision Impairment in Adults
The level of vision impairment within Ireland is estimated by the VLEG to be 5.3% or approximately
270,000 people affected in 2020.5,256 Approximately 0.2% of the population of Ireland is estimated to
be blind.5,256 These figures are projections based on modelling using data from other countries and
the level of access to eyecare available within Ireland.257,258 VLEG currently have no data on vision
impairment in Ireland and have identified a lack of vision impairment data in Western countries as a
limitation in their projections.5,256
Although the VLEG have not included any data from Ireland in their analysis, there are a small
number of studies on vision impairment in Ireland. The studies that have been conducted typically
describe vision impairment and blindness in either children or adults. Most of these studies do not
report undercorrected refractive error as a cause of vision impairment or blindness as the most
common methodology used is to perform an audit of the Irish blind register which does not allow
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registration due to undercorrected refractive error. This methodology also only captures those with
more severe vision impairment, typically those that are legally blind,259 resulting in no information
on the number of individuals suffering with milder forms of vision impairment.
The most recent study of adult blindness covers the period 1996 – 2003 and estimated the number
of blind adults in Ireland.259 This study performed an audit on the Irish blind register and observed a
level of 0.23% blind adults in Ireland in 2003. This is very similar to the figure estimated by the VLEG
and represented a 37% increase from 1996.259,260 The authors of this study noted however that their
reported prevalence was likely underestimating the true level of blindness as they observed 57% of
patients attending an ophthalmology outpatients clinic that met the criteria for blind registration
were not registered. Significantly, 21% of patients attending the clinic had no appropriate reason for
not being registered. These results are in line with those found in the UK where over 50% of patients
eligible to be registered as blind were not registered.261
Among the adult population in Ireland, the most common reason for blind registration in 2003 was
age related macular degeneration (AMD) with 25% of those registered blind being due to AMD.259
This was followed by glaucoma (12%), retinitis pigmentosa (7%), myopia (5%) and diabetic
retinopathy (5%).259 AMD and diabetic retinopathy (DR) as a cause of blindness had more than
doubled since 1996.260 All other causes were relatively stable apart from cataract which had more
than halved from 11% to less than 4%.259,260 The reduction in blindness due to cataract is almost
certainly due to improved access to cataract surgery. The number of people registered as blind due
to DR was found to have reduced over the following 10 years however the number of people with
vision impairment due to DR had increased over the same time period.262 Given the most recent
audit of the blind register was almost 20 years ago, predating the widespread use of effective
treatments for neovascular AMD such as anti-vascular endothelial growth factor (anti VEGF) drugs263
and the existence of the Irish National Diabetic RetinaScreen Programme,264 it would be interesting
to determine if these trends had been reversed.
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4.3.2 Vision Impairment in Children
There have been 3 studies reporting on vision impairment and blindness in children in Ireland. A
1991 report determined the causes and prevalence of blindness in those aged under 16 by seeking
eligible patients for examination from ophthalmologists and social and educational facilities involved
in the care of blind children.265 The rate of blindness in children found was 0.02% with most cases of
blindness occurring in the prenatal stage with optic nerve hypoplasia (Figure 4.2) the most
commonly diagnosed cause of blindness. 265 A similar study was performed in 2004 and found a rate
of blindness in children of 0.05%.266 The authors suggested the increased rate of blindness was
artificial and actually due to better registration of and follow up of blind children enabling the
authors to more easily identify those children affected. Most significantly the study showed a
changing pattern of blindness in children in Ireland with much lower rates of acquired blindness due
to conditions such as retinopathy of prematurity and higher rates of blindness due to
cerebrovascular impairment likely due to increased survival rates in preterm infants.266
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Figure 4.2: An example of optic nerve hypoplasia, one of the most common causes of blindness in
children in Ireland.265,266 Reproduced from
https://webeye.ophth.uiowa.edu/eyeforum/cases/case10.htm

To date only one study has reported on rates of vision impairment including undercorrected
refractive error as a potential cause. The IES assessed 1,626 children in 2 age cohorts to determine
the prevalence of refractive error and vision impairment.216 Unlike other studies of vision
impairment or blindness in children in Ireland, the IES was a representative cross sectional study that
used random cluster sampling to select schools for participation. Presenting vision impairment was
defined as ≥ 0.3 logMAR with spectacles if worn. The prevalence of “better eye” presenting vision
impairment was 3.7% in the younger cohort and 3.4% in the older cohort. Higher levels of presenting
vision impairment were observed in minority groups and the overall level of presenting vision
impairment was significantly higher than that found in similar populations. 215
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4.4 Vision Impairment Due to Refractive Error
It is clear that undercorrected refractive error is a significant cause of vision impairment256 however
refractive error is itself a risk factor for uncorrectable vision impairment,267 something for which the
general public does not seem to have an awareness.268 It has been demonstrated that increasing
refractive error, both myopic and hyperopic are associated with an increased risk of vision
impairment however the causes of vision impairment are usually different.267

4.4.1 Causes of Vision Impairment in Myopia
The increasing prevalence of myopia discussed in chapter 3 makes the potential for associated vision
impairment very concerning. Myopia can cause a number of complications with the retina frequently
involved. These complications are thought to occur in response to the changes in shape of the ocular
globe that occurs with increasing axial length.269 A structural change that can occur in those with
high myopia is the development of a posterior staphyloma. This is a posterior outpouching of the
fundus which has a radius of curvature which is less than the globe28 (Figure 4.3). In eyes with high
myopia, those with the posterior staphyloma have been found to be at higher risk of reduced visual
acuity and macular complications.28 Macular complications in myopia are usually referred to as
myopic macular degeneration (MMD) or myopic maculopathy and represent one of the most
common causes of vision impairment in myopia.267 The first description of MMD was given by Curtin
and Karlin270 with the authors describing several retinal lesions and their association with axial
length. Since then several attempts have been made to create a unified classification system for
MMD.269,271 Ohno-Matsui et al describe MMD in four stages going from the presence of a tessellated
fundus with minimal effect on visual acuity to macular atrophy which can cause severe vision
impairment.271 The authors also described plus features including Lacquer cracks, Fuch’s spot and
choroidal neovascularisation all of which confer an increased risk of vision impairment.271
Progression through the stages of MMD (Figure 4.4) and the resultant loss of visual acuity appears to
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be a function of the level of myopia and axial length combined with the age of the patient.272
Hayashi et al followed a series of patients having bilateral high myopia and high axial length
measurements over a mean follow-up period of 12.7 years to assess the progression of MMD in high
myopia over the life course.272 The authors observed progression of MMD in 40.6% of eyes with the
development of myopic choroidal neovascularisation having the most significant effect on visual
acuity. This level of MMD progression was not observed in another group of highly myopic eyes in
Australia, however this may be explained by the much shorter follow-up period of 5 years for all
participants and also the sample of eyes with MMD was far less.273

Figure 4.3: Normal ocular shape (A), axial elongation in myopia (B) and axial elongation with
posterior staphyloma (C). Adapted from Ohno-Matsui.274
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Figure 4.4: Progression of MMD from a tessellated fundus (image A) to diffuse chorioretinal
atrophy (image B) to patchy chorioretinal atrophy (image C). Adapted from Hayashi et al.272

The peripheral retina is not spared in myopia with a higher risk of retinal detachment (RD) with
increasing levels of myopia. There is an increased prevalence of peripheral retinal degenerations
such as lattice degeneration (Figure 4.5) in myopia which, when combined with the occurrence of
posterior vitreous detachment at a younger age in myopia, results in higher rates of RD.275 There is
also an increased risk of RD following cataract surgery in myopia when compared to non-myopes.275
There have been several reports describing an increase in RD prevalence over time.276,277 It is difficult
to establish the exact cause for this population level increase in RD prevalence but some authors
point to increasing myopia prevalence as the most likely culprit.276,277 The association of RD with
cataract surgery makes this conclusion difficult to confirm due to the increasing number of cataract
surgeries performed every year however there are also increases in RD prevalence in phakic eyes
which likely is associated with myopia prevalence.277 Some authors have also noted an increasing
prevalence of RD at younger ages which may be as a result of a generational shift in myopia
prevalence given RD prevalence usually increases with age to a maximum prevalence at age 70.278
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Figure 4.5: Lattice degeneration confers an increased risk of retinal tears and occurs with greater
frequency in myopia. Adapted from https://www.asrs.org/patients/retinal-diseases/36/latticedegeneration

The retina is not the only structure affected by myopia with significant alteration of the optic nerve
head (ONH) and associated structures occurring in myopia.279 Myopia is considered a risk factor for
the development of open angle glaucoma (OAG) with a meta-analysis of 48,161 individuals showing
an OR of developing glaucoma of 1.92 for any level of myopia and 2.46 for high myopia (≤ -3.00 D
SER).280 There are very few population based longitudinal studies of OAG development in myopia. An
Italian study conducted comprehensive exams on 411 participants 12 years apart and found high
myopia (< -6.00 D SER) was the highest risk factor for developing OAG.281 The exact mechanism by
which myopia confers an increased risk of OAG is poorly understood but is thought to involve the
stretching of the lamina cribrosa as a result of the axial elongation that takes place in myopia.279 This
results in increased strain on retinal ganglion cells making them more susceptible to damage due to
higher intra-ocular pressure (IOP).282 One of the difficulties in establishing the link between myopia
and OAG, is the difficulty in diagnosing OAG in myopia. Many of the structural changes that take
place at the ONH in myopia can simulate glaucomatous optic neuropathy making diagnosis of OAG
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challenging (Figure 4.6) which has resulted in the suggestion that the relationship between OAG and
myopia may be overstated and may in fact be due to an over-diagnosis of OAG in high myopia.279

Figure 4.6: Two optic nerves in highly myopic eyes. Image 1 has been diagnosed with glaucoma
while image 2 has no glaucoma. The similarity in appearance of the two optic nerves
demonstrates the difficulty in making this diagnosis. Adapted from
https://www.aao.org/eyenet/article/myopia-glaucoma-sorting-out-diagnosis

Age related cataract has also been associated with myopia however the development of index
myopia with nuclear sclerotic cataracts confounds the exact relationship. A meta-analysis found
myopia was associated with prevalent nuclear and posterior subcapsular cataract however no
longitudinal relationship was found between myopia and any form of cataract.283 The authors
suggested the association with prevalent cataract was likely due to the confounding of index myopia.
A borderline significant relationship was observed between incident posterior subcapsular cataract
and myopia with the authors suggesting a more significant relationship may be observed with a
larger sample size and longer follow-up. To overcome the issue of index myopia some investigators
have used the need for distance glasses at a young age as a surrogate for myopia. Using this
strategy, myopia was found to be an independent risk factor for posterior subcapsular cataract.284
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4.4.2 Causes of Vision Impairment in Hyperopia
The association between vision impairment and hyperopia is less well studied than myopia. The
most significant ocular disease associations for hyperopia have been found with AMD and angle
closure glaucoma (ACG). A meta-analysis investigated the relationship between hyperopia and AMD
increased odds of both incident and prevalent AMD in hyperopes.285 The authors found a 6 – 9%
increase in risk of AMD each dioptre increase in hyperopia. They also found that myopia was
protective against AMD. The mechanism by which hyperopia increases the risk of AMD has not been
established. It has been suggested the increased scleral rigidity in hyperopic eyes when compared to
myopic eyes may contribute to the risk of AMD.286 The higher rate of posterior vitreous detachment
in myopic eyes has also been suggested as being protective against the development of AMD
possibly explaining the comparatively higher rate of AMD in hyperopia.285
Hyperopia is also considered a risk factor for ACG. The first association of hyperopia as a risk factor
for ACG was made in 1970.287 Since then, several studies have examined this in differing populations
with conflicting results. The Beijing Eye Study found hyperopia was associated with having a shallow
anterior chamber which was in turn associated with ACG.288 A study in India also found a relationship
between hyperopia and ACG but only in participants living in an urban environment.289 The authors
suggested that index myopia due to cataract may have masked underlying hyperopia in the rural
participants. Conversely, a Dutch study did not observe the association between hyperopia and
ACG.290 All of the above studies did observe having a shorter axial length as a significant risk factor
for ACG.288–290 These conflicting results may stem from two sources. The true risk factor for ACG is
likely having a shorter axial length, for which hyperopia is a surrogate measure however as
hyperopia is a balance of the axial length and refracting surface of the eyes, not all eyes that are
hyperopic have a shorter axial length. Additionally, hyperopia is treated as a categorical rather than
continuous variable in these studies. As an eye with a high level of hyperopia is far more likely to
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have a short axial length when compared to an eye with a low level of hyperopia, it is not necessarily
correct to consider both eyes the same when analysing the risk of ACG.

4.4.3 Impact of Myopic Complications
In recent times several studies have been carried out to determine the prevalence of complications
due to myopia and also the impact these complications have by causing vision impairment. Similar
work has not been carried out for hyperopia most likely as the changes in myopia prevalence as
described in chapter 3 necessitate more urgent action. The overall risk associated with hyperopia to
ocular health is also not as significant as that found for myopia.29
The prevalence of MMD in highly myopic eyes has been studied in both European291 and Asian292,293
populations. A high prevalence was observed in Asian eyes in one study292 with 22.9% of eyes
demonstrating clinically significant MMD. Lower prevalence of MMD of approximately 8 – 9% was
observed in both Asian and European populations.291,293 The exact distribution of myopia was not
fully described in any study making direct comparison difficult but a variation in this distribution may
explain the difference in MMD prevalence. All studies observed MMD prevalence increased both
with increasing level of myopia and increasing age. Significantly, the increase in MMD prevalence
was not linear but increased exponentially with increased level of myopia and age. This highlights a
significant limitation of many epidemiological studies of refractive error which often do not report
the prevalence of myopia or hyperopia as a distribution. In many cases just the total prevalence is
reported which makes accurately estimating the risk of vision impairment due to refractive error
impossible as the risk varies as refractive error increases and importantly, the risk does not vary in a
linear manner.
Several studies have assessed the risk of vision impairment due to myopia and have also found the
risk increases non-linearly with increasing age and level of myopia.294,295 Tideman et al294 estimated a
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cumulative risk of vision impairment by age 75 or older of over 90% for eyes having an axial length of
30mm or greater. This is supported by a recent French study which observed a rate of vision
impairment in 60 years olds having very high myopia (< -10 D SER) of 25.71%. Using these results a
recent study296 developed a model to predict the age-related cumulative risk of vision impairment
which the authors used to predict lifetime years of vision impairment at various thresholds of
myopia. The highest number of estimated years of vision impairment was observed at higher levels
of myopia however even lower levels of myopia such as -3 D SER resulted in an estimated 4.4 years
of vision impairment.
These estimates are concerning due to the apparent generational shift in myopia prevalence rates
described in chapter 3. As these younger myopes age there is likely to be a significant increase in the
number of individuals affected by vision impairment due to complications related to myopia. Fricke
et al297 estimated that by 2050 over 55 million people worldwide would have some form of vision
impairment due to MMD alone, exceeding the current number of people over age 50 estimated to
have moderate to severe vision impairment due to AMD, glaucoma and DR combined.256 Fricke et al
did not include the fact that low and moderate myopes can also develop MMD in their estimates
which may mean these figures are an underestimation however the authors state the likely increase
in the use of myopia control and the development of better treatments may offset this
underestimation.297 There is relatively little global prevalence data on MMD however the VLEG
recently estimated that blindness and MSVI due to MMD had increased in China by 200% and 340%
respectively256 which although only representing one county, may support the projections by Fricke
et al.297
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4.4.4 Near Vision Impairment
Near vision impairment (NVI) is estimated to effect over 500 million people globally and is the most
common type vision impairment.5,207 NVI is primarily associated with uncorrected and
undercorrected presbyopia and as such primarily affects older individuals however hyperopia can
also cause NVI and can be present in both young and old. Establishing trends in NVI is difficult due to
a relative lack of epidemiological data for both presbyopia and hyperopia (chapter 3) however
changes in the published prevalence over the last decade indicate NVI is increasing as a result of an
aging population.163,207 The prevalence of NVI due to uncorrected and undercorrected presbyopia is
estimated to have increased from 517 million in 2005 to 826 million in 2015,163,207 a substantial
increase in just 10 years. This increase is not expected to continue due to the increasing prevalence
of myopia and the compensatory effect myopia has on NVI due to presbyopia. It is predicted that by
2050 presbyopia prevalence may decrease by as much as 20% due to the predicted increase in
myopia prevalence.207 It should be noted however that NVI primarily occurs in low and middle
income countries due to a lack of access to refractive error correction207,256 so even if NVI reduces
due to increasing myopia many of these individuals will have a distance vision impairment due to
uncorrected myopia unless refractive error correction becomes more available in these countries.
Apart from the impact on the individual, this level of uncorrected and undercorrected presbyopia
has been estimated to have a significant economic impact with an estimated global productivity loss
of $25 billion or 0.037% of global gross domestic product (GDP).298 Some work has been done
estimating the effect of the provision of near refractive error correction. Chan et al summarised the
published results of near vision correction provision finding several observational studies and one
RCT study which demonstrated the improvement in QoL for the individual and improved work life
and productivity.299 Significant increases in productivity were seen among 268 textile workers in
South Africa that were provided with a near refractive error correction having previously had
correctable near vision of 6/9 Snellen or worse.300 Strong evidence of this improvement of
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productivity with near vision correction is provided by the only RCT study in this field.301 The authors
divided Indian tea pickers into intervention and control groups and provided near refractive error
correction to the intervention group and the same to the control group 11 weeks later, after the
study period had elapsed. They found an increase in productivity of 20% in the intervention group
with over 98% of participants finding the glasses useful or very useful 95% saying they would pay to
replace them if they were broken.
The provision of near refractive error correction is a simple and inexpensive method to significantly
improve QoL and productivity among low- and middle-income country inhabitants. This simple
intervention was at least as good and, in many cases, better when compared to other interventions
to improve productivity in this type of population.301 This intervention also extends to other aspects
of life such as the increasing use of smartphones playing an important part of daily communications
for people from all over the world, the ability to see well at near distances is likely to become even
more important.299

4.5 Summary
Vision impairment has significant individual and societal costs. The rate of blindness has reduced
internationally however the rate of vision impairment has increased. There is relatively little data on
vision impairment in the Republic of Ireland with the most recent estimation predating significant
changes in eyecare such as the widespread use of anti-VEGF treatments that will likely have altered
the main cause of vision impairment. Refractive error remains a significant contributor to vision
impairment, primarily due to undercorrection. This is particularly an issue with regards to
uncorrected presbyopia and NVI as NVI represents the most common reason for vision impairment
globally and is likely to increase due to aging populations. The increasing prevalence of myopia is
likely to be a significant challenge when addressing global vision impairment, not only due to the
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need provide correction for myopia, but also due to substantial increase in risk of uncorrectable
vision loss associated with higher levels of myopia.
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5.2 Abstract:
Big Data and artificial intelligence are technologies that are poised to significantly alter the provision
of healthcare in the near future. As a field that generates large volumes of digital clinical data in the
form of both electronic medical records and imaging, eyecare is at the forefront of these changes. To
date eyecare has already benefited from the use of Big Data and artificial intelligence in the areas of
disease epidemiology, disease screening and surveillance and treatment outcomes. In this review,
we introduce the concept of Big Data and artificial intelligence and explore their relationship. We
also describe the types of Big Data that can be utilised in eyecare, provide examples of the
application of Big Data and artificial intelligence in eyecare and describe how to interpret research in
this area.
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5.3 Introduction
By the end of 2020 it was estimated that the volume of digital information in existence will exceed
44 trillion gigabytes or over 40 times as many bytes as the estimated number of stars in the
observable universe.6 The pace of data generation is also accelerating rapidly with the amount of
data generated daily expected to reach almost 500 billion gigabytes by 2025.6 This massive
proliferation of data has led to use of the term “Big Data” (BD) in an effort to describe this ever
expanding amount of heterogenous data. Harnessing the value within BD may facilitate new
knowledge discovery with data being referred to in recent times as a more valuable resource than
oil.302
Healthcare being a field that generates large volumes of data is one which has been shown to
benefit from the use of Big Data analytics (BDA).7 Subspecialities within healthcare that make
increased use of imaging technology may particularly benefit from BDA due to the large data storage
requirements needed. The use of imaging is commonplace in the field of eyecare which has resulted
in this being the area with the most BDA research taking place in all of healthcare.303 As a new and
rapidly expanding field, BDA in eyecare may be unfamiliar to many practitioners. This review
therefore seeks to describe BDA, how it might be applied in eyecare and the tools it may provide
practitioners in the future.

5.3.1 How Big is Big Data?
The exact definition of BD is somewhat vague and would appear to vary with domain.304 In the realm
of healthcare, the characteristics of BD are usually described using 5 V’s; volume, variety, velocity,
veracity and value.305 The “Big” in Big Data derives from the volume of data usually associated with
this type of analysis. How large the volume of data must be to be considered BD is somewhat
disputed. Baro et al suggest the logarithm of the number of individuals multiplied by the number of
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variables i.e. log(n*p) should equal 7 or more to be considered BD, however many published works
using the term BD do not meet this criteria.304 The size of the data is not the only characteristic
common to BD. Diversity in the type of data collected is another feature with much of the data used
in this field collected for other purposes such as insurance billing.306 The increasing use of wearable
health sensors allows data to be gathered and analysed in real time307 with this type of BD
generation referred to as velocity. BD is often generated in real world settings as opposed to data
generated through typical research which is highly controlled. This can lead to concerns over the
veracity of the data with appropriate steps necessary to ensure the data is accurate. Lastly, BD needs
to have value, simply having a larger sample size does not add value unless this can provide new
insights or improve clinical care giving better outcomes for both patients and clinicians.

5.3.2 Big Data and Artificial Intelligence
A number of terms in this field of research are used to describe different methodologies with
significant overlap between these methodologies which may lead to confusion for a clinician that is
new to this area. Artificial intelligence (AI) is a technique in computer science that allows software to
mimic human intelligence. AI is an umbrella term that includes machine learning (ML) and deep
learning (DL). Machine learning is a form of AI that is not pre-programmed but instead learns from a
training set of data. An example of a training set may be both normal and abnormal retinal images.
Based on the training set of retinal images the software will create an algorithm to detect abnormal
images. A test set of images will then be assessed using the algorithm which will allow the
calculation of the accuracy, sensitivity and specificity of the algorithm. This would be considered an
example of unsupervised ML. Supervised ML is a similar technique however the training set of
images will be labelled as normal or abnormal otherwise known as the “ground truth” which can
improve the ML algorithm. Deep learning, also known as convolutional neural networks, is a form of
ML that utilises multiple layers of algorithms to generate results.
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The association between BD and AI techniques is shown in Figure 5.1. Although BDA and AI can be
used independently of each other, there is significant overlap. Many ML and DL techniques require
huge datasets to appropriately train the underlying algorithm and hence make use of BD. Equally
some insights on BD can only be observed using ML or DL.

Figure 5.1: Association between Big Data (BD) and Artificial Intelligence (AI)

5.4 Big Data in Eyecare
In the field of eyecare, BD is derived from multiple sources which vary from EMRs and national
insurance records containing observations on thousands to millions of individuals to genomic testing
which can generate millions of variables for each individual assessed. Each of the various sources of
BD present their own opportunities and challenges and often need varying approaches to analysis.
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5.4.1 Electronic Medical Records
In most fields of medical care, EMRs have replaced traditional paper based records with up to 95% of
primary care physicians reporting they used EMRs in 2012,308 a figure which has likely only increased
in the intervening years. EMRs represent a potentially enormous wealth of untapped patient data to
be exploited. In recent years, several authors have used EMR data to answer research questions
relating to epidemiology of ocular disease,295,309–312 treatment efficacy,313–315 disease progression
prediction316–318 and to develop novel screening and disease monitoring systems.318,319 Recognising
the potential of EMRs, the American Academy of Ophthalmology created the Intelligent Research In
Sight (IRIS) registry which allows their members to upload deidentified EMR data which can be made
available for research purposes.320 At the time of writing approximately 350 million visits of 60
million patients have been collated with insights published on glaucoma321 and cataract surgery,322
amblyopia,323 complications of myopia310 and treatment outcomes for diabetic macular oedema324 to
name a few.
A challenge present in EMR data is the data format. The data available is often both structured and
unstructured in nature. For example, refractive error data will likely be recorded in an easy to
analyse numeric format while ocular health information may be recorded using free text. The
possible impact of this variation was illustrated nicely by Stein et al325 who used a combination of
International Statistical Classification of Diseases and Related Health Problems (ICD) codes and
natural language processing (NLP) of free text notes to determine the prevalence of exfoliation
syndrome in a large EMR dataset. The prevalence of exfoliation syndrome found when using ICD
codes alone was only 40% of that found when NLP was used indicating the variability of the
completeness of the records. Researchers using EMR data need to be cognisant of this when
conducting their analysis and ensure the analysis is correctly tailored to the type of data available.
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5.4.2 Insurance Records
Some of the earliest forms of BD research in eyecare used insurance claims records as the primary
data source.326 These records represent a readily available source of data on ocular disease and
treatment and typically contain information on huge numbers of the population. Insurance claims
records are usually more limited in scope than EMRs as they usually contain demographic
information and disease and treatment coding for each patient but often do not contain more
nuanced information.327 For example, a patient may be coded as having glaucoma but the record
might not provide more accurate coding which indicates if it is closed angle or open angle glaucoma.
Even if more accurate coding is present, it is usually not possible to determine the severity of the
condition or the effect on the patient.328 There is also the potential for referral bias as those with
mild forms of the disease under consideration may not present for treatment. The most significant
limitation with this type of data is the ability to draw population level conclusions. In most cases the
relevant insurance may only be accessed by a particular cohort of a population such as those able to
afford the insurance or a particular segment of society to whom national insurance schemes may be
targeted e.g., the elderly.306,329 Conversely, some jurisdictions with universal health insurance
coverage can provide findings which are generalisable to the entire population.330,331

5.4.3 Image Databases and Biobanks
One of the most common applications of BD in eyecare is as a data source for AI models. In recent
years there has been significant interest in developing AI models to detect ocular disease using
images generated by ocular imaging techniques such as fundus photography and optical coherence
tomography (OCT) scans.332–334 Developing such an AI model requires train, test and validation image
datasets. Publicly available image sets have been available for a number of years, many of which
have been reviewed by domain experts and have been appropriately labelled to serve as a ground
truth for AI models.335–338 Most of these datasets consist of images numbering in the hundreds, it is
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only in recent times that substantially larger image datasets have become available. Kaggle is a data
science education platform and hosts thousands of public datasets including several large retinal
image datasets with some numbering close to 100,000 OCT scans.339,340
The UK Biobank is step further than an image dataset and is a prospective large scale population
study designed to determine environmental and genetic effects on health outcomes.341 A group of
500,000 participants aged 40-69 were assessed between 2006 and 2010 and continue to be followed
through repeat assessments and through linkages with other national datasets.341 Included within
the data collected for each participant are datasets containing refractive error, intraocular pressure,
visual acuity and OCT images.341 Combining this with each participants health, environment and
genetic data has already resulted in many interesting findings that may influence not only disease
treatment342 and monitoring343,344 in individual patients but also public health decisions.345–347

5.4.4 Smart Health Devices
The internet of things (IoT) enables physical devices to collect and report data in real time. The
introduction of IoT health devices may allow for near constant monitoring of areas of concern by
clinicians, patients and health-conscious members of the public. This constant monitoring generates
huge volumes of data which will only increase as the use of these devices becomes more
widespread. There are several devices in development and in active use in eyecare that aim to
provide ongoing patient monitoring. The Clouclip is a wearable device that was developed for use in
children at risk of progressive myopia. The device detects the light intensity of the environment and
the distance at which near work348 is being undertaken both of which have been found to increase
the risk of progressive myopia.41,50 Typically, studies assessing the effect of near work and time spent
outdoors on the development or progression of myopia rely on self-reporting by the study
participants or their parents41,50 which carries a risk of misreporting.349 More objective monitoring of
these risk factors using a device such as the Clouclip may help researchers to more fully understand
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the relationship between myopia development and these risk factors. This device has also been used
to modify behaviour in children and was successful at reducing behaviours that increase the risk of
myopia development.350 Intra-ocular pressure measurement is another area that would benefit from
constant monitoring. The SENSIMED Triggerfish (Sensimed AG, Lausanne, Switzerland) is a contact
lens that infers the diurnal variation in IOP by detecting small changes in ocular circumference when
it is worn.351 Although this device is only used for a single 24-hour period, it is not difficult to imagine
a future device being used by glaucoma patients to self-monitor their IOP in much the same way
diabetic patients monitor their blood glucose levels. Devices such as the Clouclip or Triggerfish may
potentially provide clinicians with a large volume of real-time health data for their patients which
could allow for more individualised health planning and interventions.

5.4.5 Multi-omics
The term “omics” refers to characterization and quantification of biological molecules that are
grouped according to their structure and function.352 Just some of the areas of study encapsulated
within “omics” include genomics, epigenomics and proteomics with genomics being the first and
most widely studied field of “omics”.352 Over the last decade the number of GWAS has increased
dramatically since the first GWAS was performed to determine any genetic risk factors for the
development of AMD.353 GWAS are usually designed as observational studies using a case control
design with cases recruited for individuals with the disease of interest and controls recruited from
individuals without the disease. Each individual is genotyped for approximately one million single
nucleotide polymorphisms (SNPs) with odds ratios for the relevant disease calculated for each
SNP.354 This results in a huge volume of data for each study participant and requires significant
computational resources.
Numerous GWAS have been performed in the field of eyecare since the first study identifying risk
factors for AMD.353 To date GWAS have been carried out which have identified genetic risk factors
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for ocular diseases such as glaucoma,355,356 DR357,358 and AMD353,359–362 along with GWAS that have
established genetic links to ocular parameters such as refractive error,105,363,364 corneal curvature,365
axial length365,366 and IOP.367,368 As many ocular conditions have a complex aetiology with no single
causative agent, the interaction between the genetic risk of a disease and the environment is of
particular interest. GWAS can facilitate a better understanding of this interaction such as the
significantly increased risk of myopia when both high levels of education and higher genetic risk are
present compared to when only one is present.107

5.5 Interpreting Results
It is important to recognise that although BD can provide answers to questions that were previously
impossible to answer, merely having a larger dataset does not negate the potential limitations that
are present in all study designs. For example, a GWAS is an observational study and despite the huge
volume of data and genetic associations that would previously have been unknown, as an
observational study a GWAS can only establish correlation but not causation.369 Care also needs to
be taken when reporting statistical significance. Due to the very high number of SNPs (≈ 1 million)
for each participant and their relatively small effect size, there is a risk of a type 2 error in a
GWAS.354,370 To avoid this possibility, the best GWAS have large sample sizes numbering thousands
of cases and controls.354,370 The very large number of SNPs in each GWAS implies traditional
statistical significance values of p < 0.05 are far more likely to occur by chance and hence much
smaller significance values of the order of p < 5 x 10-8 are to be expected.354 Any BD study of
sufficient size will suffer from similar problems and hence the clinical significance of a finding should
be considered of greater importance than if an arbitrary statistical significance value of p < 0.05 has
been reached.
Typically, a well-designed and comprehensively reported study using AI will describe using both a
training and testing data set. A BD dataset such as those found in EMRs or from imaging tools is split
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in two with approximately 70-80% of the data assigned to the training dataset and 20-30% assigned
to the testing dataset. Ideally data for the same patient is not found in both datasets. Studies with
the best design will make use of a completely separate dataset for testing which has come from a
different population.
Many AI studies quote figures for sensitivity and specificity when describing their results. Most
healthcare practitioners will be familiar with these concepts as they apply to the accuracy of
different testing techniques with tests with high sensitivity able to correctly identify a patient with a
disease and tests with high specificity able to correctly identify patients without a disease.371 In the
field of AI, these terms are often used to describe the performance of a disease predication model
although the terms recall and precision are sometimes used as alternatives to sensitivity and
specificity respectively.371 The ideal medical test or disease prediction model will give 100%
sensitivity and 100% specificity meaning all diseased patients are detected as having the disease and
no healthy patients are detected as having the disease. In reality, this is impossible to achieve but
some diagnostic tests can approach these values. This limitation gives rise to designing medical tests
to be biased towards greater sensitivity or specificity as both cannot typically be achieved. In AI
models the concept of thresholding achieves the same outcome with thresholds selected that will
give higher sensitivity or specificity. Disease screening AI models usually have thresholds selected
that will give outcomes with higher sensitivity to ensure as few patients with the disease are missed
as is possible even if this means some normal patients are incorrectly found to have the disease. As
these models are used for screening purposes, any normal patient detected as diseased should be
correctly classified at a later stage when reviewed by a domain expert.
The accuracy of any AI model used in eyecare can be described by its ability to correctly classify
individuals into subgroups e.g., a disease is present or is not present. The most common method of
reporting accuracy is using the receiver operating characteristic (ROC) curve. The unusual name
derives from its initial use by operators of radar receivers during World War II.372 The ROC curve
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shows sensitivity of the test on the y axis and 1 - specificity of the test on the x axis. This allows the
trade-off between sensitivity and specificity to be visualised. Examples of various ROC curves are
given in Figure 5.2.

Figure 5.2: Examples of receiver operator characteristic (ROC) curves with levels of accuracy
represented by area under the curves (AUC) ranging from perfect (pink line) to random (orange
line.

A perfect test that provides 100% sensitivity and 100% specificity and hence perfectly detects all
individuals with a disease and all those without a disease will have a ROC curve with a point at (0, 1)
represented by the pink line in Figure 5.2. This may also be described as having an area under the
curve (AUC) of 1.0. The opposite situation i.e., a useless test, is represented by the orange line going
from (0, 0) to (1, 1) in Figure 5.2. This test is as likely to give a true positive result as it is a false
positive result and is essentially no different from flipping a coin with an AUC of 0.5. Most AI models
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will be somewhere between these two examples with the best models approaching an AUC of 1.0.
The use of descriptive terms for AI models such as excellent or poor is somewhat arbitrary and
models should ideally be compared to alternatives in the field. A model which provides an AUC of
0.90 may be considered poor when compared to an alternative that achieves an AUC of 0.98 while a
model with an AUC of 0.6 may be considered good if no alternative is currently available.

5.6 Applications of Big Data in Eyecare
The value of BD and AI has been increasingly recognised within the research community with a
significant increase in the number of publications using these and related terms in their titles in
recent years (Figure 5.3). BD has been used to good effect in multiple areas of ocular research
including; disease epidemiology, disease screening and treatment outcomes.

Figure 5.3: Results of a Web of Science search for the number of publications per year containing
any of the terms “Big Data”, “Artificial Intelligence”, “Machine Learning” or “Deep Learning” in the
fields of ophthalmology or optometry
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5.6.1 Epidemiology
One of the most obvious uses of BD in eyecare is in disease epidemiology. Most epidemiological
studies of disease examine the disease prevalence at a single point in time with relatively few largescale longitudinal studies. This is most likely due to the significant time and cost involved in carrying
out such studies. This can make accurate public health planning and forecasting difficult if the
needed epidemiological data is either outdated or non-existent.3 BD offers an opportunity to exploit
readily available longitudinal data which can address this problem with studies on dry eye,311
uveitis,330,331 retinal detachment,276 AMD,373 diabetic eye disease,374 adult onset strabismus,375
glaucoma,376,377 endophthalmitis378 and many others having been conducted using data from EMRs
and insurance claims records in recent years.
BD is of particular use in the epidemiology of rare diseases. Accurately determining the prevalence
of a rare disease within a population can be very difficult and requires large sample sizes. Figure 5.4
gives an example using refractive error data from a recently published BD study of refractive error.309
The data is taken from spectacle lens manufacturing records (n = 134,280,063) and the Gutenberg
Health Survey (GHS),14 a large (n = 13,959) typical population survey of refractive error. Although
refractive error is in no way a rare disease, higher absolute values of refractive error become
increasingly rare within a population due to the leptokurtotic population distribution of refractive
error. Figure 5.4 shows the number of occurrences for each value of SER for worse levels of myopia.
Intuitively, the number of occurrences should reduce uniformly with worsening myopia. The GHS
shows increased variability when compared to the spectacle lens data. As both datasets are
essentially population samples, this pattern indicates it may be necessary to use much larger sample
sizes to accurately determine the occurrence of rare ocular diseases within the population.
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Figure 5.4: Comparison of the distribution of myopia in the Gutenberg Health Survey (GHS), a
typical population survey of refractive error (n = 13,959) and a Big Data study using spectacle lens
manufacturing records (n = 134,280,063). At these higher levels of myopic refractive error there is
increased variance in the GHS as the sample size is likely too small to adequately describe the
underlying population trend.

5.6.2 Disease Screening
The increase in chronic disease associated with an aging population has put increased pressure on
the need for disease screening and surveillance. The number of eyecare professionals available to
meet this need is not keeping pace with the growing global population.5,258 This unmet need may
result in increased levels of vision impairment5 and is the primary reason that disease screening
represents one of the areas of most interest in BD and AI research in eyecare.334 Outlined below are
some of the positive findings and developments from AI for three common ocular conditions;
diabetic retinopathy, glaucoma and refractive error.
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5.6.2.1 Diabetic Retinopathy
Much of the initial usage of AI and BD in the field of eyecare has centred around diabetic retinopathy
(DR) screening. As the rates of diabetes are increasing internationally,379 the need for more DR
screening has increased significantly and, in many countries, this exceeds the capacity of the
available eyecare services.380 AI which can accurately diagnose the presence of DR to determine if
review by an eyecare clinician is necessary would significantly relieve these capacity issues. The first
successful AI tool developed for DR screening was described by Gulshan et al.381 It used a training
dataset of 128,175 retinal images to develop the screening algorithm which was validated against
two test datasets comprising 9,963 and 1,748 retinal images. Optimizing the algorithm for high
sensitivity, as would be needed for a screening service, the sensitivity and specificity were 97.5% and
93.4% for the first test data set and 96.1% and 93.9% for the second test data set. This model was
later tested against both non-physician trained graders of retinal images and retinal specialists to
determine the difference in sensitivity and specificity for moderate to severe DR and referable
diabetic macular oedema (DMO).382 In all cases the AI algorithm was observed to be as good or
better than both the trained graders and retinal specialists at detecting both DR and DMO. When
used as a tool to aid in diagnosing DR by ophthalmologists with varying levels of training, the
sensitivity of the ophthalmologists was improved by using the AI algorithm demonstrating its
usefulness in diagnosis as well as screening.383

5.6.2.2 Glaucoma
Glaucoma is another condition that has been of significant interest to AI researchers. The majority of
AI research in glaucoma has focussed on the diagnosis of glaucomatous optic neuropathy (GON)
using OCT scans.384 Multiple approaches have been used with AI models trained to utilise OCT
parameters such as retinal nerve fibre layer (RNFL) thickness,385,386 en face images,385 b scan
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images387 and volumetric scans.388 Several different methodologies have been used when creating AI
models to detect GON using OCT data with some observed to be more effective than others. Most AI
models achieved a better AUC to detect GON when compared to OCT parameters alone.384
Despite the success that has been achieved using AI and OCT in glaucoma diagnosis, there are some
limitations. Most significantly, despite increased adoption of OCT in clinical practice in high income
countries, the high purchase price of an OCT will prevent an AI model based solely on OCT
parameters from being clinically useful in areas without access to OCT such as low- and middleincome countries. AI models have also been developed which are based on fundus images which are
much more widely used and less costly.389,390 These models have shown very good sensitivity to
detect GON with AUCs of 0.945389 and 0.986390 found in two separate models. These models are,
however, built on a ground truth of labelled normal and glaucomatous fundus images which may
itself be subject to a misclassification error as the agreement between experts when labelling these
images is only slight to fair.391 A recent study attempted to overcome this limitation by using an AI
model to determine RNFL thickness from fundus images and use these values to detect GON.392 The
authors found close agreement between the AI determined RNFL thickness values and those directly
measured by OCT.392 This may provide a more objective method to assess fundus images for GON
and as such overcome this limitation when developing AI models for GON screening using fundus
images.

5.6.2.3 Refractive Error
Refractive error is another area in which useful applications of BD and AI have been developed. The
increasing levels of myopia, and in particular high myopia, globally3 are of significant concern due to
the associated vision loss in later life.114,294 Due to the significant research that has taken place in the
area of myopia control we are now entering an era where myopia may be considered a modifiable
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risk factor for vision impairment.62,393,394 Identifying children at an early age that would most benefit
from myopia control is crucial to achieve the best outcomes.394 A recent study utilised BD in the form
of electronic medical records of 129,242 children to develop a ML model that could predict the
likelihood of a child becoming highly myopic.316 When assessed on external test datasets, the model
was able to accurately predict the likelihood of high myopia by 18 years old as early as age 10. Use of
this model could allow practitioners to identify those most at risk of high myopia at a young age and
provide appropriate intervention.
The use of AI to determine refractive error using fundus images only has been recently reported.395
The DL model used was able to predict the refractive error with a mean absolute error of 0.56
dioptres. The exact features that allow the model to predict refractive error are unknown however
heat maps showed the fovea was the area that most contributed to the prediction. The anatomical
changes of the fundus that take place with myopia are well established270 however no clinician
would be able to predict the refractive error associated with those changes with any degree of
precision. The accuracy achieved and ease of use of this methodology is no better than
autorefraction so this model is unlikely to have any real-world application. However, by identifying
associations between retinal appearance and refractive error that human clinicians cannot observe,
new insights into the pathophysiology of refractive error may be determined.395
These are just three examples of the disease screening capabilities of AI. Work is progressing on AI
powered disease screening in many areas of eyecare with encouraging results observed in detecting
cataract,396 AMD,397 retinopathy of prematurity398 and cardiovascular risk.399

5.6.3 Treatment Outcomes
In recent times there is an increasing recognition that although randomised controlled trials (RCTs)
represent the gold standard in determining the safety and efficacy of a treatment, the results are not
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always replicated in real-world clinical scenarios.400 RCTs by their nature require strict inclusion and
exclusion criteria which means the results may not be as generalisable to a heterogenous clinical
population. This has given rise to increased use of real-world data in place of and in addition to
results from RCTs to optimise patient treatment, a practice that appears to be supported by the
literature.401
One of the most significant examples of real-world data affecting clinical treatment in eyecare is the
finding that the use of anti-VEGF drugs for patients with neovascular AMD but still having good
visual acuity (> 6/12 Snellen) offered better outcomes when compared to those whose initial
treatment was after visual acuity had deteriorated.402 The authors results were determined using a
large EMR dataset of patients that had received treatment for neovascular AMD. As the patients
involved had good visual acuity to begin, it is unlikely this research question would have been
explored using an RCT as there may not have been a perceived benefit in treating patients with good
vision. There are several other examples of BD providing information on treatment outcomes that
have implications for clinical practice. For rare events such as endophthalmitis following cataract
surgery, it is necessary to have sufficient statistical power to determine if the case rate has reduced
following a change in practice such as combined surgery or the use of intracameral antibiotics.315
Additional studies have also used BD to demonstrate an increased reoperation rate in strabismus
surgery with increasing age403 and an indication for earlier use of anti-VEGF drugs in myopic
choroidal neovascularisation.314

5.7 Limitations
Despite the apparent potential BD and AI hold as both public health and clinical tools, there are
some challenges to be overcome before widespread adoption can occur. Accessing data and
ensuring the data used is of high quality are issues that still need to be overcome in future
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applications of BD and AI in eyecare. In many cases despite the proliferation of medical data, data
from EMRs, insurance records and image capture devices is not easily accessible to researchers in BD
and AI with the result that some datasets currently in use may lack heterogeneity and as such may
not be applicable to all populations.334 Greater collaboration between data holders and researchers
can overcome this issue however issues of data privacy need to be respected to ensure widespread
acceptance. Greater collaboration and use of larger datasets can also help with issues of data
accuracy, particularly in the case of AI disease screening models. These models use a “ground truth”
dataset to make their diagnosis, if this is a small dataset labelled by one or two individuals, the
subsequent model may learn the same biases as the clinicians that initially labelled the “ground
truth”.404 A recent call for researchers to make datasets available publicly in an easily accessible
repository may be the first step towards overcoming this issue.405
One of the most significant challenges lies in convincing clinicians of the accuracy and reliability of
these tools. Many of the AI models developed to date provide little explanation as to how the clinical
decision has been made and leave clinicians in a position of trusting a “black box”.334,406 To overcome
this limitation several models have added heatmaps to their output to allow clinicians understand
what part of the image has contributed most to the diagnosis.388,395 Heatmaps however have been
criticised as being difficult to interpret and can struggle to adequately demonstrate a situation
where no disease is present.334 Further development is ongoing in this area with a recent study using
adversarial examples to more clearly highlight how the AI model diagnosis was generated.407
Conversely in settings where the tools provided by BD and AI become more commonplace, clinicians
are at potential risk of losing their clinical skills and decision-making ability. Automation
complacency is a form of bias that can occur in clinicians that make frequent use of automated
diagnostic tools.408 Clinicians can base their decision solely on the guidance of a machine without
attempting seek additional confirmatory evidence.406 This has been found to occur most frequently
when the case is predicted to be normal409 and clinicians are performing multiple tasks.408
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5.8 Conclusion
The use of BD and AI in the field of eyecare and medicine in general looks set to grow at a rapid pace
in the coming years. This changing clinical environment offers the opportunity to gain new insights
into disease epidemiology, pathophysiology and treatment. Most significantly, some AI enabled
tools may offer the solution to overburdened disease screening and surveillance systems allowing
more efficient use of clinician time and achieve better public health outcomes. To make these
possibilities a reality, it is vital that clinicians understand what an AI model can and cannot achieve.
This will require a willingness to adapt to a changing clinical environment on the part of the clinician
but will also require an increased effort on the part of researchers and developers to ensure the
tools they develop are easy to use and interpretable.
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6 Data Collection and Demographics

6.1 Introduction
Chapter 3 describes many of the epidemiological studies of refractive error carried out to date.
Although there is a much-improved understanding of refractive error distribution and the changes
that have taken place over the last several decades, there are significant gaps in our knowledge.
Many countries and geographic areas have no published data on refractive error.3 The first survey of
refractive error distribution in the Republic of Ireland was only carried out quite recently216 and it is
unclear if any future surveys will take place.
Traditional methods of reporting refractive error data are by cohort, cross-sectional or longitudinal
study. These study designs involve recruiting participants and in the case of longitudinal studies
reassessing these same participants at given intervals. The data collection therefore requires
significant time and financial resources to acquire which likely explains the lack of data in some
areas. Another possible explanation for a lack of refractive error data in some areas may be that
increasing myopia prevalence is not perceived as a significant problem by the general public.
McCrann et al268 showed that the majority of parents in Ireland did not consider myopia to be a
health risk. The authors noted that the number of parents that considered myopia an inconvenience
was the same as the number that considered it a health risk. This is despite myopia being as
significant a health risk for ocular disease as hypertension is for cardiovascular disease.29 This may
not be the case in all locations with more widespread use of myopia control initiatives in Asia
indicating greater understanding of the problem among the public.54 The findings of McCrann et al268
may indicate there is a lack of understanding of the health risks associated with refractive error
among the public is some countries making funding and adequate recruitment for epidemiological
studies more difficult.
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6.1.1 Hypotheses
Alternative sources of refractive error and vision data may provide a unique opportunity to address
some of these gaps in the research. EMRs and spectacle lens sales records represent two such
sources of data. Therefore, the primary aim of this research was to examine and validate alternative
data sources and methods to determine the distribution of refractive error and vision across the
general population and validate these results against pre-existing research. Secondary aims were to
use these results to estimate the vision impairment due to myopia in a population and demonstrate
how these data sources and methods can be used as a basis for public health policy. The following
research questions were posed in order to achieve these aims:

i.

Can alternative sources of refractive error data be used as a surrogate for population surveys
of refractive error?

ii.

What is the distribution of refractive error in Europe/Ireland using alternative data sources?

iii.

Can the levels of vision impairment due to refractive error be estimated using these
techniques?

iv.

Are the current vision screening standards for driving done at appropriate intervals?

This chapter describes the method by which the data was acquired for this project. An overview and
analysis of the available demographic information contained within the data is provided.
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6.2 Methods
6.2.1 Ethics
Approval for this study was obtained from the Technological University Dublin (TU Dublin) (formerly
known as the Dublin Institute of Technology) Research Ethics Committee. The research adhered to
the principles of the Declaration of Helsinki.

6.2.2 Data Collection
After consultation between researchers at TU Dublin and Ocuco Limited, an agreement was reached
to provide anonymised patient information from private optometry practices. Ocuco provides an
EMR system tailored for use in eyecare called Acuitas. This system has been available for over 20
years and is currently used in over 8,000 practices worldwide. Before the data is supplied, the
practice owner as the data controller must sign a consent form (Appendix 1) to allow extraction of
their patient data. Practices were recruited through word of mouth, through the Association for
Optometrists Ireland (Appendix 2) and at educational events around the country. Once consent has
been obtained, the data is extracted as 14 separate comma-separated values (CSV) files for each
practice with each CSV providing various clinical data such as refraction, VA, IOP, and fundoscopy. A
new anonymised patient identifier is generated for each patient which allows patients to be tracked
across the 14 separate CSV files and across multiple visits. The data can be re-extracted on an as
needed basis to allow ongoing monitoring.
A similar agreement was reached with Carl Zeiss Vision International GmbH (CZVI). CZVI is an
international manufacturer in the area of optics and optoelectronics. CZVI has a substantial
spectacle lens manufacturing business and is usually included among the top producers of spectacle
lenses internationally. CZVI agreed to provide data on all spectacle lenses they had shipped from
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their European production facility based in Germany. Data was provided in a single large CSV file
with accompanying information describing lens codes and delivery locations.

6.2.3 Data Management
To facilitate analysis, the EMR data needed to be converted form the delivered 14 CSV files to one
single file containing the required data. This was achieved by creating a database using the SQLite
database engine (Hipp, Wyrick & Company, Inc., Charlotte, North Carolina, USA) and performing a
series of joins (Appendix 3) to allow a single data file to be extracted.
As CZVI provided data in a single file, pre-processing before analysis was unnecessary however due
to the very large data size minimum computing hardware requirements were necessary. The primary
computing bottleneck was having sufficient random-access memory (RAM) with local machines
requiring at least 64 gigabytes of RAM or the use of cloud computing resources. The data was
analysed using the R programming language (R Core Team (2020). R: A language and environment
for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL
https://www.R-project.org/).
Several refraction values were provided in the EMR dataset. These included auto-refraction,
focimetry, retinoscopy, subjective refraction and refraction given. The most consistently recorded
value was the refraction given which represents the refraction to be dispensed if the patient was to
purchase spectacles. As this was the most consistently recorded refraction this was used for all
analysis. Refraction values for both datasets were converted to SER by adding half the cylinder value
to the sphere value. The method by which refraction was carried out was not available for the
spectacle lens data and whether cycloplegia had been used was not recorded for either dataset.
Visual acuity values within the EMR data when available were typically recorded as Snellen and
saved as a string variable. To allow appropriate analysis these values were converted to logMAR
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using a custom function written in the R programming language (Appendix 4). Due to the uneven
number of letters on each line of a Snellen chart the function first rounds to the nearest achieved
line and then converts this to a logMAR value.

6.2.4 Data Protection Compliance and Data Storage
This study is compliant with the general data protection regulations which came into force on the
25th May 2018 (Data Protection Act 2018). The European Union General Data Protection
Regulations (GDPR) were implemented in Ireland by the Data Protection Act 2018. Recital 26 of the
GDPR discusses anonymisation of data and advises only data which could be used to identify a
natural person should be considered personal data and subject to the GDPR. The data used in this
study was anonymised before delivery to the researchers in such a way as to remove personally
identifying data and to prevent the data from being de-anonymised.
The data used in this study was subject to appropriate data access controls with password
protection of all primary and backup data which was stored on secured TU Dublin servers. Consent
forms provided by practice owners were also stored on secured TU Dublin servers. Consent forms
that were returned as hard copies were scanned so that an electronic copy could be stored on
secured TU Dublin servers. The original hard copy was stored in a locked filing cabinet with restricted
access.

6.2.5 Data Description and Demographic Analysis
An overview of the data collected to date was generated with any temporal trends in the data
assessed using linear regression. Where available, demographic information was presented and
compared to publicly available census data.
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6.3 Results
6.3.1 Data Overview
At the time of writing, the most recent extract of EMR data took place in July 2020 with the data
representing 40 practices around Ireland. At this time the dataset comprised 722,393 visits of
303,727 unique patients which represents approximately 6% of the population of the Republic of
Ireland. A sample of the format of 10 patient visit records following conversion to a single data file is
given in Table 6.1. Significantly more variables were available for each patient record however the
majority of the work carried out as part of this project was confined to analysis of refractive error
and visual acuity data as represented in Table 6.1. Patient data is available from 1980 up to the
present day although the number of records before 2000 are minimal. From the year 2000 onwards
the percentage of patient visits increased every year and could be modelled with a linear regression
(t = 23.09, p < 0.001, R2 = 0.97) as shown in Figure 6.1.
In total there were 141,547,436 spectacle lens sales records ranging from the 1998 to 2016. A
sample of the format of 10 spectacle lens sales records is given in Table 6.2. Prior to the year 2001
very few records were available and from the year 2002 onwards there was no statistically
significant change (t = 1.459, p = 0.86) in the percentage of records each year (Figure 6.2).
For both datasets there was very little missing or malformed data with less than 1% of the data for
both datasets considered missing or uninterpretable. Missing or uninterpretable data was easily
dealt with by confining the analysis to realistic values and excluding unrealistic values. For example,
excluding sphere values greater than an absolute value of 30.
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Table 6.1: Sample of 10 electronic medical record (EMR) patient visit records following conversion from 14 separate comma-separated values (CSV) files.

Table 6.2: Sample of 10 spectacle lens records as supplied by Carl Zeiss Vision International GmbH (CZVI).
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Figure 6.1: Percentage of electronic medical record (EMR) patient visits in each year. The
percentage increases linearly with time (t = 23.09, p < 0.001, R2 = 0.97) as shown by the linear
regression (red line) with 95% confidence intervals (dashed red lines).
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Figure 6.2: Percentage of spectacle lens sales records in each year. No correlation was found
between the year and sales records.

6.3.2 Geographic Overview
The significant majority (≈ 98%) of spectacle lenses produced were for delivery in Europe (Table 6.3)
with Germany consistently the largest consumer accounting for an average of 48% of all lens
deliveries over the period 2007 – 2015 (Table 6.4). The geographic distribution of the EMR data is
shown in Figure 6.3 which is a screengrab of an interactive map (available at
https://irelandrefractiveerror.shinyapps.io/PatientDistribution/). All counties are represented within
the dataset however they are not evenly represented with the highest percentage of patient visits
occurring in Dublin (25.8%) while several counties have less than 1% of all patient visits.
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Table 6.3: Proportion of Carl Zeiss Vision International GmbH (CZVI) spectacle lenses produced in
Europe by final destination in global regions.
2007

2008

2009

2010

2011

2012

2013

2014

2015

Europe

97.4%

98.3%

98.4%

98.6%

98.3%

98.2%

98.1%

97.3%

97.3%

Asia

1.9%

1.3%

1.3%

1.2%

1.2%

1.0%

1.1%

1.0%

1.3%

America 0.4%

0.2%

0.1%

0.1%

0.3%

0.5%

0.3%

0.4%

0.6%

Africa

0.2%

0.1%

0.1%

0.1%

0.1%

0.3%

0.5%

0.4%

0.6%

Oceania

0.2%

0.1%

0.1%

0.0%

0.0%

0.0%

0.1%

0.9%

0.1%

Table 6.4: Top 15 countries for Carl Zeiss Vision International GmbH (CZVI) spectacle lens delivery
for the years 2007 – 2015.
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Figure 6.3: Geographic distribution of electronic medical record (EMR) patient visits around Ireland. All counties are represented with the highest number
of visits occurring in Dublin. Interactive version available at: https://irelandrefractiveerror.shinyapps.io/PatientDistribution/
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6.3.3 Age and Gender Analysis
Age and gender information was not available for the spectacle lens sales data. A method for
inferring the age of some of the spectacle lens users is described in chapter 7.4. The mean age for
the total EMR dataset was 47.08 ± 22.20 years while it was 47.61 ± 21.98 years in females and 47.39
± 22.72 years in males. The mean age was observed to increase over time and could be accurately
modelled with a linear regression (t = 12.71, p < 0.001, R2 = 0.89) as shown in Figure 6.4.

Figure 6.4: The mean age of EMR patients increased with exam year as shown by linear regression
(red line) with 95% confidence intervals (dashed red lines).

The gender distribution for the EMR dataset was 52.8% female, 36.1% male and not recorded in
11.1% of cases. This was statistically different (two-sided binomial test, p < 0.001) to the most recent
census report of 51.1% female.410 This difference was apparent across all age groups apart from
young children (Figure 6.5).
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Figure 6.5: Gender and age distribution of EMR patients. The gender distribution for the EMR
dataset was 52.8% female, 36.1% male and not recorded in 11.1% of cases. The mean age for the
total EMR dataset was 47.08 ± 22.20 years.

6.4 Discussion
The data collected for this study presents a unique opportunity to explore the potential of
alternative sources of refractive error and vision data. This is of particular interest given the
significant lack of refractive error and vision data available around the world.3,5 The level of detail
available in both datasets is significantly different allowing a far more nuanced exploration of the
EMR data.
The time trends in both the EMR and spectacle lens datasets are interesting even if they are
somewhat anticipated. The consistent level of lenses produced from the year 2002 onwards is
explained by the complete switch over to electronic ordering of lenses that occurred in CZVI in the
early 2000’s (Figure 6.4). The relatively static number of lenses produced each year reflects the
established position of CZVI in spectacle lens market. The increasing number of records available per
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year in the EMR data is also expected due to the increasing use of EMRs among healthcare providers
over this time period.411 Although these results are expected further exploration of these trends may
provide more useful findings such evidence for or against the theory of seasonal a variation in
myopia progression.412,413 This might be observed by increased myopic spectacle lens orders during
winter months and higher myopia progression rates in children and young adults in the EMR data
during winter months.
The geographic trends indicate the population under consideration in both datasets is largely
Western European and should compare well with studies of similar populations. The large
representation of Germans in the spectacle lens sales data (Figure 6.5) is unsurprising given lens
production takes place in Germany. Despite the significant number of lenses that were for delivery in
Germany there is still a wide spread of locations in Western Europe so the data should be
representative of this population. EMR patient visits are not evenly spread around the country but
occur with a much higher density in some counties, particularly Dublin. To some extent this is likely
as a result of the population density in Ireland with the highest densities occurring in the Greater
Dublin Area (GDA) however other urban areas with high population densities in the Republic of
Ireland are not represented to a similar extent. There are two possible explanations for this
variation. Firstly, the EMR product from which the data is derived may not have equal market
penetration all over the country resulting in a deviation from the population distribution as reported
by the census.414 Secondly, the author is based in Dublin which may have led to increased practice
recruitment in the GDA with less recruitment in other parts of the country. Despite the EMR data not
reflecting the population distribution in Ireland, all counties are represented with a good spread of
data in both urban and rural locations.
The mean age found in the EMR data is older than that found during the most recent census carried
out in Ireland.415 This is likely due to the increased prevalence of ocular disease416,417 and the need
for presbyopia correction in later life.144 The overall pattern of population distribution by age is
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similar to that found by the most recent census with lower population numbers in young adults and
the highest numbers occurring in middle age (Figure 6.8).410 The proportion of young children aged 1
– 5 years is less than observed by the census.410 This is likely as a result of the eyecare structures in
the Republic of Ireland with children of this age needing eyecare usually seen in a hospital or
community ophthalmology setting. The gender distribution observed within the EMR data was more
significantly skewed to females than that observed in the most recent census. This is likely due to
the established lower attendance of men for healthcare checks.418

6.5 Conclusion
Alternative sources of data on refractive error and vision provide a unique opportunity to address
some of the gaps in scientific research on these topics. Further validation by comparison with
published results is necessary to confirm the appropriateness of utilising these alternative data
sources for research purposes. A deep understanding of the underlying data and the limitations
associated with the data is necessary to ensure accurate conclusions can be drawn.
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7.2 Abstract:

Purpose:
To examine whether data sourced from electronic medical records (EMR) and a large industrial
spectacle lens manufacturing database can estimate refractive error distribution within large
populations as an alternative to typical population surveys of refractive error.
Subjects:
A total of 555,528 patient visits from 28 Irish primary care optometry practices between the years
1980 and 2019 and 141,547,436 spectacle lens sales records from an international European lens
manufacturer between the years 1998 and 2016.
Methods:
Anonymized EMR data included demographic, refractive and visual acuity values. Anonymized
spectacle lens data included refractive data. Spectacle lens data was separated into lenses
containing an addition (ADD) and those without an addition (SV). The proportions of refractive
errors from the EMR data and ADD lenses were compared to published results from the European
Eye Epidemiology (E3) Consortium and the Gutenberg Health Study (GHS).
Results:
Age and gender matched proportions of refractive error were comparable in the E3 data and the
EMR data, with no significant difference in the overall refractive error distribution (χ²=527, p=0.29,
DoF=510). EMR data provided a closer match to the E3 refractive error distribution by age than the
ADD lens data. The ADD lens data, however, provided a closer approximation to the E3 data for total
myopia prevalence than the GHS data, up to age 64.
Conclusions:
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The prevalence of refractive error within a population can be estimated using EMR data in the
absence of population surveys in countries with high levels of access to refractive services. Industry
derived sales data can also provide insights on the epidemiology of refractive errors in a population
over certain age ranges. EMR and industrial data may therefore provide a fast and cost-effective
surrogate measure of refractive error distribution that can be used for future health service planning
purposes in countries with good access to optometric and spectacle dispensing services.
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7.3 Introduction:
Refractive error occurs when the eye does not correctly focus light at the retina which results in
blurred vision. It arises as a result of the eye growing too long (myopia/short sightedness), the eye
not growing long enough (hyperopia/long sightedness), uneven focussing due to corneal shape
(astigmatism) or a failure to focus at close ranges due to aging (presbyopia). In order to obtain clear
vision, correction either through the use of optical aids such as spectacles or contact lenses or
refractive surgery is required.
Refractive errors are a leading cause of vision impairment and blindness globally, due to limited
access to optical correction in some regions,419 and the range of ocular diseases for which refractive
errors, in particular myopia, are an identified risk factor.420,421 There is a growing concern about
myopia due to the rapid rise in global prevalence over the last few decades.3 Vitale et al8 found an
increase in myopia prevalence from 25% in 1971 - 1972 to 41.6% in 1999 –2004 in the United States
of America. Similar increases have been observed in Europe, with higher levels of myopia observed
in more recent birth cohorts.38 The largest increases in myopia prevalence have been observed in
Asia,422 particularly east Asia, with rates reaching 84% in older children.151 The level of myopia
prevalence is not as high in South America191,423 or Africa,195 however, it is expected to rise
significantly in all parts of the world in the coming years.3 Holden et al3 estimated that almost half of
the world’s population will be myopic by 2050, with almost 10% set to be highly myopic. The authors
extrapolated these myopia rates by using data from published population surveys of refractive error.
The primary limitation identified in this study was the significant lack of global epidemiological
refractive error data, with many countries having no data whatsoever or significant gaps in data
across different regions, age groups and ethnicities. The authors made specific reference to the
reduced certainty with regards to their high myopia predictions, with only 48 studies contributing
data to these projections.
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In order to assess the public health implications of refractive errors, it is essential to have accurate
population-based epidemiological data. In light of the observed differences between countries and
changing prevalence over time, such data needs to be both representative of a given population and
current. In Europe, epidemiological data has been collected over many decades, often from
historical cohorts. The largest such study,154 the European Eye Epidemiology (E3) consortium of 33
groups from 12 European countries, collated data on 124,000 European participants from population
cohort and cross-sectional studies on refractive error conducted between 1990 and 2013. While this
data does show a trend of increased myopia prevalence for people born in more recent decades, the
available data from recent years and on younger population cohorts is relatively sparse.
Gathering comprehensive epidemiological data that can determine global prevalence trends in
refractive error over time using this traditional methodology is slow and open to question in terms
of cost effectiveness.424,425 For this reason, the growing volume of data gathered in healthcare in
recent years is of specific interest. Data such as electronic medical records (EMR) and industrial
manufacturing or sales records represent a potentially valuable source of secondary data, i.e. data
used for a purpose that is different from that for which it was originally collected. The scale of such
data is often far larger than conventional research datasets and it is now commonly referred to as
Big Data. Big Data is now recognized as an important resource for scientific research, allowing
conclusions to be drawn that would otherwise be impossible using traditional scientific
techniques426,427.
In the field of eyecare, several studies have demonstrated the usefulness of EMR data for
determining disease epidemiology310,311 and treatment outcomes.314,402 The application of such
approaches to myopia genetics research has shown strong correlation with the results obtained
using conventional epidemiological research methodologies.104,105 National330,331 and private
insurance claims records have also been used to determine the epidemiology of several ocular
diseases, as have hospital records.329 Big Data sources of this type can be used as an alternative form
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of epidemiological data, particularly in the absence of conventional epidemiological studies.
Datasets such as national insurance claims records can be generalised to an entire population while
EMR and hospital record data are useful when considering specific population cohorts.
The potential of Big Data as a tool to monitor population trends in refractive error has received little
attention. Optometric EMR data provides an obvious example of a rich source of data on refractive
error that has yet to be exploited for this purpose. Another novel, but less obvious, source of data is
the manufacturing and sales records of companies involved in the supply of optical appliances such
as spectacle and contact lenses. This data source is much more limited in terms of the information
available, but the ubiquity of these optical appliances indicates such data may still elicit useful
insights on refractive error epidemiology.
This study was designed, therefore to examine whether optometric EMR data or spectacle lens data
can provide estimates of refractive error distribution that are comparable to traditional population
surveys.

7.4 Methods:
Anonymized EMR data was gathered from 28 Irish optometry practices. The data was extracted
remotely through the EMR provider following provision of explicit consent from the data (practice)
owners during the period of May 2018 to June 2019 for all 28 practices. The data extracted
comprised all practice records since first use up to the date of extraction for each practice. The EMR
provider removed any personally identifying data and anonymized the data prior to delivery so that
the anonymization could not be reversed by the researchers. The data was analysed using the R
programming language (R Core Team (2020). R: A language and environment for statistical
computing. R Foundation for Statistical Computing, Vienna, Austria. URL https://www.Rproject.org/.). At the time of extraction, a new unique identifying number was generated for each
subject within the EMR data allowing their data to be tracked across multiple visits. The data
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available for each subject included demographic, refractive, visual acuity, binocular vision, contact
lens, ocular health and clinical management data. For this analysis only demographic, refractive and
visual acuity data were considered with most refractions having been performed as non-cycloplegic
subjective refractions.
Anonymized patient spectacle lens sales data was provided by a major European manufacturer. This
comprised lenses that had been manufactured and dispatched after an order was received from a
practitioner with the majority of lenses for delivery within Europe. The data was collated into
histogram data using the SQLite database engine (Hipp, Wyrick & Company, Inc., Charlotte, North
Carolina, USA) and analysed using the R statistical programming language. The data provided
included the spherical power, cylindrical power and axis of the spectacle prescription. The lens
design, diameter, laterality (prescribed for right or left eye) and date of manufacture were also
included. For lens designs with an addition, this was also specified. The presence of an addition
allowed the lenses to be separated into two groups, the single vision (SV) lens group and the
addition (ADD) lens group. The data was validated for missing and malformed data fields and any
lenses with incomplete or invalid data were excluded. The spherical equivalent power was calculated
for each lens.
Data from the E3 study was extracted by digitizing the published results using Plot Digitiser.428 Data
from the GHS study,14 a population based observational study, was also digitized as an additional
comparison. The GHS was chosen as an additional comparison as it took place in Germany, had a
similar age range (35-74) and was one of the component studies of the E3 study. In addition,
Germany was the largest contributor to the spectacle lens data.
Myopia was defined according to the International Myopia standards,93 with a spherical equivalent
refraction (SER) of ≤ -0.50 D being considered myopic, and ≤ -6.00 D SER considered highly myopic.
Hyperopia was defined as ≥ +0.75 D SER and emmetropia defined as > -0.50 D SER and < +0.75 D
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SER. For comparison with the E3 study, analysis was also performed using the myopia definition
used in that study, i.e. ≤ -0.75 D SER.
The E3 study, a meta-analysis on refractive error prevalence in Europe, was chosen as a comparative
study for several reasons. Firstly, the manufacturer database reflected almost exclusively European
lens sales. Secondly, as the spectacle lens data comprised a substantial proportion of reading addition
lenses typically used by older presbyopic adults429 (age ≥ 40-45 typically),163 the adult age profile of
the E3 consortium (age 25-89 years) was deemed suitable, and it was assumed that the datasets could
be comparable. These age assumptions were also validated using the EMR data. With this more
detailed optometric data, both the age and spectacle correction data were available, allowing
determination of the age distribution of patients with single vision and reading addition spectacles.
The relationship between age and reading addition was determined by fitting a logistic function to the
age and right eye reading addition found in the EMR data using the ‘drc’ extension package for R.430 A
logistic function was also created to determine the number of individuals requiring a reading addition
at each age from 1 to 100 years old within the EMR data. The base R predict function was then used
to generate 95% prediction intervals for both logistic models. Probability density functions were
generated for each reading addition value to determine the distribution of age associated with that
reading addition. The ADD lens group then had an estimated age assigned for each spectacle lens
based on the reading addition value for that lens using the probabilities generated from the EMR data.
The EMR data was randomly sampled to provide an age and gender matched population for
comparison with the E3 population. The ADD lens data was also age matched with the E3 population
using the estimated age for each lens. From the age matched EMR and ADD lens data, the proportion
of myopia, high myopia and hyperopia present was calculated in 5-year age brackets to allow
comparison with the E3 and GHS data.
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This study was approved by our institution’s ethics committee and adheres to the tenets of the
Declaration of Helsinki. Due to the irreversible nature of the data anonymization patient level consent
was not required.

7.5 Results:
7.5.1 Spectacle Lens Dispensing and EMR Refractive Error Distribution:
Initially the spectacle lens dataset comprised 141,547,436 lenses from the manufacturer sales
records ranging from the year 1998 to 2016. The acquired EMR dataset included 555,528 patient
visits ranging from the year 1980 to 2019. Records with incomplete or missing data were excluded
from both datasets and only years with complete data were included in the analysis (Figure 7.1). In
total 134,280,063 spectacle lenses were included, comprised of 84,561,994 SV lenses and
49,709,191 ADD lenses. The final EMR dataset was composed of 524,868 patient visits.
Over 97% of spectacle lenses were for delivery within Europe with Germany accounting for the
largest proportion (≈48%) of all lenses delivered. The EMR data included 244,002 unique patients
representing 5.1% of the population of the Republic of Ireland 415. The gender distribution of EMR
patient visits was 51.3% female, 34.9% male and not recorded in 13.8% of records. The 28
optometric practices were located all across the Republic of Ireland representing both rural and
urban populations.
The distribution of refractive error within the EMR data and spectacle lens data are presented in
Figure 7.2, including the complete datasets and also segregated according to lens type (SV or ADD
lens). Table 7.1 summarises the descriptive statistics for each distribution.
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Figure 7.1: Number of spectacle lenses and EMR visits included in analysis
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Figure 7.2: Distribution of spherical equivalent in each dataset
Top Panel - EMR from Irish optometry practices right spherical equivalent distribution for all visits
(n = 536,249), single vision prescriptions (n = 215,207) and addition prescriptions (n = 321,013).
Bottom Panel - Spectacle Lens Distribution from manufacturer data for all lenses (n = 134,280,063),
single vision, (SV) lenses (n = 84,561,994) and addition, (ADD) lenses (n = 49,709,191).

Table 7.1: Mean, range and distribution characteristics of spectacle lens and optometric electronic
medical record (EMR) data.
Dataset
All Spectacle Lenses
SV Lenses
ADD Lenses
All EMR Visits
Visits with SV Rx
Visits with Add Rx

Mean SER (D) ± SD
+0.02 ± 3.08
-0.03 ± 3.22
+0.11 ± 2.84
-0.13 ± 2.50
-0.91 ± 2.74
+0.39 ± 2.17

Skew
-0.80
-0.74
-0.89
-0.74
-0.30
-1.09

Kurtosis
1.73
1.47
2.20
3.19
2.09
5.82

All distributions demonstrate the classic negatively skewed leptokurtotic curve found in most studies
of refractive error, with the majority of observations centred close to emmetropia. The only
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exception to this pattern was the SV spectacle lenses which were found to have a bimodal
distribution with a significant notch apparent at zero spherical equivalent.

7.5.2 Estimating Age Using Reading Addition:
Figure 7.3 shows the relationship between age and the presence of an addition by comparing the
EMR distribution of SER for single vision prescriptions with those aged under 45 and the SER
distribution of prescriptions with an addition and those aged 45 and over. It can be seen that the
distribution of SER for those under age 45 (left panel, histogram bars) is very similar to the
distribution of those prescribed a SV lens (left panel, dashed line), while the distribution of SER for
those over age 45 (right panel, histogram bars) is very similar to the distribution of those prescribed
an ADD lens (right panel, dashed line). The remarkable degree of similarity between being under age
45 and being prescribed single vision (χ² = 552, p = 0.2365, DoF = 529) and being 45 years or older
and being prescribed an addition (χ² = 899, p = 0.2408, DoF = 870) indicates that age and the
prescribing of an addition are highly correlated. Table 7.2 shows the relationship between age and
the likelihood of prescribing a reading addition in the form of a contingency table. A summary of the
distributions and their statistical relationship is given in Table 7.3.
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Figure 7.3: Age and the prescribing of an addition are highly correlated
Distribution of spherical equivalent for those under age 45 (left panel bars) and those age 45 and
over (right panel bars). The dotted line represents the distribution of spherical equivalent for those
given a single vision prescription (left panel) and those given a prescription containing an addition
(right panel).

Table 7.2: Contingency table comparing the frequency of addition prescribing for patients under
age 45 and those age 45 and over.
No Addition Prescribed
204,027
13,515

Under 45
Age 45 or Over

Addition Prescribed
24,512
298,807

Table 7.3: Descriptive statistics comparing single vision optometric electronic medical record (EMR)
prescriptions to younger patients and addition EMR prescriptions to older patients.
Dataset
Single Vision
Under Age 45
Addition
Over Age 45

Mean SE (D)
-0.91 ± 2.74
-0.80 ± 2.66
+0.39 ± 2.17
+0.36 ± 2.25

Skew
-0.30
-0.30
-1.09
-1.16

Kurtosis
2.09
2.26
5.82
5.58
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Chi-Square Test
χ² = 552, p =
0.2365, DoF = 529
χ² = 899, p =
0.2408, DoF = 870

The relationship between age and the power of the addition given in glasses for the EMR data is
shown in Figure 7.4. This relationship could be accurately fitted to a logistic function with nonlinear
regression (estimate = 2.2 D, t = 818.94, p < 0.001). The residual standard error found was 7.56
years.

Figure 7.4: Predicted age based on the prescribed reading addition with 95% prediction intervals

Figure 7.4 also shows the 95% prediction limits for estimating age if only the add is known, as is the
case with lens dispensing data. A logistic function was also fitted to the relationship between the
probability of being prescribed a reading addition and age (estimate = 42.29 years, t = 653.73, p <
0.001). The residual standard error was 1.73%. This allows estimation of the proportion of
individuals at each age likely to require a reading addition (Figure 7.5). These relationships were then
used to infer ages for the ADD lens data. This allowed the generation of sub-populations of a given
age for comparison with the EMR, E3 and GHS data. Using these two functions to determine age
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ranges and by generating probability density functions for each value of reading addition in the EMR
data, the level of myopia, hyperopia and astigmatism was calculated for age groups from ≥45 years
to ≤ 80 years for the ADD lens data.

Figure 7.5: Likelihood of needing a reading addition at different ages with 95% prediction intervals

7.5.3 Comparison with E3:
The distributions of spherical equivalent refraction in the E3 study and the age matched EMR data
were closely matched (χ² = 527, p = 0.29, DoF = 510) with both being negatively skewed
leptokurtotic distributions (Figure 7.6).
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Figure 7.6: Comparison of spherical equivalent distribution between E3 and EMR. E3 distribution of
refractive error spherical equivalent (dotted line) compared to the gender and age matched EMR
distribution of right eye refractive error spherical equivalent (bars).

Age-matched comparison of the level of myopia, hyperopia and astigmatism for EMR relative to E3
data revealed broadly similar distributions across the refractive error types, albeit that the distribution
of myopia was lower and hyperopia higher in the EMR data relative to the E3 data (Table 7.4). The
ADD lens data distributions of myopia, hyperopia and astigmatism were all higher but also similar to
the age matched E3 data (Table 8.5).
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Table 7.4: Age matched comparison of refractive error rates between the E3 consortium and optometric electronic medical record (EMR) data (mean age
= 60.16 ± 12.23 years)
Data Set

E3 (n =
62,393)
EMR (n =
200,076

All
Myopia
≤ -0.75
30.60%

Low Myopia
≤ -0.75 to > -3.00

Moderate Myopia
≤ -3.00 to > -6.00

High Myopia
≤ -6.00

All Hyperopia
≥ +1.00

Emmetropia
> -0.75 to < +1.00

Astigmatism
≥ 1.00

25.23%

High
Hyperopia
≥ +3.00
5.37%

19.50%

8.08%

2.71%

44.17%

23.86%

21.52%

13.56%

5.70%

2.26%

37.89%

7.38%

40.59%

28.38%

Table 7.5: Age matched comparison of refractive error rates between the E3 consortium and spectacle lenses with an addition (ADD) lens data (mean
age = 62.55 ± 8.59 years)
Data Set

All
Myopia
≤ -0.75
22.44%

E3 (n =
50,010)
ADD
28.60%
Lenses (n =
35,720,655

Low Myopia
≤ -0.75 to > -3.00

Moderate Myopia
≤ -3.00 to > -6.00

High Myopia
≤ -6.00

All Hyperopia
≥ +1.00

14.08%

6.24%

1.93%

15.12%

9.52%

3.95%
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Emmetropia
> -0.75 to < +1.00

Astigmatism
≥ 1.00

37.23%

High
Hyperopia
≥ +3.00
7.98%

40.33%

26.96%

43.02%

9.98%

28.38%

31.45%

The E3 reported levels of myopia, hyperopia and high myopia across various age groups were
compared to the EMR, ADD lenses and GHS data across the same age groups (Figure 7.7 – 7.9).
These figures show the EMR data is the closest match to the E3 data. Confidence intervals for the
EMR data were found to be overlapping with the confidence intervals for E3 data at 7 age points for
myopic refractions (Figure 7.7), 6 age points for hyperopic refractions (Figure 7.8) and 12 age points
for highly myopic refractions (Figure 7.9). The ADD lens data, however, provides a closer
approximation to the E3 data for total myopia compared to the GHS data, particularly up to age 64
(Figure 7.7).

Figure 7.7: Total myopia proportion for EMR (inverted triangle), ADD Lenses (triangle), GHS (circle)
and E3 (square) data as a function of age group. The E3 data confidence intervals (dark shaded
area) are plotted to illustrate comparison with the other data sets. The EMR data confidence
intervals (light shaded area) are plotted to show the overlap with the E3 data.
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Figure 7.8: Total hyperopia proportion for EMR (inverted triangle), ADD Lenses (triangle), GHS
(circle) and E3 (square) data as a function of age group. The E3 data confidence intervals (dark
shaded area) are plotted to illustrate comparison with the other data sets. The EMR data
confidence intervals (light shaded area) are plotted to show the overlap with the E3 data.
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Figure 7.9: Total high myopia proportion for EMR (inverted triangle), ADD Lenses (triangle) and E3
(square) data as a function of age group. The E3 data confidence intervals (dark shaded area) are
plotted to illustrate comparison with the other data sets. The EMR data confidence intervals (light
shaded area) are plotted to show the overlap with the E3 data. GHS not present as high myopia
data was unavailable.

7.6 Discussion:
Our results indicate that EMR data provides a close approximation to refractive error prevalence
values found as part of the E3 study. Age related variation in the proportions of myopes and
hyperopes are similar across the EMR and E3 data. Although the EMR data falls outside the E3
confidence intervals at some points in both comparisons, this is also true of the GHS data which was
a component study of the E3 dataset, with the EMR data providing a closer match to the E3 than the
GHS data. As the confidence intervals indicate the likely position of the mean of the study population
some fluctuation is expected when comparing different study populations.
It was possible to estimate the likely recipient age for every spectacle lens prescription containing a
reading addition by using the EMR data. This was achieved based on the observation that a
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significant majority of EMR patient visits below the age of 40 years were not prescribed an addition
while the majority of patients visits above the age of 50 years were prescribed an addition. Along
with the presence of an addition, the power of the reading addition was also found to provide a
means of estimating a patient’s age. These inferences allowed an estimated age to be associated
with each spectacle lens containing an addition within the spectacle lens sales dataset. The
combination of disparate data sources to provide greater insight is a hallmark of Big Data analysis,305
and in this case allowed a deeper understanding of the usefulness of the spectacle lens sales data as
a source of epidemiological data of refractive error.
Having accurate and current information on the prevalence of refractive error is vital to allow health
services to plan for the increasing need for optical correction and the increased burden due to the
ocular comorbidities273,276,280,421,431 associated with increasing refractive error. Myopia is of particular
concern as it is estimated that up to 49.8% of the global population will be myopic by 2050 and 9.8%
of those will be highly myopic.3 The combination of high myopia and increasing age have been found
to be a risk factor for vision impairment and blindness.294 A recent meta-analysis found a significantly
increased risk of myopic macular degeneration and retinal detachment in high myopes with reduced
visual acuity and worse treatment outcomes in eyes with these conditions.114 Assessing any change
to the prevalence of high myopia within a population is the area of most concern when considering
the ocular comorbidities associated with refractive error. EMR data contains refractive error
information and patient demographics including age, which can help to determine the population
risk of vision impairment. The EMR data provides a good match to the E3 study for high myopia
(Figure 7.9) and as such may be an invaluable method to determine the ongoing risk of vision
impairment.
While conventional epidemiological studies remain the gold standard, they have some
disadvantages. The most reliable studies have large sample sizes allowing their results to be
generalized to the entire population. Such sample sizes require significant investment and time to
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conduct the study, which perhaps explains the relative lack of epidemiological studies of refractive
error and significant lack of longitudinal studies of refractive error. This paucity of data also
contributes to uncertainty with regards to future projections of myopia prevalence.3 Where such
data is not available, EMR or industrial data may have a useful role as these are increasingly being
collected as a matter of routine and can be collected with greater ease and at more regular intervals.
It is important to acknowledge that all epidemiological studies suffer from various forms of bias. For
example, it is well established that most cross sectional studies suffer from volunteer bias, with
volunteers usually from higher socio-economic backgrounds with a higher level of education.432
Longitudinal studies frequently suffer from loss to follow up which may induce a bias in the profile of
the remaining study population. It is important, therefore, when designing an epidemiological survey
of refractive error to attempt to minimise these biases. Big data studies on refractive error will not
suffer with the same biases as the data was not collected for the purpose of determining the
population burden of refractive error. This type of epidemiological study will however, have a
different set of biases which need to be considered. A frequent criticism of the secondary use of
EMR data concerns the lack of access to healthcare of some population cohorts433 due to a lack of
health insurance. As this EMR data has come from a jurisdiction with free access to eyecare which is
widely availed of, this should not create a significant bias in our data,434,435 although it should be
acknowledged some population cohorts do not access healthcare readily, even when provided free
of charge, for a myriad of reasons. Results from the UK indicating very high usage of refractive
services imply these individuals are likely to represent a very small cohort.436 Less frequent
replacement of spectacle lenses from those of lower socio-economic backgrounds may present a
more significant issue with regards to the spectacle lens dispensing data and is a very significant
limitation in countries where poor access to spectacles is a leading cause of vision impairment.256
Measurement error can exist as a bias in any epidemiological study but may be well controlled in
small studies through standardization of equipment and procedures. In a Big Data study of this
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nature, this is not possible. Nevertheless, error rates of subjective refraction in adults are typically
low at between 1% and 2%, indicating the vast majority of refractions should be accurate to within ±
0.50 D of the correct refraction.437,438
It should be acknowledged that both EMR and spectacle lens datasets are likely to only be available
in countries with good access to eyecare and as such this methodology will have a much more
limited application in countries with poor access to refractive services. In those countries with good
access to refractive services, for this data to be representative, there needs to be a high level of use
of these services. There are no published usage rates for refractive services in Ireland however a
2013 survey from the UK, Ireland’s nearest neighbour, indicates very high use of refractive services
with 74% of the population using a refractive correction and greater than 96% of the population
over the age of 50 using a refractive correction.436
There are several limitations to this study that must be considered. In relation to spectacle lens data,
demographic information of the individuals purchasing the spectacle lenses is not typically available
in industrial datasets. Geographic information is likely to be available, however, which can provide
some useful information. Using the EMR data to infer the age of a cohort of the spectacle lens users
enhances the usefulness of this data, but the overall lack of demographic information means that
further conclusions on subpopulations cannot be drawn. In this study, the spectacle lens data was
supplied by one manufacturer. Economic factors and market penetration may have an effect on the
background of the consumer choosing lenses from this manufacturer. Industrial data could be
biased, for example, to particular socio-economic, ethnic or other demographic subgroups for
reasons such as product cost, geographic location and other factors specific to individual
manufacturers. Higher educational attainment is associated with both socio-economic status and
myopia,38 for example, so the possibility that the oversampling of individuals from particular
backgrounds within individual datasets might influence population estimates of refractive error
needs to be considered.
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Under sampling of emmetropic patients is a more significant issue for the spectacle lens data as
these represent spectacle lens sales. This will tend to produce an apparent increased proportion of
hyperopic and myopic refractive errors, especially for younger subjects, as observed in this study. It
is unlikely that emmetropic patients are purchasing spectacle lenses in significant numbers. This is
particularly evident when considering the SV lenses in Figure 7.3. The notch apparent at zero dioptric
power represents the reduction in purchasing of spectacle lenses by this group. It might be expected
that the number of zero power lenses would be smaller than was observed, but there are plausible
reasons to explain this. In cases of anisometropia one eye may have a zero-power lens when the
fellow eye needs correction. In addition, the computation of spherical equivalent may result in zero
spherical equivalent power for lenses prescribed to patients with mixed astigmatism. The lack of
emmetropes represented within the spectacle lens sales data presents a problem and may explain
the poorer match to the E3 study relative to EMR data. This implies that such data may be more
representative of the distribution of refractive error within a population above a certain threshold of
refractive error. The greatest risk of uncorrectable visual impairment due to refractive error are
associated with high levels of myopia,114 and also high levels of hyperopia.421 These are both
categories likely to seek optical correction due to the significant symptoms associated with each,
particularly in countries with easy access to free eyecare such as Ireland. Further analysis and
modelling may remove the limitation associated with the under sampling of emmetropes and allow
the determination of the risk of vision impairment in those using spectacle lenses to correct higher
refractive errors (Chapter 8).
There are fewer limitations applicable to the EMR data due to the increased demographic detail
captured in this data. Under sampling of emmetropic patients is likely to be less problematic for the
EMR data which includes refraction data found as part of a patient’s eye examination. Emmetropic
patients are still likely to attend routine eye examinations for the purposes of screening for common
ocular pathologies such as glaucoma and cataract.439 Importantly, EMR data is likely to be highly
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representative of the older population given the almost universal need for optical correction as
presbyopia begins to manifest as a problem, even for emmetropes and low hyperopes who did not
previously need correction. This is particularly the case in most countries in Europe where subsidised
eye examinations are accessible to the majority of the population.257 The close match of the EMR
and E3 data observed herein suggests that the EMR is representative of the population at large. The
results indicate that the EMR and E3 data are a close match but the underlying assumption that a
European meta-analysis of refractive error is the best comparator to an Irish population is not
necessarily true. The most ideal comparator would be an Irish population survey of refractive error;
however, none exist. As the E3 study is the largest such study in Europe and the results are similar to
other surveys of refractive error of populations similar to Ireland in Western Europe,14,154,159 this is
the best currently available data with which to draw a comparison.
In this EMR dataset, it was not possible to tell what type of refraction had been performed to reach
the refractive error prescribed. Cycloplegic refraction is performed to avoid the errors in refraction
that can be induced by accommodation in children and the use of cycloplegia is considered the most
appropriate method to assess refractive error for research purposes.169 Although it is unknown how
many of these refractions have been performed with the aid of cycloplegia, a significant number of
epidemiological surveys on refractive error have been carried out without the use of cycloplegia.422 It
has been found that accommodation mostly affects the determination of refractive error in children
and has little impact on adults164,165, particularly older adults.166 The technique of refraction used,
therefore, should have little impact on the primarily adult dataset used herein.

7.7 Conclusion:
The prevalence of refractive error within a population can be estimated using EMR data in the
absence of population surveys in countries with high levels of access to refractive services. Results
from EMR data also allow age to be inferred from the addition in a spectacle lens. Industry derived
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sales can then be used to provide insights on the epidemiology of refractive errors in a population
over certain age ranges. EMR and industrial data may therefore provide a fast and cost-effective
surrogate measure of refractive error distribution that can be used for future health service planning
purposes in countries with good access to optometric and spectacle dispensing services.
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8.2 Abstract
Objective:
To investigate whether spectacle lens sales data can be used to estimate the population distribution
of refractive error amongst ametropes and hence estimate the current and future risk of vision
impairment.

Design:
Cross Sectional Study

Subjects:
A total 141,547,436 spectacle lens sales records from an international European lens manufacturer
between the years 1998 and 2016.

Methods:
Anonymized patient spectacle lens sales data including refractive error information was provided by
a major European spectacle lens manufacturer. Data from the Gutenberg Health Survey was
digitized to allow comparison of a representative, population-based sample to the spectacle lens
sales data. A bootstrap analysis was completed to assess the comparability of both datasets. The
expected level of vision impairment due to myopia at age 75 was calculated for both datasets using a
previously published risk estimation equation combined with a saturation function.

Main Outcome Measures:
Comparability of spectacle lens sales data on refractive error to typical population surveys of
refractive error and its potential utility to predict vision impairment due to refractive error.

Results:
Equivalent estimates of the population distribution of spherical equivalent refraction can be
provided from spectacle lens data within limits. For myopia, the population distribution was
equivalent to the Gutenberg Health Survey (≤ 5% deviation) for levels ≤-2.0 dioptres, while for
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hyperopia the distribution was equivalent (≤ 5% deviation) for levels ≥ +3.0 diopters. The estimated
rates of vision impairment due to myopia were not statistically significantly different (χ2 = 182, DoF =
169, p = 0.234) between the spectacle lens data and Gutenberg Health Survey data.

Conclusions:
The distribution of refractive error and hence the risk of vision impairment due to refractive error
within a population can be determined using spectacle lens sales data. Pooling this type of data from
multiple industry sources could provide a cost effective, timely and globally representative
mechanism for monitoring the evolving epidemiology of refractive error and associated vision
impairment.
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8.3 Introduction
Vision impairment is a huge challenge internationally which is projected to worsen as a consequence
of global population aging unless significant effort is made to address the many underlying causes.
Refractive error has been identified as a risk factor for the development of numerous ocular
pathologies which can lead to vision impairment. Significant refractive errors, both myopic and
hyperopic, are known to be amblyogenic in children.440 Higher degrees of hyperopia is a risk factor
for the development of age-related macular degeneration (AMD),421 while higher levels of myopia
are known to increase the risk of glaucoma,441 cataract,442 retinal detachment443 and myopic
maculopathy.272
The individual and societal cost of vision impairment is substantial. Societal costs can be measured
by the loss of productivity254 and the need to provide adequate medical care and support to those
affected by vision impairment.444 Those with vision impairment are more likely to require support in
day to day living, suffer from falls and have health or emotional problems interfere with their
life.245,444 Quality of life is also significantly affected, with vision impairment having a similar impact
as stroke, heart attack and diabetes,445 and even mild vision impairment associated with reduced
quality of life.446
Refractive error typically develops in childhood.29 The association between refractive error and
vision impairment, however, does not become apparent for many decades and is a function of
refractive error type and magnitude as well as increasing age.285,294,295 Myopia is the refractive error
that is of most concern. It has been demonstrated that there is an increased lifetime risk of vision
impairment with all levels of myopia, but particularly at higher levels.294 A recent meta-analysis
indicated that one in three high myopes are at risk of bilateral vision impairment within their lifetime
and that even low to moderate myopes are at significantly increased risk of ocular disease and
disability.114 There is an increasing amount of evidence that the prevalence of myopia within the
population has increased over the last number of decades. The most significant increases have been
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observed in Asian populations422 with some countries seeing over 90% of children become myopic by
the late teenage years.153,447 Although ethnicity appears to play a role, there is evidence of increasing
prevalence of myopia in many populations around the world.8,38,236,448
It is important to have current and easily accessible refractive error epidemiological data in order to
plan appropriate public health resource allocation to meet the need for correction of refractive error
and treatment of any associated pathology, particularly in the context of a changing population
burden of refractive error. Holden et al.’s landmark paper3 predicted that by 2050 almost 50% of the
global population will be myopic, with nearly 10% of the population falling into the highly myopic
category (using a threshold of -5 D). This is of great concern given the likelihood of increased levels
of vision impairment due to both uncorrected refractive error and the ocular pathology associated
with myopia. Holden et al.3 used existing epidemiological studies to make their predictions. They
identified the lack of epidemiological data in “many countries and age groups, across representative
geographic areas”3 as a significant limitation of their study, with predictions of high myopia
prevalence particularly susceptible to the paucity of available evidence. The lack of epidemiolocal
data is not surprising given the time and financial investment required to carry out these studies.
As the risk of vision loss associated with increasing refractive error is non-linear,114,294,295 it is not
sufficient to merely establish the proportion of the population affected by myopia or hyperopia. It is
necessary to determine the number of individuals affected by different levels of refractive error
within a population to gain a true insight into the population risk of vision impairment due to
refractive error.
Spectacle lens sales data represents a potential source of contemporary refractive error data which,
if made accessible, could provide valuable insights into the changing epidemiology of refractive error
and associated risks of vision impairment. The value and limitations of spectacle lens sales data as an
epidemiological tool to determine refractive error distribution in a population has previously been
described.309 Principally, the distribution of refractive error found in spectacle lens sales data does
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not follow standard population distributions of refractive error as individuals with no refractive error
do not typically purchase spectacles lenses, hence emmetropes and near-emmetropes are underrepresented in such data. The symptomatic nature of higher levels of refractive error implies that
the majority of the population affected are likely to use spectacles, particularly in high income
countries where the visual demands associated with education and employment are high and where
subsidised access to eyecare is available.257 Most studies of refractive error epidemiology report
their distributions across the entire range of refractive error. By concentrating analysis on the
myopic and hyperopic ends or tails of the distribution, rather than the central emmetropic range of
the distribution it may be possible to use spectacle lens sales data as an epidemiological tool.
The aim of this paper, therefore, was to investigate whether spectacle lens sales data can be used to
estimate the population distribution of refractive error amongst ametropes and hence estimate the
current and future impact of refractive errors on the risk of vision impairment.

8.4 Methods
Anonymized patient spectacle lens sales data were provided by a major European spectacle lens
manufacturer. This dataset (n=141,547,436) comprised lenses that had been manufactured and
dispatched after an order was received from an eye care practitioner, with the majority (> 98%) of
lenses for delivery within Europe. The data was collated into histogram data using the SQLite
database engine (Hipp, Wyrick & Company, Inc., Charlotte, North Carolina, USA) and analyzed using
the R statistical programming language (R Core Team (2021). R: A language and environment for
statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL https://www.Rproject.org/.). The Technological University Dublin Research Ethics Committee approved this study
and which adhered to the tenets of the Declaration of Helsinki. The data provided included the
spherical power, cylindrical power and axis of the spectacle prescription, lens design, diameter,
laterality (prescribed for right or left eye) and date of manufacture. For lens designs with a addition,
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this was also specified. The presence of an addition allowed the lenses to be separated into two
groups, the single vision (SV) lens group and the addition (ADD) lens group. The data was validated
for missing and malformed data fields and any lenses with incomplete or invalid data were excluded.
The spherical equivalent power was calculated for each lens.
Data from the Gutenberg Health Study14 (GHS) study was extracted by digitizing the published
results using Plot Digitiser (http://plotdigitizer.sourceforge.net/). The GHS was chosen as a
comparison for several reasons. Firstly, the GHS took place in Mainz, Germany and the manufacturer
database reflected almost exclusively European lens sales, with Germany the largest contributor (≈
48%). Secondly, as the spectacle lens data comprised a substantial proportion of reading addition
lenses typically used by older presbyopic adults429 (age ≥ 40-45 typically),163 the adult age profile of
the GHS (age 35-74 years) was comparable.
Myopia and hyperopia were analyzed using the definitions given by the GHS i.e., a spherical
equivalent (SE) refractive error of < -0.50 D being considered myopic and a SE refractive error of >
0.75 D being considered hyperopic. High myopia was defined as SE ≤ -6.00 D. The International
Myopia Institute recommends the adoption of an agreed standard for myopia of ≤ -0.50 D93 so
results using this criterion are also reported.
To determine confidence intervals of the estimates, a bootstrapping technique was used to generate
1,000 new distributions of refractive error from the SV and ADD lens data, with each new
distribution comprising the same original sample size as the GHS (n = 13,959). Bootstrapping is a
statistical technique which involves constructing many samples by randomly drawing sets of
observations from a dataset.449,450 These multiple samples can then be used to calculate test
statistics and confidence intervals.449,450 The new distributions were constructed using the ‘infer’
extension package for R. With this technique, the mean number of cases for each 1 D bin value of
spherical equivalent was calculated along with 95% confidence intervals. This was repeated for both
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the myopic and hyperopic tails of the distributions and the results were compared to the GHS
distribution of refractive error.
In order to determine the range of refractive error values over which the bootstrap analysis should
take place, the analysis was repeated with different spherical equivalent starting values, starting at 0
D spherical equivalent and changing in 1 D steps for both the myopic and hyperopic tails of the
distribution. This allowed the deviance between the calculated 95% confidence intervals and the
GHS distribution to be determined.
The final fitted bootstrapped distributions were generated which allowed comparison with the GHS.
The proportion of each diopter value of myopia and hyperopia was calculated within the range that
was found to match the GHS well. The odds ratio of vision impairment due to myopia at each diopter
value of myopia was determined using equation 1 as described by Bullimore et al296 and was
modelled on published data and models that relate refractive error and age to vision impairment
risk.294,295 Vision impairment was defined as 20/67 (0.3 decimal visual acuity equivalent) or worse,
the same definition used by Bullimore et al.296 The odds ratio was converted into vision impairment
risk percentage using equation 2. This allowed the expected level of vision impairment by age 75 for
a sample of 100,000 SV spectacle lens users to be calculated. This was compared to the expected
level of vision impairment at age 75 over the same range of myopia for participants in the GHS.

𝑽𝒊𝒔𝒊𝒐𝒏 𝑰𝒎𝒑𝒂𝒊𝒓𝒎𝒆𝒏𝒕 𝑶𝒅𝒅𝒔 𝑹𝒂𝒕𝒊𝒐 = 𝟏. 𝟐𝟔 × 𝟏𝟎(𝟎.𝟎𝟓𝟕 × 𝑨𝒈𝒆 − 𝟎.𝟏𝟐𝟐 × 𝑺𝑬 − 𝟒.𝟎𝟑)
Equation 8.1: Vision Impairment Odds Ratio due to Myopia

𝑽𝒊𝒔𝒊𝒐𝒏 𝑰𝒎𝒑𝒂𝒊𝒓𝒎𝒆𝒏𝒕 𝑹𝒊𝒔𝒌 = (

𝑶𝒅𝒅𝒔 𝑹𝒂𝒕𝒊𝒐
) × 𝟏. 𝟐𝟔 × 𝟏𝟎𝟎
(𝟏 − 𝟏. 𝟐𝟔) + (𝟏. 𝟐𝟔 + 𝑶𝒅𝒅𝒔 𝑹𝒂𝒕𝒊𝒐)
Equation 8.2: Vision Impairment Risk due to Myopia
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8.5 Results
The spectacle lens dataset comprised 141.5 million lenses from the manufacturer sales records
ranging from the year 1998 to 2016. Records with incomplete or missing data were excluded, and
only years with complete data were included in the analysis. In total 134.3 million spectacle lenses
were included, comprised of 84.6 million SV lenses and 49.7 million ADD lenses.
The distribution of refractive error for the SV, ADD lenses and the GHS are shown in Figure 8.1. All
distributions demonstrate the classic negatively skewed leptokurtotic curve found in most studies of
refractive error, with the majority of observations centred close to emmetropia. The only exception
to this pattern was the SV spectacle lenses which were found to have a bimodal distribution with a
significant notch apparent at zero spherical equivalent. Table 8.1 shows the proportion of myopia
and hyperopia found in each dataset. The most significant difference observed was in the proportion
of emmetropia present, with much lower levels in all spectacle lens datasets.
Repeating the bootstrapping technique for both the myopic and hyperopic tails of each distribution,
it was found that the deviation between the actual occurrence of each 1 D value of spherical
equivalent for the GHS and all of the spectacle lens data sets was greatest (over 50%) at 0 D
spherical equivalent. The deviation reduced to 5% or less between -2 D and -15 D for the myopic end
of the distributions and between +3 D and +15 D for the hyperopic end of the distributions (Figure
2).
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Figure 8.1: Spectacle Lens Distribution of refractive error from manufacturer data for single vision
(SV) lenses (n = 84,561,994), addition (ADD) lenses (n = 49,709,191) and from the Gutenberg Health
Survey (n= 13,959).

Table 8.1: Proportion of refractive error types in each dataset

All Spectacle
Lenses
SV Lenses
ADD Lenses
GHS

Total
Emmetropia
(SE ≥ -0.50 D
and ≤ +0.75D)
19.1%

Total
Hyperopia (SE
> +0.75 D)

Total Myopia
(SE <-0.50 D)

Total
Myopia (SE
≤-0.50 D)

High
Myopia (SE
≤ -6.00 D

44.9%

36.0%

38.0%

4.8%

15.5%
25.0%
35.1%

44.9%
45.1%
29.8%

39.6%
29.9%
35.1%

41.7%
31.9%
39.9%

5.3%
4.0%
3.5%
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Figure 8.2: Deviation between bootstrapped confidence intervals and the observed occurrence of
refractive error in the Gutenberg Health Survey. The deviation is greatest when starting at zero
dioptres spherical equivalent and trends towards zero at higher absolute values of spherical
equivalent.

Figures 8.3 and 8.4 show the mean number of lenses with 95% confidence intervals for each 1 D
from all 1,000 generated distributions for the myopic and hyperopic tails of the SV lens distribution
over the range of refractive error where the deviation was less than 5%. Figures 8.5 and 8.6 show
the mean number of lenses with 95% confidence intervals for the myopic and hyperopic tails of the
ADD lens distribution. These are compared with the GHS over the same range of refractive error. The
GHS was found to be statistically indistinguishable from the 1,000 generated distributions as it
mostly sat within the 95% confidence intervals.
As the tails of the spectacle lens distributions were found to match the GHS between -2 D to -15D
and +3 D to +15D, it was possible to determine the estimated risk of vision impairment at age 75
among myopic SV spectacle lens wearers (Table 8.2). Using the spectacle lens data, it was estimated
that 8.18% of myopic spectacle lens wearers (n = 8,179 cases per 100,000 population) will be visually
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impaired by age 75. Over the same range of myopia in the GHS, 7.72% of myopic individuals (n =
7,720 cases per 100,000 population) were estimated to be vision impaired by age 75. The estimated
rates of vision impairment were not statistically significantly different (χ2 = 182, DoF = 169, p =
0.234).

Figure 8.3: Bootstrapped myopic mean distribution with 95% confidence intervals for Single Vision
lenses (solid line and shaded area) compared to the Gutenberg Health Survey (dotted line).
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Figure 8.4: Bootstrapped hyperopic mean distribution with 95% confidence intervals for Single
Vision lenses (solid line and shaded area) compared to the Gutenberg Health Survey (dotted line).

Figure 8.5: Bootstrapped myopic mean distribution with 95% confidence intervals for Addition
lenses (solid line and shaded area) compared to the Gutenberg Health Survey (dotted line).
186

Figure 8.6: Bootstrapped hyperopic mean distribution with 95% confidence intervals for Addition
lenses (solid line and shaded area) compared to the Gutenberg Health Survey (dotted line).
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Table 8.2: Refractive distribution within the myopic tail of the SV spectacle lens data and the GHS
data, estimated risk of vision impairment at age 75 from equation 1 and 2 and estimated number
of individuals with vision impairment at age 75 per 100,000 people with myopia of -2 D or worse
for both the SV lens group and GHS
Spherical
Proportion
Proportion
Equivalent of myopia in of myopia
(D)
SV lenses
in GHS

Risk of
Vision
Impairment
at Age 75

-2
-3
-4
-5
-6
-7
-8
-9
-10
-11
-12
-13
-14
-15

4%
5%
6%
8%
11%
14%
18%
22%
27%
33%
40%
46%
53%
60%

0.322
0.215
0.149
0.102
0.068
0.046
0.031
0.022
0.015
0.010
0.007
0.005
0.004
0.003

0.307
0.224
0.160
0.122
0.069
0.040
0.026
0.016
0.011
0.010
0.006
0.003
0.004
0.001

Total estimated vision impairment cases per 100,000
population at age 75 due to myopia ≤ -2.00D

Estimated number
of cases of vision
impairment due to
myopia per 100,000
population at age 75
(spectacle lens data)
1,219
1,067
962
854
733
634
548
472
402
330
285
248
225
200

Estimated number of
cases of vision
impairment due to
myopia per 100,000
population at age 75
(GHS data)
1,164
1,112
1,032
1,021
745
557
455
352
287
327
229
158
219
62

8,179

7,720

8.6 Discussion
This study describes a new method to estimate refractive error distribution. For spherical equivalent
refractive errors exceeding +3 D for hyperopia and -2 D for myopia, spectacle lens sales data can
provide equivalent estimates of the distribution of refractive error to those determined by
conventional population surveys of refractive error. Furthermore, by accurately estimating the shape
of the hyperopic and myopic tails of the distribution outside these threshold levels, this approach
can provide useful estimates of future population risks of vision impairment.
There are some limitations with the use of spectacle lens sales data. Ametropes may not be
corrected with spectacle lenses for numerous reasons, including, for example, lack of access to
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correction, a leading cause of preventable vision impairment in some parts of the world,256 or the
use of alternative forms of correction such as contact lenses. A recent study from the USA indicated
the majority of contact lens wearers also make use of spectacles, however, with only approximately
15% of contact lens wearers reporting they did not own any spectacles and over 75% reporting their
spectacle prescription provided clear vision indicating it was up to date.451 It is not certain that
European contact lens wearers have the same habits as those in the USA however given the
widespread availability of spectacles and contact lenses in both jurisdictions it would be surprising if
there were significant differences in spectacle usage among contact lens wearers. It is also not
possible to account for individuals who may have had refractive or cataract surgery in the current
dataset. The literature indicates, however, that although the rates of surgery have increased they
still represent less than 1% of all individuals.452,453 Conversely, some individuals may purchase
multiple sets of spectacles however given the very large sample size exploited herein, it is unlikely
that these factors would have a significant impact on the results. This is supported by the similar
levels of vision impairment predicted using both the spectacle lens data and GHS data. By utilising
multiple datasets, it may be possible to better account for individuals not captured within spectacle
lens data. In Europe, statistics are published on the number of surgical procedures performed,454
with similar data available for most countries,455 which may account for those undergoing cataract
and refractive surgery. Applying the same methodology to contact lens sales data can account for
patients that only use contact lenses for refractive error correction.
Other limitations also apply to the use of industrial type datasets. Drawing conclusions on
subpopulations, for example, can be more difficult as spectacle lens manufacturers and other
industry suppliers do not typically record data on their customers gender, ethnicity or age. If this
data was to be captured by manufacturers in the future it could facilitate subpopulation analysis. It
has, however, previously been demonstrated that lenses with a reading addition can be used to
estimate a customer’s age.309 As the relationship between increasing age and increasing refractive
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error is the primary driver for vision impairment due to refractive error,294,295,421 accurate forecasting
for the population risk of vision impairment using this methodology should be possible.
Emmetropes are also not well represented within this data. This is not surprising as it is unlikely that
individuals with minimal or no refractive error purchase spectacle lenses in any significant quantities.
This can be observed by the atypical distribution of refractive error for the SV lenses in Figure 8.1.
Another contributing factor to this atypical distribution may be the use of low plus SV lenses as a
reading correction by emmetropic presbyopes. It was expected that the ADD lens data would
provide a closer match to the GHS in the emmetropic range due to the similar age profile to the GHS
and the near universality of presbyopia over the age of 50.309 A likely explanation for the deviation of
the ADD lens data at emmetropia in Figure 8.2 is the wide availability of over the counter reading
glasses that can be used by emmetropes and low hyperopes and the ability of low myopes to read
comfortably when no correction is in place, meaning those in this range of SE are less likely to
purchase progressive addition spectacle lenses. The lack of representation of those with
approximately emmetropic refractive errors in our data is a significant limitation, but
epidemiological studies are best placed to establish baseline vision impairment risks for
emmetropes/near emmetropes. In the GHS, the percentage of individuals estimated to be vision
impaired by age 75 increases by 1.2% to 8.92% if those with myopia > -2.00 D SE are included in the
calculations, which translates to approximately 9.38% if extrapolated to the SV spectacle lens
wearers. Further modelling of the spectacle lens data may allow for more accurate estimates of the
proportion of individuals in this low myopia group which in turn could allow a full population
estimate of vision impairment due to myopia to be calculated. From a public health perspective,
obtaining the current population burden of those with higher absolute refractive errors, especially
myopia, is of particular importance as we are entering an era where myopia can reasonably be
considered as a modifiable risk factor for vision impairment. These represent the individuals most at
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risk of vision impairment due to refractive error and estimating the number of people affected by
higher refractive error can allow better public health planning.269
Due to the nature of the data, it is impossible to state how the refraction for each individual was
carried out. Ideally all refractions would be carried out under cycloplegia in order to avoid the effects
of accommodation, particularly for myopic refractions.169 It has been shown that the assessment of
refractive error in adults is not significantly affected by the use of cycloplegia,165 particularly in older
adults,166 those most at risk of vision impairment. The data used in this study likely represents
predominantly adult populations, particularly the ADD lens data from which approximate ages can
be calculated,309 so the probable lack of cycloplegia should have minimal effect on the refractive
error and vision impairment estimations. It should also be noted that many well regarded population
surveys of refractive error do not make use of cycloplegia156,158 including the main comparison study
used herein.14 Additionally, the probable lack of cycloplegia in this study is unlikely to be significant
as the higher myopic threshold should reduce the risk of a misclassification error and is the approach
suggested by the International Myopia Institute when this risk may apply.93
The comparability of the results obtained from spectacle lens data and a conventional
epidemiological study demonstrates the utility of industrial datasets as a public health tool in
refractive error and vision impairment. The use of industrial data can potentially address the paucity
of epidemiological data available for both refractive error3 and vision impairment.5 Manufacturers
with large market share for spectacle lens sales may have refractive error data which can accurately
determine the number of ametropes in a population and hence the risk of vision impairment due to
refractive error, myopia in particular.
How this methodology could be best exploited to produce ongoing estimates of the population
burden of refractive error and consequential vision impairment needs to be determined. The most
significant challenge is gaining access to commercial data for public health purposes. One possible
solution would involve the creation of an international consortium of industry, academic,
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professional, intergovernmental and non-governmental organisations and other key stakeholder
bodies. This could provide a forum for international collaboration in the form of a Big Data coalition
and lead to a Global Myopia Observatory of data analytic and data visualisation resources which
could be used for public health planning, research, commercial and other uses. In providing the
platform to gather and merge disparate sources of industry data, this consortium could provide a
readily accessible, current and globally representative body of resources to monitor the changing
epidemiology of refractive error and associated eye disease and the impact of new treatments and
public health interventions essentially in real time. Furthermore, these resources would inform
health planning decisions, drive clinical practice reform, stimulate industrial innovation and
ultimately lead to better population health.
In conclusion, the distribution of refractive error within a population over a large range of refractive
error can be determined using spectacle lens sales data. This provides a good alternative when
population level data on refractive error is either absent or outdated. This is a particularly useful
methodology to determine the population burden of higher absolute levels of refractive error which
represents the population cohort most at risk of vision impairment due to refractive error. An
estimation of the future risk of vision impairment due to myopia can also be calculated from such
data.
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9.2 Abstract:
Purpose:
Visual acuity assessment is the most commonly performed vision screening method for drivers. The
standards and repeat assessment intervals used, however, are arbitrary, lack an evidence base and
are highly variable across different countries. This study utilises the power of Big Data to provide
evidence-based recommendations for standardised driver vision screening.
Methods:
Anonymised electronic medical record data was gathered from 40 Irish optometry practices
comprising 81,184 unique patients. A Kaplan-Meier Survival (KMS) analysis was used to determine
the effect of increasing age and time since screening on the likelihood of passing the visual acuity
standard for driving. A logistic function was fit to assess the effect of varying the minimum visual
acuity standard required to drive on the screening pass rate within the population.
Results:
The likelihood of failing repeat screening increased as a function of time since initial screening for all
age groups (χ2=1447, df=6, p<0.001), with older patients most affected. Rescreening intervals for
individuals who initially met the vision standard unaided reduced as a function of age. Using an 80%
survivability threshold, intervals ranged from every eight years for drivers under 50, reducing to
every two years for those aged over 80. Rescreening intervals for drivers requiring optical correction
to meet the standard, also decreased with age. Approximately 1% of individuals are excluded from
driving using a 0.3 logMAR visual acuity standard with correction.
Conclusion:
Visual acuity-based screening should take place at regular intervals for all drivers, not just those over
70. Re-screening intervals should be based on age, with shorter intervals for older drivers due to the
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combined effect of age and time on the likelihood of passing the driving visual acuity standards. The
most commonly used standard of 0.3 logMAR results in a minimal number of potential drivers being
excluded from driving.
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9.3 Introduction:
The ability to drive safely is complex, involving detailed sensory, cognitive and motor factors which
have to be integrated and enacted within a limited timeframe.456 Vision provides the most important
sensory input when driving and several studies have linked various forms of reduced vision with
increased traffic collisions.457,458 Vision loss has also been associated with decreased cognition in
older adults,459 itself a factor for road traffic crashes.460 There is conflicting evidence, however,
regarding the influence of commonly tested aspects of vision such as visual acuity (VA) and visual
field on driving performance.461,462 Furthermore, there is a distinct paucity of high quality evidence
exploring the relationship between mandatory vision screening and driver safety.463 Nevertheless,
most countries require evidence that vision meets a pre-defined standard in order to be legally
permitted to drive.
The vision screening standards used for driving vary widely across different countries, including in
Europe. The European regulatory directives on driving licences (EC Directives 2006/126/EC and
2009/113/EC)464 required harmonisation of driving licence vision screening standards by 2013,
however this has not taken place. A wide spectrum of vision standards persists, therefore, varying
from licence plate figure recognition tests carried out by non-qualified driving test employees in
some countries, to a full vision and ocular health assessment carried out by an ophthalmologist in
others. Currently the primary method by which vision is assessed to determine suitability for driving
is by measuring visual acuity, but the level required to be eligible to drive is country specific. The
most common minimum standard with or without optical correction required in Europe is binocular
acuity of 0.5 decimal (0.3 logMAR, 6/12 (20/40) Snellen), although this varies from 0.0 logMAR in
Italy and Turkey to identifying figures on a licence plate at a specified distance in countries such as
the Netherlands and the United Kingdom,465 an approach which does not compare favourably to the
use of vision charts.466 The use of licence plates may encourage self-assessment however it has been
found many drivers do not recall the correct distances at which to conduct this self-assessment.467
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Many countries have a standard for visual field assessment, with the most common requirement
that the field extends to 120 degrees horizontally,465 while others also require additional vision
assessments such as colour vision, contrast sensitivity and glare recovery although it is unclear how
frequently these additional assessments are performed.465 Another significant source of variance in
standards across countries relates to the frequency of repeat screening. Some jurisdictions require
repeat screening every 10 years up to age 70 (and more frequently thereafter), while others place
the responsibility on the driver themselves to self-report any changes in their vision, with no
mandatory screening after the initial assessment until age 70.465
Driver vision screening standards have been criticised as lacking an adequate evidence base,468,469 a
view that appears justified by the apparent lack of consensus demonstrated between countries.
Irrespective of whether visual acuity is a good indicator of driver safety, the clinical implications of
the substantial variation in existing standards merits investigation. In Ireland, mandatory vision
screening takes place when initially applying for a licence (minimum age 16 for motorcycles; 17 for
cars). No further screening is required until the driver reaches the age of 70, after which vision is
assessed at 3-year intervals at each licence renewal. Screening is conducted by registered
optometrists or medical doctors, with applicants needing to meet the most common standard for
visual acuity of 0.3 logMAR, either with or without correction.
This study was designed to examine the suitability of driver vision screening standards as currently
used in Ireland and many other European countries to determine fitness to drive. Specifically, EMR
data derived from optometric practices involved in the routine measurement of visual acuity (e.g. as
part of routine driver vision screening and refractive error management) was initially used to assess
how uncorrected and corrected visual acuity vary as a function of age within the population.
Subsequently, the EMR data was analysed using a machine learning approach to examine: (i) what
effect does variation in the legal visual acuity threshold have on the probability of failing the vision
standard even with correction; and (ii) how does age and the length of time between vision tests
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influence the probability of meeting the required vision standard for driving at a subsequent vision
test, after initially meeting the standard either with or without correction. These analyses were used
to develop evidence-based recommendations regarding the frequency of driver vision screening and
threshold acuity level required to be legally permitted to drive.

9.4 Methods:
Anonymised EMR data was gathered from 40 Irish optometry practices. The data was extracted
remotely through the EMR provider following provision of explicit consent from the data (practice)
owners during the period of May 2018 to June 2020 for all 40 practices. The data extracted
comprised all practice records since first use up to the date of extraction for each practice. The EMR
provider removed any personally identifying data and anonymised the data prior to delivery so that
the anonymisation could not be reversed by the researchers. The data was provided in multiple CSV
files which were combined using the SQLite database engine V 3.30.00 (Hipp, Wyrick & Company,
Inc., Charlotte, North Carolina, USA) with further analysis carried out using the R programming
language (R Core Team (2020). R: A language and environment for statistical computing. R
Foundation for Statistical Computing, Vienna, Austria. https://www.R-project.org/). At the time of
extraction, a new unique identifying number was generated within the EMR data allowing individual
subject data to be tracked across multiple visits. The data available for each individual clinical
practice patient included demographic, refractive, visual acuity, binocular vision, contact lens, ocular
health and clinical management data. For this analysis, only demographic, refractive and visual
acuity data were considered. This study was approved by the Research Ethics Committee of the
Technological University of Dublin and adheres to the tenets of the Declaration of Helsinki.
A custom function was written to remove erroneous visual acuity values and convert all Snellen and
decimal uncorrected visual acuity (UCVA) and corrected visual acuity (CVA) values to logMAR
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notation. All patient records without complete and interpretable visual acuity data for both UCVA
and CVA were excluded from the analysis. Patient visits under the age of 21 were also excluded from
the analysis to specifically capture individuals most likely to drive. Patient visits were grouped in 10year age intervals up to age 80, with all those aged over 80 grouped together due to the smaller
number of patient visits. The average level of UCVA and CVA for each age group was calculated. The
effect of age group on both UCVA and CVA was also assessed using the Kruskal-Wallis rank sum test.
Given the most widely adopted standard for visual acuity as it applies to driving is 0.3 logMAR, this
was used as a reference to categorise measured UCVA and CVA according to vision standards
criteria. A visual acuity of ≤ 0.2 logMAR in either eye was considered a pass, a visual acuity of > 0.2
logMAR and ≤ 0.4 logMAR in both eyes considered borderline and a visual acuity of > 0.4 logMAR in
both eyes considered a fail. The proportion of visual acuity measurements in each visual acuity
category and age group was determined for both CVA and UCVA. Subsequent analyses relating to
vision standards were conducted separately for those without visually significant refractive error
who passed based on their initial presenting UCVA and for those with refractive error who required
optical correction to meet the standards based on CVA.
A Kaplan-Meier survival (KMS) analysis was used to determine the survival time before patients that
initially passed the UCVA standard (≥ 0.3 logMAR in either eye) would fail the standard in a subgroup
of patients that attended for multiple visits at least six months apart and were observed to pass the
UCVA standard at their first visit. Patients were categorised into age groups according to their age at
the initial visit. Right censoring was used in order to account for patients that never failed the UCVA
standard over their observation period. The log-rank test was used to compare the survival curves
for each age group.
To determine the effect of changes in refractive error on the likelihood of passing the standard in
those using optical correction, the KMS analysis was repeated for a subgroup of patients that were
found to: (i) be myopic (right eye spherical equivalent refraction (SER) ≤ -0.50 D) or hyperopic (right
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eye SER ≥ +0.75 D) at their first and subsequent visits (without regression towards emmetropia at
subsequent visits); (ii) failed the standard based on UCVA, but passed the standard based on CVA
with correction; and (iii) had multiple visits at least six months apart. Progression of refractive error
was analysed in these patients over time, and the calculated progression was used to provide an
estimate of change in visual acuity, with a deterioration of 0.3 D SER assumed to be equivalent to a
0.1 logMAR deterioration in CVA if the original optical correction used to pass the initial vision
screening was not updated.470 These patients were considered to have failed the standard when
their estimated change in visual acuity resulted in a new estimated CVA greater than 0.3 logMAR
(necessarily assuming that spectacle correction was not updated). For the purposes of this analysis,
accommodation effects were ignored. The log-rank test was used to compare the survival curves for
each age group.
The KMS analysis was also used to determine optimised repeat vision screening intervals for both
the UCVA and CVA standards. This involved determining vision screening intervals as a function of
the proportion of the population expected to still pass the UCVA or CVA standard. The time between
visits was assessed for those with refractive error to determine if the frequency of repeat eye exams
was less than the KMS analysis recommended repeat vision screening intervals for the UCVA
standard.
To determine an appropriate visual acuity standard, the number of patients that would pass at
different acuity threshold levels with and without correction were assessed. The thresholds used
followed the typical Snellen chart letter size progression (the most commonly used chart type in
clinical practice). A logistic function was fit to the percentage of patients passing at each acuity
standard.
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9.5 Results:
The original data set comprised of 697,098 practice visits of 288,777 unique patients, representing
5.9% of the population of the Republic of Ireland.415 The 40 participating optometric practices were
located all across the Republic of Ireland comprising both rural and urban populations. After
excluding patients under age 21 and with incomplete data, 154,824 practice visits of 81,184 unique
patients remained. The absence of either UCVA or CVA values was the primary reason for exclusion,
accounting for 96.7% of records removed. The gender distribution was 54.7% female, 37.9% male
and unrecorded in 7.4% of records. The mean age was 49.6 ± 21.1 years.
The mean right eye UCVA was 0.35 ± 0.36 logMAR while the mean right eye CVA was 0.01 ± 0.15
logMAR (females: UCVA 0.35 ± 0.36, CVA 0.01 ± 0.15; males: UCVA 0.33 ± 0.36, CVA 0.01 ± 0.16).
Gender was found to have a statistically significant effect on both UCVA (t = -11.55, df = 167051, pvalue < 0.001) and CVA (t = -4.89, df = 167051, p-value < 0.001), however this was likely due to the
large sample size as the difference in the means were not considered clinically significant. There was
higher variability of UCVA when compared to CVA across all age groups, a likely reflection of the
range of refractive errors that affect individuals of all ages (Figure 9.1). Additionally, both UCVA and
CVA deteriorated with increasing age, with an obvious reduction in CVA from the seventh decade
onwards (Table 9.1). The effect of age group was statistically significant for both UCVA (χ2 = 8225, df
= 6, p-value < 0.001) and CVA (χ2 = 18241, df = 6, p-value < 0.001). Pairwise comparisons using
Dunn's test indicated significant differences between every age group (p < 0.001 for all).
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Table 9.1: Detailed breakdown of data included in analysis showing the number of patient visits in
each age group along with the mean, standard deviation and range for uncorrected visual acuity,
corrected visual acuity and spherical equivalent refraction (right eye only included).
Age Group
(years)
21-30

Number of
patient visits
14504

Mean ± SD (range) Mean ± SD (range)
Mean ± SD (range)
UCVA (logMAR)
CVA (logMAR)
SER (D)
0.36 ± 0.41
-0.03 ± 0.12
-0.94 ± 2.05
(-0.30 – 2.18)
(-0.30 – 1.38)
(-16.63 – +9.00)
31-40
15874
0.33 ± 0.40
-0.02 ± 0.13
-0.73 ± 2.05
(-0.20 – 2.08)
(-0.30 – 1.60)
(-18.38 – +14.75)
41-50
28714
0.26 ± 0.36
-0.02 ± 0.13
-0.13 ± 1.76
(-0.30 – 2.08)
(-0.30 – 1.60)
(-19.75 – +10.00)
51-60
33610
0.32 ± 0.34
-0.01 ± 0.14
+0.30 ± 1.68
(-0.30 – 1.78)
(-0.30 – 1.48)
(-16.13 – +12.25)
61-70
30351
0.39 ± 0.33
0.02 ± 0.15
+0.74 ± 1.67
(-0.30 – 2.08)
(-0.30 – 1.78)
(-20.00 – +15.25)
71-80
22449
0.44 ± 0.33
0.08 ± 0.17
+0.85 ± 1.61
(-0.20 – 1.82)
(-0.20– 1.82)
(-14.38 – +11.00)
Over 80
9322
0.47 ± 0.33
0.14 ± 0.22
+0.64 ± 1.61
(-0.18 – 2.08)
(-0.18 – 2.08)
(-14.50 – +11.25)
Abbreviations: CVA, corrected visual acuity; D, dioptres; SER, spherical equivalent refraction; SD,
standard deviation; UCVA, uncorrected visual acuity

Figure 9.1: Boxplot for right eye uncorrected visual acuity (UCVA) (left panel, n = 154,824) and right
eye corrected visual acuity (CVA) (right panel, n = 154,824) for each age category
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The relative proportions of VA measurements falling into each vision standard category (pass,
borderline and fail) were observed to vary as a function of age for both UCVA (χ2 = 4555, df = 2, pvalue < 0.001) and CVA (χ2 = 2349, df = 2, p-value < 0.001). An increasing percentage of
measurements fell into the borderline and fail categories with increasing age, particularly for UCVA
(Figure 9.2). Over 40% of VA measurements were categorised as failing or borderline according to
UCVA, while less than 2% of VA measurements were similarly categorised for CVA, primarily among
older drivers aged over 70.

Figure 9.2: Percentage of VA measurements falling into each vision standard category for both
uncorrected visual acuity (UCVA) and corrected visual acuity (CVA)

9.5.1 Longitudinal Analysis – Uncorrected Visual Acuity
In total, 23,393 patients who initially passed the vision standard with UCVA were eligible for
inclusion in the longitudinal analysis. The mean time between visits was 1.86 ± 2.12 years, with a
mean total follow up time of 3.62 ± 3.76 years. For patients with longitudinal data, the mean
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annualised change in UCVA and CVA was 0.022 ± 0.531 logMAR per year and 0.003 ± 0.157 logMAR
per year respectively.
The KMS analysis revealed that increasing time since the initial visit was found to negatively affect
the likelihood of passing at subsequent visits. Older initial age was also found to negatively affect the
likelihood of passing at subsequent visits (χ2 = 1447, df = 6, p-value < 0.001). Reassessment intervals
determined using the KMS analysis were observed to vary according to different survivability
threshold levels across each age group (Table 9.2), with lower threshold values (e.g. 50% survivability
where just half the population will be expected to still meet the standard) resulting in long
reassessment intervals for all age groups, and high thresholds (e.g., 90% survivability where most of
the population will be expected to still meet the standard) requiring frequent reassessment intervals
for all.

Table 9.2: Reassessment intervals needed in order for a given proportion of the population to still
pass the uncorrected visual acuity (UCVA) standard
Age Group
(years)

RI for 90%
RI for 80%
Pass Rate
Pass Rate
(years)
(years)
21-30
3.6
7.0
31-40
5.1
8.1
41-50
4.0
7.1
51-60
3.4
5.9
61-70
2.3
4.3
71-80
2.1
3.1
Over 80
1.5
2.1
Abbreviations: RI, Reassessment Interval

RI for 75%
Pass Rate
(years)
8.5
9.5
8.5
7.1
5.4
3.8
2.5

RI for 70%
Pass Rate
(years)
10.5
10.7
9.6
8.0
6.2
4.4
2.9

RI for 50%
Pass Rate
(years)
16.2
18.3
13.1
11.6
10.0
7.7
4.6

Figure 9.3 illustrates the relationship between initial age and time since first visit on the likelihood of
passing. All age groups were negatively affected by increasing time since first visit. Using a
survivability threshold of 80% (i.e., 80% of individuals still pass the standard), survival time reduced
as a function of age, with older age groups exceeding the threshold at progressively shorter
intervals, dropping from an expected survival time of 8 years for patients in their 30s, to just over 2
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years for those aged over 80.

Figure 9.3: Kaplan-Meier curves demonstrating the reducing likelihood of passing the standard in a
cohort of individuals that initially passed the standard with uncorrected visual acuity (UCVA).
Increasing time since the initial vision assessment reduces the likelihood of passing for all age
groups. The dotted lines indicate the time interval for each age group by which 80% of individuals
will still pass the UCVA standard.

Reassessment intervals to achieve an approximate 80% survivability are provided in Table 9.3, which
also illustrates the expected survivability rates for the most common re-screening criteria currently
used in countries where periodic rescreening is required (rescreening every 10 years until age 70).
This analysis demonstrates a progressive age-related decrease in survivability from 71% among the
youngest drivers to just 50% after 10 years among those aged 61-70. For the youngest drivers, just
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17% are expected survive after 20 years (the longest period available for analysis within this data),
long before the most common mandatory rescreening at age 70.

Table 9.3: Reassessment intervals required to achieve an approximate 80% survivability rate based
on uncorrected visual acuity (top panel) compared to survivability rates for the most commonly
used screening intervals used in countries that require regular vision screening (bottom panel).
Age Group (years)
21-30
31-40
41-50
51-60
61-70
71-80
Over 80
Age Group (years)
21-30
31-40
41-50
51-60
61-70
71-80
Over 80

Reassessment Intervals Based on 80% Survivability
Reassessment Interval (years) Percentage Expected to Pass
8
77%
8
80%
8
76%
6
80%
4
82%
3
81%
2
86%
Common Reassessment Intervals
Reassessment Interval (years) Percentage Expected to Pass
10
71%
10
73%
10
67%
10
59%
10
50%
3
81%
3
68%

9.5.2 Longitudinal Analysis – Corrected Visual Acuity
There were 9,209 myopic patients and 15,155 hyperopic patients that met the inclusion criteria for
longitudinal analysis. For the myopic subgroup, the mean time between visits was 2.89 ± 2.15 years,
with a mean total follow up duration of 5.02 ± 3.32 years. For the hyperopic subgroup, the mean
time between visits was 2.79 ± 2.03 years, with a mean total follow up duration of 5.37 ± 3.42 years.
Reassessment intervals were observed to vary according to different survivability threshold levels
across each age group for the myopic and hyperopic cohorts in a similar way to the uncorrected
cohort, with low survivability thresholds requiring longer reassessment intervals and high
survivability thresholds requiring shorter reassessment intervals (Table 9.4).
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Table 9.4: Reassessment intervals needed in order for a given proportion of the population to still
pass the corrected visual acuity (CVA) standard
Age Group
(years)

RI for 90%
Pass Rate
(years)

RI for 80%
RI for 75%
RI for 70%
RI for 50%
Pass Rate
Pass Rate
Pass Rate
Pass Rate
(years)
(years)
(years)
(years)
Myopia (SER ≤ -0.50 D)
21-30
3.2
4.1
4.4
4.6
6.2
31-40
3.8
4.6
5.1
5.9
8.6
41-50
3.8
4.8
5.4
6.1
8.3
51-60
3.6
4.6
4.9
5.7
8.0
61-70
2.9
4.1
4.7
5.2
7.8
71-80
2.2
3.5
4.1
4.5
7.7
Over 80
2.1
3.2
3.8
4.5
7.5
Hyperopia (SER ≥ +0.75 D)
21-30
2.3
3.5
3.8
3.9
5.6
31-40
3.3
4.5
5.3
5.7
7.6
41-50
3.3
4.2
4.5
4.9
7.0
51-60
3.6
4.6
5.1
5.7
8.0
61-70
3.5
4.4
4.8
5.4
7.8
71-80
2.8
3.8
4.1
4.5
6.5
Over 80
2.1
3.2
3.7
4.2
6.8
Abbreviations: RI, Reassessment Interval; SER, Spherical equivalent refraction; D, dioptre

The mean reassessment interval for both the myopic and hyperopic cohorts to achieve 80%
survivability was 4.1 years. Figures 9.4 (myopic subgroup) and 9.5 (hyperopic subgroup) demonstrate
the relationship between initial age and time since first visit on the likelihood of continuing to pass
the standard. All age groups were negatively affected by increasing time since first visit. For the
myopic subgroup, there was a statistically significant difference in the risk of failing between all age
groups (χ2 = 159, df = 6, p-value < 0.001). This was also the case for the hyperopic subgroup (χ2 =
51.2, df = 6, p-value < 0.001). Older age groups were likely to fail the standard in the shortest time,
although the difference between age groups was not as great as that found for the UCVA group.
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Figure 9.4: Kaplan-Meier curves demonstrating the reducing likelihood of passing the standard in a
cohort of myopic (right eye SER ≤ -0.50 D) individuals (n = 9,209) that initially passed the standard
with corrected visual acuity (CVA). Increasing time since the initial vision assessment reduces the
likelihood of passing for all age groups. The dotted lines indicate the time interval for each age
group by which 80% of individuals will still pass the CVA standard if their refractive error correction
is not updated.
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Figure 9.5: Kaplan-Meier curves demonstrating the reducing likelihood of passing the standard in a
cohort of hyperopic (right eye SER ≥ +0.75 D) individuals (n = 15,155) that initially passed the
standard with corrected visual acuity (CVA). Increasing time since the initial vision assessment
reduces the likelihood of passing for all age groups. The dotted lines indicate the time interval for
each age group by which 80% of individuals will still pass the CVA standard if their refractive error
correction is not updated.

Figure 9.6 shows the time between eye exam visits for both male and female patients in the myopic
and hyperopic groups. The significant majority of visits occurred within 1-3 years of the previous
visit, with just 16.4% of visits occurring at intervals greater than the respective 80% survivability
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threshold intervals across all age groups. There was no statistically significant difference in the time
between visits for female and male patients (Wilcoxon signed-rank test; W = 62674901, p = 0.52).

Figure 9.6: Time between eye exams for female and male patients with refractive error (SER ≤ 0.50 D or SER ≥ +0.75 D). Cumulative percentage shown by dashed line.

Figure 9.7 shows the percentage of patients that would pass at various thresholds for the binocular
CVA standard. At a low CVA threshold of 1.0 logMAR (6/60 Snellen), almost 100% of patients pass
the standard, irrespective of age. The proportion of patients passing reduces only marginally (≈1%)
when the threshold is increased to the most commonly used standard of 0.3 logMAR (6/12 Snellen).
Increasing the threshold further results in a more significant number of patients failing the standard,
with 12% failing at the 0.0 logMAR (6/6 Snellen) standard (estimate = -1.6, t = -9.0, p < 0.001).
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Figure 9.7: Logistic function demonstrating the age-independent change in percentage of patients
that fail the binocular visual acuity standard (even with correction), when the threshold is varied
between 0.0 and 1.0 logMAR

9.6 Discussion:
This study exploited a sizeable EMR dataset containing detailed cross sectional and longitudinal
UCVA and CVA data for the purposes of evaluating visual acuity thresholds as a legal driving
standard. The finding that the most commonly used visual acuity threshold (0.3 logMAR (6/12
Snellen) excludes just a small minority of potential drivers is important for a number of reasons. It is
well established that the cessation of driving in older drivers is associated with increased rates of
depression471,472 through loss of independence and steeper declines in general health.473 Given that
older drivers are most likely to experience reducing visual acuity, it is important to set standards at a
level which does not unfairly bias screening against older drivers. This must, however, be weighed
against the increased risk potentially posed to other road users by those with reduced vision.474 The
available evidence pertaining to the relationship between visual acuity and driver safety is
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somewhat conflicting, with some studies suggesting no relationship,475,476 while others have found a
small but statistically significant relationship.461,477 A recent meta-analysis of vision function and
traffic safety outcomes in low and middle income countries observed a 46% increased risk of traffic
crash in those with visual acuity of ≤ 6/18 Snellen (≥ 0.48 logMAR),478 adding to the evidence base
that reduced visual acuity contributes to an increased risk of traffic crashes. The lack of definitive
evidence is not surprising given that concomitant reductions in other aspects of visual function such
as contrast sensitivity, visual field and useful field of view may also impact driver safety and are not
necessarily captured by visual acuity measures.479,480 It is important to have a measure of visual
performance, however, as diminishing visual function has been shown to negatively impact both
driver safety and driver performance.479
Irrespective of whether visual acuity provides the best index of driver safety or performance, several
factors dictate that visual acuity standards are likely to persist as a core component of driver vision
screening. It does capture certain visual requirements for driving such as road sign recognition and
hazard avoidance.481 Additionally, visual acuity screening is the most commonly performed and
widely understood method for assessing vision, requires relatively little specialist equipment or
training, and is widely enshrined in policy and legislation as an accepted means of classifying vision
(e.g. legal classification of a patient as vision impaired or blind). Setting the standard at 0.3 logMAR
ensures that up to 99% of potential drivers can comfortably be expected to pass this commonly used
visual acuity standard for driving. This is the standard currently used in Norway and Sweden, which
have some of the lowest road deaths per vehicle distance travelled in Europe.482 Other countries
with more stringent visual acuity standards (which would prevent a higher percentage of people
from driving) have substantially poorer road death statistics,482 suggesting that other factors may be
more important determinants of driver safety. Uncertainty regarding the importance of visual acuity
for driver performance481,483 and safety,479 coupled with the established association between driving
cessation and poor health outcomes, suggests there is limited value in setting the standard at a
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threshold value which might unnecessarily exclude a significant percentage of people from driving
without any supporting safety evidence. A 0.3 logMAR standard, therefore, appears a balanced and
fair threshold which virtually all (≈99%) drivers will meet either with or without correction in the
absence of significant ocular disease or other cause of reduced CVA.
Another key finding from this Big Data analysis is that the frequency of driver vision screening
assessments appears to be inappropriately long for younger drivers in Ireland and many other
European countries. Exploring the relationship between time since initial screening, age and the
likelihood of passing the standard for individuals who originally met the standard unaided revealed
that the likelihood of passing reduced with time for all age groups, not just for elderly drivers. With
an average reduction in UCVA of +0.022 logMAR per year, a driver who initially passed the standard
unaided would lose approximately 2-3 lines of visual acuity over a 10-year licence renewal period,
which could result in an individual changing from the comfortably passing category to the borderline
or fail category without correction. Furthermore, in the myopic subgroup, the youngest drivers
included herein (age 21-30) were found to have the fastest reduction of UCVA of all potential
drivers, likely due to increased myopic progression in this age cohort.484 The current standards
adopted in many countries, where repeat visual function assessments are only required when
individuals reach a certain age, usually over the age of 70,465 would fail to detect such drivers and
instead have to rely on driver discretion with respect to their ability to see sufficiently well to drive in
all conditions. In such countries, drivers are expected to self-regulate, recognise and report changes
in their vision. This raises the possibility of lengthy gaps between vision screening assessments,
particularly for drivers who do not wear optical correction and therefore do not routinely attend an
eye care practitioner. This is contrary to public preference, with a 2014 study finding that 87% of
those surveyed thought drivers should have to provide evidence of meeting the vision standard
when renewing their licence.485
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The age-related decrease in CVA and sizeable reductions in likelihood of passing the vision standard
observed among older individuals herein suggests that more frequent vision screening in older
drivers is justified. In most countries, older drivers, usually over the age of 70, are already required
to undertake regular vision screening at each licence renewal.465 There is little evidence to support
the idea that targeting elderly individuals for vision screening reduces the risk of motor vehicle
crashes.463 Increased frequency of screening of this age cohort seems sensible, however, given that
the prevalence of many of the major causes of vision impairment and blindness such as cataract,
glaucoma and age-related macular degeneration is highly age-dependent.256,416,417 Both UCVA and
CVA were observed to deteriorate with increasing age and over time herein, evidenced by the
increasing proportion of older individuals falling into the borderline and failing vision standard
categories. Among individuals that initially met the standard without correction, the likelihood of
passing a future vision screening unaided therefore reduced over time. These findings are not
unexpected as it is well established that visual function diminishes with age,486 but they provide solid
evidence to support a requirement that screening protocol should be age-specific.
Our analyses suggest that separate vision screening protocol should be considered for those who
meet the standard unaided and those who require optical correction to drive. Rescreening intervals
were notably shorter at every survivability threshold for those requiring refractive error correction,
particularly among younger drivers under the age of 50 who would have to be screened every 4-5
years to meet an 80% survivability criterion. Drivers who initially meet vision standards unaided may
subsequently fail due to pathology, or more likely due to the development of new refractive error or
loss of acuity over time due to the progressive manifestation of latent hyperopia. Based on our
observations herein, this gradual decline in UCVA appears to be slower than the change in CVA
affecting drivers who require optical correction to meet the standard. It is likely that the reduction in
CVA is due to progression of existing refractive error in most cases, which may lead individuals to fall
below the standard more quickly if their correction is not updated routinely. Such individuals,
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however, are typically under the care of an eyecare practitioner and likely to attend for regular
review eye exams.487 The majority of individuals with refractive error requiring optical correction in
our dataset attended for repeat visits within the recommended rescreening interval for their
respective age group, so any deterioration in CVA is likely to be addressed for most drivers before
CVA falls below the legal standard. Although the survivability data suggests the need for separate
protocol, it seems reasonable to consider that a single protocol could be implemented. This would
avoid the necessity to implement different screening protocol based on whether refractive
correction is required to drive or not as long as specific provisions are incorporated to address the
issue of poorer survivability among those who require correction to pass the CVA standard. The use
of a single protocol would be a more realistically achievable approach given the apparent difficulties
involved in implementing a single harmonised policy across Europe.
Rescreening intervals varied according to the selected survivability threshold. For those who initially
meet the standard unaided, selecting a survivability threshold of 90% would require approximately
biennial testing across many age cohorts. This would have huge resource implications and is unlikely
to be a sustainable model. Lower thresholds at the level of 50% would require far less frequent
screening, with the oldest drivers only requiring rescreening at 5-year intervals, which would lead to
a scenario where half the population of drivers would no longer meet the vision standards by the
time they are re-screened, which is certainly not desirable. Aligning re-screening intervals with
driving licence renewals might make practical sense, and would certainly represent an improvement
in countries like Ireland. A survivability threshold around 75 to 80% would appear to provide a
reasonable compromise, with an interval between screening that remains relatively close to
standard 10-year licence renewal periods up to age 50, but requires more frequent screening
thereafter.
This study provides the most comprehensive analysis of driver vision standards completed to date.
Particular strengths of the study include the large sample size and longitudinal nature of the data.
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The refraction and visual acuity data were acquired by highly trained optometrists which should
represent high quality clinical data. Limitations of the study include the retrospective nature of the
study. The data analysed was not captured specifically for this purpose, although it is unlikely that a
prospective study of a similar scale would be feasible to conduct. It is unknown what proportion of
the data in this study represents actual drivers or what proportion of patient examinations involved
actual driver vision screening. However, over 75% of all adults in Ireland hold a valid driving
licence,488 and the data is certainly representative of adults eligible to undertake driver vision
screening. Selection bias might be considered as a limitation given the clinical nature of the data
analysed, as it is unknown what proportion of examinations were for the purpose of driver vision
screening. This is unlikely to be a major concern herein, however, as most driver vision screening is
conducted by optometrists in Ireland, so our dataset naturally contains a subset of such data. The
large number of individuals with longitudinal data that maintained good UCVA for long periods of
time (≥ 10 years) should mean the survival analysis is also representative of those with stable good
UCVA. The dataset analysed also contained more female than male participants. This is not
surprising as it has been found elsewhere that female patients are more likely to attend optometric
services likely as a result of attitudinal differences on seeking health services between men and
women.489 Despite this difference the very large number of both female and male participants
should ensure these results can be applied to both the adult male and female populations. All of the
data analysed is specific to the Republic of Ireland which may be perceived to limit generalisability,
but it is unlikely there are significant population differences in terms of change in UCVA or CVA over
time across Europe. Refractive error has been found to vary with ethnicity, with much higher rates of
myopia and faster progression observed in Asia.3 This may mean the reassessment intervals
calculated for CVA are not applicable in all parts of the world. These analyses also do not include a
specific assessment of changes in visual field, an important parameter for fitness to drive, or other
affects ocular pathology may have on the eye. The survival analyses conducted herein are influenced
by individuals with conditions that affect vision, but the data was not available to evaluate their
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precise impact on vision over time. In high income countries such as Ireland with good access to
eyecare, most patients in these categories will be under more regular review, however, this may not
be the case in all countries. These results also apply to the most commonly used visual acuity criteria
for driving of 0.3 logMAR which is the standard typically used for cars and motorcycles.465 The
standard for heavy goods vehicles and buses is usually more stringent, with more frequent
reassessment required. This analysis does not apply to this cohort who represent a small proportion
of drivers, accounting for less than 2% of the 200+ million total drivers in the European Union and
for whom, stricter standards are already in place.490 Lastly, the analyses contained herein represent
an evaluation of the technical suitability of current visual acuity based driver vision screening
standards. The findings do not relate in any way to driver safety, which would require a more
significant body of prospective research to identify which battery of vision screening tools might
provide the best indicator of individual fitness to drive. Indeed, a recent Cochrane review failed to
find any suitably designed study which could evaluate the general efficacy of vision screening in
reducing crashes,463 so it is simply not possible, at present, to implement an evidence-based vision
screening strategy based on safety data.
This Big Data powered analysis confirms that the commonly used 0.3 logMAR standard seems an
appropriate threshold from an inclusionary perspective, and that regular visual acuity screening
should be extended to include all drivers at age-appropriate intervals. To develop these findings into
a harmonised protocol, key decisions would need to be made in relation to the chosen survivability
threshold and in relation to the treatment of drivers who require optical correction, particularly if a
single protocol was to be prioritised. Electronic medical record data derived from ophthalmic clinical
practice has previously been validated as a useful epidemiological tool for refractive error.309 This
type of data represents an ideal resource to develop evidence-based recommendations for acuitybased driver vision screening standards, which might perhaps lead to a harmonised Europe-wide
standard for driver vision screening.
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10 Summary, Conclusions, and Directions for Future
Work
10.1 Summary and Conclusions
This work was designed to investigate the use of Big Data as an epidemiological and public health
tool in eyecare with a particular focus on refractive error and vision. The findings reported are based
on two sources of data; a large dataset of spectacles lenses manufactured for delivery in Europe and
anonymised EMRs of 40 optometric practices in the Republic of Ireland. The findings of the research
presented in this thesis (i) demonstrates the viability of EMR data as a population level source of
refractive error information, (ii) describes a method to use spectacle lens sales data to determine
refractive error distribution in a population and (iii) provides an example of how this data can be
used as evidence to influence public health policy.
Our initial analysis (chapter 7) of both the EMR data and spectacle lens data revealed the EMR data
closely matched the distribution of refractive error found as part of a meta-analysis of refractive
error prevalence in Europe. The EMR data was also a closer match to the prevalence of hyperopia,
myopia and high myopia by age to the meta-analysis than one of the component studies of the
meta-analysis. The spectacle lens data did not offer as close a match, likely due to the effect of
underrepresentation of those that are approximately emmetropic. Interestingly, by combining
information from both datasets it was possible to gain more insight into the spectacle lens data and
estimate the age of those using an addition which allowed an age matched comparison.
Further analysis of the spectacle lens data revealed that outside the approximately emmetropic
range of refractive error, the distribution of refractive error for spectacle lenses closely matched the
that found in population surveys of refractive error (chapter 8). This is not surprising, as due to the
symptomatic nature of refractive error, it can be expected most individuals will seek correction if it is
available. By using previously described work296 it was possible to estimate the likelihood of vision
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impairment due to myopia by age 75 among spectacle lens wearers with myopia worse than -2.00 D
SER. This was found not to be statistically different to the likelihood of vision impairment due to
myopia over the same range of refractive error as estimated from a typical population survey of
refractive error. Significantly, it was estimated by age 75, over 9% of myopes will be vision impaired.
High myopes had a higher risk of vision impairment however the overall number of those estimated
to become vision impaired also contained a significant cohort of low to moderate myopes due to
their large numbers within the population despite their lower risk.
Our analysis of visual acuity in a large number of Irish adults (chapter 9) showed the current driver
vision reassessment intervals are inappropriately long, particularly in young individuals. Although
there is some debate over the relationship between visual acuity and driver safety,461,475–477 it is
visual acuity is likely to remain a core part of driver vision screening and as such the reassessment
intervals should be evidence based. We also observed an exponential increase in the number of
individuals potentially excluded from driving as the visuals acuity standard is made more stringent
than the most commonly used standard of 0.3 logMAR.
There are several recommendations to emerge from this work. The current driver vision
reassessment intervals need to be re-evaluated with key decisions made around the proportion of
drivers expected to still meet the standard at reassessment and how reassessment intervals should
be handled for those with refractive error. A sensible approach may be to align reassessment
intervals with licence renewal (typically every 10 years) for drivers aged 50 and younger with
progressively shorter intervals for older drivers. A single protocol for drivers with and without
refractive error is more practical to have in place and is supported by the finding that the significant
majority (≈ 84%) of those with refractive error will reattend their optometrist before the required
reassessment interval. Given the uncertainty over the relationship between visual acuity and driver
safety, countries that currently enforce a more stringent standard than 0.3 logMAR should consider
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lowering their standard to 0.3 logMAR to avoid the unnecessary exclusion of older individuals from
driving.
Both EMR and spectacle lens data provide a unique solution to the documented3 lack of available
population level refractive error data. The ability to acquire the data with relative ease and on an as
needed basis may allow for almost real time monitoring of the population burden of refractive error
and associated risk of vision impairment. This level of representative and current information can
facilitate public health policy and provide an evidence base upon which to base key decisions. The
burgeoning myopia epidemic will require accurate and current data to encourage widespread use of
myopia control and ongoing monitoring will be needed to assess the effectiveness of these
interventions on a population level. With an aging population, the burden of vision impairment is
likely to increase. Current estimates of vision impairment in the Republic of Ireland are outdated and
likely do not capture the true prevalence.259 The work described as part of this project may provide
an additional way to capture vision impairment risk and plan appropriate resources for those
affected. Some public health policies currently in place, such as the driver vision rescreening
intervals, are not evidence based. This data can provide evidence on which to base these polices to
improve outcomes for the public.

10.2 Directions for Future Work
This project has evolved into a much larger piece of work than was originally envisioned. Data
collection is still ongoing with new data sources becoming available while multiple additional
analyses are taking place. The spectacle lens data supplied by CZVI is due to be updated to reflect
lens delivery to the current year. An additional spectacle lens data source has been acquired
representing over 3 million lens sales in North America. Ocuco Ltd, the developer of the EMR
software used in this project has customers in several countries in Europe and North America, it is
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hoped in the future that data may be acquired from these countries to create a more global dataset
and facilitate comparisons between countries.
Two key next steps should take place to most fully realise the potential of the spectacle lens data as
described in chapter 7 and 8. In chapter 8, we suggest the development of an international
consortium of lens manufacturers, research intuitions and public health bodies. The spectacle lens
data used as part of this study was almost wholly for delivery in Europe and sourced from one
manufacturer. The creation of this consortium would allow the methodology described in chapter 8
to be applied on a global basis and overcome the limitations associated with using data from one
manufacturer supplying one geographic region. Additionally, temporal trends in the spectacle lens
data collected to date require investigation to determine if the prevalence of refractive error has
changed in Europe over time, particularly over the range of refractive error determined in chapter 8
to match population distributions of refractive error.
Additional work using the EMR data acquired is currently ongoing. Establishing the baseline
prevalence of refractive error in this population and historical changes in prevalence will provide
useful insights which may indicate the overall population burden of refractive error in Ireland,
particularly in the current circumstances, in which no other population level data is available.
Current work indicates an overall prevalence of myopia (≤ -0.50 D SER) of 33% with highest rates
observed in the 20 – 30 age cohort. Confining analysis to the presbyopic age group that are more
likely to be representative of the population, a much higher proportion of myopia is evident in
younger age groups. More in-depth analysis is required using higher threshold values of myopia to
confirm these findings.
Having established a baseline level of refractive error prevalence, the ongoing collection of EMR data
will allow continued monitoring of refractive error trends over time. Taking inspiration from the
VLEG International Agency for the Prevention of Blindness Atlas,5,256 work has commenced on the
development of a number of visualisation tools in order to follow trends in refractive error
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prevalence over time and to allow easy to access information policy makers and other stakeholders.
An early-stage example can be found at:
https://irelandrefractiveerror.shinyapps.io/RefractiveError/.
Investigation of vision impairment has also commenced with a total level of vision impairment (< 0.3
logMAR) of 1.04% (https://irelandrefractiveerror.shinyapps.io/VisionImpairment/). Determining the
cause of vision impairment will require further investigation and likely need to employ natural
language processing techniques but will provide very useful data on vision impairment in the
Republic of Ireland and indicate directions for public health intervention.
Aside from using this data as a population monitoring tool, it can also be used in clinical applications.
Recognising the children that would benefit most from myopia control and encouraging the use of
myopia control is key to prevent the predicted global increase in myopia and associated vision
impairment.3,4 Work is ongoing to develop a refractive error centile progression tool based on this
real world data which may become a valuable tool to aid clinicians and parents when deciding to
commence myopia control.491 Centile growth charts offer the possibility of predicting the
development of high myopia however an alternative strategy using AI may be another avenue to
explore in predicting high myopia. A recent study in China described good results using a ML model
for this purpose.316 This model may not be applicable to European children given the differences in
myopia development and prevalence discussed in chapter 3. The EMR data gathered as part of our
project may offer the opportunity to develop a similar model based on European children.
This data also provides the opportunity to explore some of the theories suggested for refractive
error development. It may be possible to investigate the association between month of birth and the
development of myopia. It has previously been suggested that individuals born during the summer
months are more likely to develop myopia.492 Our EMR data can explore this trend and see if it is
consistent in across years. This would provide another risk factor for clinicians to consider when
examining children. Another area that may be explored is the theory that the degree and axis of
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astigmatism varies as a function of spherical refractive error with higher and more oblique
astigmatism thought to be associated with higher spherical refractive error.123 Early work carried out
in this area seems to confirm this association (Appendix 5) but further research is needed.

223

11 References
1.

Pararajasegaram R. VISION 2020-the right to sight: from strategies to action. Am J
Ophthalmol. 1999;128(3):359-360.

2.

Pizzarello L. VISION 2020: The Right to Sight. Arch Ophthalmol. 2004;122(4):615.

3.

Holden BA, Fricke TR, Wilson DA, et al. Global Prevalence of Myopia and High Myopia and
Temporal Trends from 2000 through 2050. Ophthalmology. 2016;123(5):1036-1042.

4.

Naidoo KS, Fricke TR, Frick KD, et al. Potential Lost Productivity Resulting from the Global
Burden of Myopia: Systematic Review, Meta-analysis, and Modeling. Ophthalmology.
2019;126(3):338-346.

5.

Bourne R, Steinmetz JD, Flaxman S, et al. Trends in prevalence of blindness and distance and
near vision impairment over 30 years: an analysis for the Global Burden of Disease Study.
Lancet Glob Heal. 2021;9(2):e130-e143.

6.

Reinsel D, Gantz J, Rydning J. Data Age 2025: The Digitization of the World From Edge to
Core.; 2018.

7.

White S. A review of big data in health care: challenges and opportunities. Open Access
Bioinformatics. 2014;(November):13.

8.

Vitale S, Sperduto RD, Ferris FL. Increased prevalence of myopia in the United States between
1971-1972 and 1999-2004. Arch Ophthalmol (Chicago, Ill 1960). 2009;127(12):1632-1639.

9.

Tsai TH, Liu YL, Ma IH, et al. Evolution of the Prevalence of Myopia among Taiwanese
Schoolchildren: A Review of Survey Data from 1983 through 2017. Ophthalmology. Published
online 2020.

10.

Flaxman SR, Bourne RRA, Resnikoff S, et al. Global causes of blindness and distance vision
224

impairment 1990–2020: a systematic review and meta-analysis. Lancet Glob Heal.
2017;5(12):e1221-e1234.
11.

Schachar RA. The Early Signs Symptoms of Presbyopia. Points Vue. 2014;(70):12-15.

12.

Flitcroft DI. Emmetropisation and the aetiology of refractive errors. Eye. 2014;28(2):169-179.

13.

Mutti DO, Mitchell GL, Jones LA, et al. Axial growth and changes in lenticular and corneal
power during emmetropization in infants. Investig Ophthalmol Vis Sci. 2005;46(9):3074-3080.

14.

Wolfram C, Höhn R, Kottler U, et al. Prevalence of refractive errors in the European adult
population: the Gutenberg Health Study (GHS). Br J Ophthalmol. 2014;98(7):857-861.

15.

Morgan IG, Ohno-Matsui K, Saw S. Myopia. Lancet. 2012;379(9827):1739-1748.

16.

Lee MW, Lee S, Lim H, Kim J. Longitudinal changes in axial length in high myopia: a 4-year
prospective study. Br J Ophthalmol. 2020;104(5):600-603.

17.

Fotedar R, Wang JJ, Burlutsky G, et al. Distribution of Axial Length and Ocular Biometry
Measured Using Partial Coherence Laser Interferometry (IOL Master) in an Older White
Population. Ophthalmology. 2010;117(3):417-423.

18.

Foster PJ, Jiang Y. Epidemiology of myopia. Eye (Lond). 2014;28(2):202-208.

19.

Morgan IG, Rose KA. Myopia: is the nature-nurture debate finally over? Clin Exp Optom.
2019;102(1):3-17.

20.

Tong L, Wong EH, Chan YH, Balakrishnan V. A multiple regression approach to study optical
components of myopia in Singapore school children. Ophthalmic Physiol Opt. 2002;22(1):3237.

21.

Stone RA, Flitcroft DI. Ocular Shape and Myopia. Ann Acad Med Singapore. 2004;33(1):7-15.

225

22.

Summers Rada JA, Shelton S, Norton TT. The sclera and myopia. Exp Eye Res. 2006;82(2):185200.

23.

Sergienko NM, Shargorogska I. The scleral rigidity of eyes with different refractions. Graefe’s
Arch Clin Exp Ophthalmol. 2012;250(7):1009-1012.

24.

Shen L, You QS, Xu X, et al. Scleral thickness in Chinese eyes. Investig Ophthalmol Vis Sci.
2015;56(4):2720-2727.

25.

Vurgese S, Panda-Jonas S, Jonas JB. Scleral thickness in human eyes. PLoS One. 2012;7(1).

26.

McBrien NA, Lawlor P, Gentle A. Scleral remodeling during the development of and recovery
from axial myopia in the tree shrew. Invest Ophthalmol Vis Sci. 2000;41(12):3713-3719.

27.

Baird PN, Saw SM, Lanca C, et al. Myopia. Nat Rev Dis Prim. 2020;6(1).

28.

Ohno-Matsui K, Jonas JB. Posterior staphyloma in pathologic myopia. Prog Retin Eye Res.
2019;70:99-109.

29.

Flitcroft DI. The complex interactions of retinal, optical and environmental factors in myopia
aetiology. Prog Retin Eye Res. 2012;31(6):622-660.

30.

Smith EL, Ramamirtham R, Qiao-Grider Y, et al. Effects of foveal ablation on emmetropization
and form-deprivation myopia. Investig Ophthalmol Vis Sci. 2007;48(9):3914-3922.

31.

Smith EL, Kee C, Ramamirtham R, Qiao-Grider Y, Hung L-F. Peripheral Vision Can Influence Eye
Growth and Refractive Development in Infant Monkeys. Investig Opthalmology Vis Sci.
2005;46(11):3965.

32.

Mutti DO, Sholtz RI, Friedman NE, Zadnik K. Peripheral refraction and ocular shape in
children. Invest Ophthalmol Vis Sci. 2000;41(5):1022-1030.

33.

Kang P, Gifford P, McNamara P, et al. Peripheral refraction in different ethnicities. Investig
226

Ophthalmol Vis Sci. 2010;51(11):6059-6065.
34.

Atchison DA, Pritchard N, Schmid KL. Peripheral refraction along the horizontal and vertical
visual fields in myopia. Vision Res. 2006;46(8-9):1450-1458.

35.

Hodos W, Kuenzel WJ. Retinal-image degradation produces ocular enlargement in chicks.
Investig Ophthalmol Vis Sci. 1984;25(6):652-659.

36.

Diether S, Schaeffel F. Local changes in eye growth induced by imposed local refractive error
despite active accommodation. Vision Res. 1997;37(6):659-668.

37.

Mirshahi A, Ponto KA, Hoehn R, et al. Myopia and level of education: Results from the
gutenberg health study. Ophthalmology. 2014;121(10):2047-2052.

38.

Williams KM, Bertelsen G, Cumberland P, et al. Increasing Prevalence of Myopia in Europe
and the Impact of Education. Ophthalmology. 2015;122(7):1489-1497.

39.

Saw SM, Cheng A, Fong A, Gazzard G, Tan DTH, Morgan I. School grades and myopia.
Ophthalmic Physiol Opt. 2007;27(2):126-129.

40.

Mutti DO, Mitchell GL, Moeschberger ML, Jones LA, Zadnik K. Parental myopia, near work,
school achievement, and children’s refractive error. Invest Ophthalmol Vis Sci.
2002;43(12):3633-3640.

41.

Huang HM, Chang DST, Wu PC. The association between near work activities and myopia in
children - A systematic review and meta-analysis. PLoS One. 2015;10(10):1-15.

42.

Jones LA, Sinnott LT, Mutti DO, Mitchell GL, Moeschberger ML, Zadnik K. Parental history of
myopia, sports and outdoor activities, and future myopia. Investig Ophthalmol Vis Sci.
2007;48(8):3524-3532.

43.

Saw SM, Chua WH, Hong CY, et al. Nearwork in early-onset myopia. Investig Ophthalmol Vis
227

Sci. 2002;43(2):332-339.
44.

Mavracanas TA, Mandalos A, Peios D, et al. Prevalence of myopia in a sample of Greek
students. Acta Ophthalmol Scand. 2000;78(6):656-659.

45.

Rose KA, Morgan IG, Ip J, et al. Outdoor Activity Reduces the Prevalence of Myopia in
Children. Ophthalmology. 2008;115(8):1279-1285.

46.

Hepsen IF, Evereklioglu C, Bayramlar H. The effect of reading and near-work on the
development of myopia in emmetropic boys: A prospective, controlled, three-year follow-up
study. Vision Res. 2001;41(19):2511-2520.

47.

Saw SM, Nieto FJ, Katz J, Schein OD, Levy B, Chew SJ. Factors related to the progression of
myopia in Singaporean children. Optom Vis Sci. 2000;77(10):549-554.

48.

Zylbermann R, Landau D, Berson D. The influence of study habits on myopia in Jewish
teenagers. J Pediatr Ophthalmol Strabismus. 1993;30(5):319-322.

49.

Morgan IG, Rose KA. Myopia and international educational performance. Ophthalmic Physiol
Opt. 2013;33(3):329-338.

50.

Rose KA, Morgan IG, Smith W, Burlutsky G, Mitchell P, Saw SM. Myopia, lifestyle, and
schooling in students of Chinese ethnicity in Singapore and Sydney. Arch Ophthalmol.
2008;126(4):527-530.

51.

Ben-Simon GJ, Peiss M, Anis E, Nakra T, Luski A, Spierer A. Spectacle use and reduced unaided
vision in third grade students: A comparative study in different educational settings. Clin Exp
Optom. 2004;87(3):175-179.

52.

Bez D, Megreli J, Bez M, Avramovich E, Barak A, Levine H. Association between Type of
Educational System and Prevalence and Severity of Myopia among Male Adolescents in Israel.
228

JAMA Ophthalmol. 2019;137(8):887-893.
53.

Peled A, Afek A, Twig G, et al. Myopia and Childhood Migration: A Study of 607 862
Adolescents. Ophthalmology. 2020;127(6):713-723.

54.

Wu PC, Chen CT, Chang LC, et al. Increased Time Outdoors Is Followed by Reversal of the
Long-Term Trend to Reduced Visual Acuity in Taiwan Primary School Students.
Ophthalmology. 2020;127(11):1462-1469.

55.

Wu PC, Chen CT, Lin KK, et al. Myopia Prevention and Outdoor Light Intensity in a SchoolBased Cluster Randomized Trial. Ophthalmology. 2018;125(8):1239-1250.

56.

Sherwin JC, Reacher MH, Keogh RH, Khawaja AP, MacKey DA, Foster PJ. The association
between time spent outdoors and myopia in children and adolescents: A systematic review
and meta-analysis. Ophthalmology. 2012;119(10):2141-2151.

57.

French AN, Ashby RS, Morgan IG, Rose KA. Time outdoors and the prevention of myopia. Exp
Eye Res. 2013;114:58-68.

58.

Wu PC, Tsai CL, Wu HL, Yang YH, Kuo HK. Outdoor activity during class recess reduces myopia
onset and progression in school children. Ophthalmology. 2013;120(5):1080-1085.

59.

Jin JX, Hua WJ, Jiang X, et al. Effect of outdoor activity on myopia onset and progression in
school-aged children in northeast china: The sujiatun eye care study. BMC Ophthalmol.
2015;15(1):1-11.

60.

He M, Xiang F, Zeng Y, et al. Effect of time spent outdoors at school on the development of
myopia among children in China a randomized clinical trial. JAMA - J Am Med Assoc.
2015;314(11):1142-1148.

61.

Xiong S, Sankaridurg P, Naduvilath T, et al. Time spent in outdoor activities in relation to
229

myopia prevention and control: a meta-analysis and systematic review. Acta Ophthalmol.
2017;95(6):551-566.
62.

Bullimore MA, Richdale K. Myopia Control 2020: Where are we and where are we heading?
Ophthalmic Physiol Opt. 2020;40(3):254-270.

63.

Wildsoet CF, Chia A, Cho P, et al. IMI – Interventions for Controlling Myopia Onset and
Progression Report. Investig Opthalmology Vis Sci. 2019;60(3):M106.

64.

Jong M, Jonas JB, Wolffsohn JS, et al. IMI 2021 yearly digest. Investig Ophthalmol Vis Sci.
2021;62(5):1-3.

65.

Jacobsen N, Jensen H, Goldschmidt E. Does the level of physical activity in university students
influence development and progression of myopia?-A 2-year prospective cohort study.
Investig Ophthalmol Vis Sci. 2008;49(4):1322-1327.

66.

Lundberg K, Suhr Thykjær A, Søgaard Hansen R, et al. Physical activity and myopia in Danish
children—The CHAMPS Eye Study. Acta Ophthalmol. 2018;96(2):134-141.

67.

Lingham G, MacKey DA, Lucas R, Yazar S. How does spending time outdoors protect against
myopia? A review. Br J Ophthalmol. 2020;104(5):593-599.

68.

Lanca C, Saw SM. The association between digital screen time and myopia: A systematic
review. Ophthalmic Physiol Opt. 2020;40(2):216-229.

69.

Yazar S, Hewitt AW, Black LJ, et al. Myopia Is Associated With Lower Vitamin D Status in
Young Adults. Investig Opthalmology Vis Sci. 2014;55(7):4552.

70.

Choi JA, Han K, Park Y, La TY. Low Serum 25-Hydroxyvitamin D Is Associated With Myopia in
Korean Adolescents. Published online 2014.

71.

Guggenheim JA, Williams C, Northstone K, et al. Does vitamin D mediate the protective
230

effects of time outdoors on myopia? Findings from a prospective birth cohort. Investig
Ophthalmol Vis Sci. 2014;55(12):8550-8558.
72.

Tang SM, Lau T, Rong SS, et al. Vitamin D and its pathway genes in myopia: systematic review
and meta-analysis. Br J Ophthalmol. 2019;103(1):8-17.

73.

Cuellar-Partida G, Williams KM, Yazar S, et al. Genetically low vitamin D concentrations and
myopic refractive error: a Mendelian randomization study. Int J Epidemiol. 2017;46(6):18821890.

74.

Read SA, Collins MJ, Vincent SJ. Light exposure and eye growth in childhood. Investig
Ophthalmol Vis Sci. 2015;56(11):6779-6787.

75.

Foulds WS, Barathi VA, Luu CD. Progressive myopia or hyperopia can be induced in chicks and
reversed by manipulation of the chromaticity of ambient light. Investig Ophthalmol Vis Sci.
2013;54(13):8004-8012.

76.

Wang M, Schaeffel F, Jiang B, Feldkaemper M. Effects of light of different spectral
composition on refractive development and retinal dopamine in chicks. Investig Ophthalmol
Vis Sci. 2018;59(11):4413-4424.

77.

Gawne TJ, Ward AH, Norton TT. Juvenile Tree Shrews Do Not Maintain Emmetropia in
Narrow-band Blue Light. Optom Vis Sci. 2018;95(10):911-920.

78.

Han JC, Lawlor DA, Kimm SY. Childhood obesity. Lancet. 2010;375(9727):1737-1748.

79.

Lawrenson JG, Hull CC, Downie LE. The effect of blue-light blocking spectacle lenses on visual
performance, macular health and the sleep-wake cycle: a systematic review of the literature.
Ophthalmic Physiol Opt. 2017;37(6):644-654.

80.

Zhang X, Qu X, Zhou X. Association between parental myopia and the risk of myopia in a child.
231

Exp Ther Med. 2015;9(6):2420-2428.
81.

Konstantopoulos A, Yadegarfar G, Elgohary M. Near work, education, family history, and
myopia in Greek conscripts. Eye. 2008;22(4):542-546.

82.

Davis-Kean PE. The influence of parent education and family income on child achievement:
The indirect role of parental expectations and the home environment. J Fam Psychol.
2005;19(2):294-304.

83.

Williams C, Miller LL, Gazzard G, Saw SM. A comparison of measures of reading and
intelligence as risk factors for the development of myopia in a UK cohort of children. Br J
Ophthalmol. 2008;92(8):1117-1121.

84.

Rah MJ, Mitchell GL, Mutti DO, Zadnik K. Levels of agreement between parents’ and
children’s reports of near work. Ophthalmic Epidemiol. 2002;9(3):191-203.

85.

Tang SM, Kam KW, French AN, et al. Independent Influence of Parental Myopia on Childhood
Myopia in a Dose-Related Manner in 2,055 Trios: The Hong Kong Children Eye Study. Am J
Ophthalmol. 2020;218:199-207.

86.

Lim DH, Han J, Chung T-Y, Kang S, Yim HW. The high prevalence of myopia in Korean children
with influence of parental refractive errors: The 2008-2012 Korean National Health and
Nutrition Examination Survey. PLoS One. 2018;13(12):e0209876.

87.

Saw S, Shankar A, Tan S-B, et al. A Cohort Study of Incident Myopia in Singaporean Children.
Investig Opthalmology Vis Sci. 2006;47(5):1839.

88.

French AN, Morgan IG, Mitchell P, Rose KA. Risk factors for incident myopia in Australian
schoolchildren: The Sydney Adolescent Vascular and Eye Study. Ophthalmology.
2013;120(10):2100-2108.

232

89.

Low W, Dirani M, Gazzard G, et al. Family history, near work, outdoor activity, and myopia in
Singapore Chinese preschool children. Br J Ophthalmol. 2010;94(8):1012-1016.

90.

Xiang F, He M, Morgan IG. The impact of parental myopia on myopia in Chinese children:
Population-based evidence. Optom Vis Sci. 2012;89(10):1487-1496.

91.

Wu MMM, Edwards MH. The effect of having myopic parents: An analysis of myopia in three
generations. Optom Vis Sci. 1999;76(6):387-392.

92.

Jiang D, Lin H, Li C, et al. Longitudinal association between myopia and parental myopia and
outdoor time among students in Wenzhou: a 2.5-year longitudinal cohort study. BMC
Ophthalmol. 2021;21(1):1-8.

93.

Flitcroft DI, He M, Jonas JB, et al. IMI – Defining and Classifying Myopia: A Proposed Set of
Standards for Clinical and Epidemiologic Studies. Investig Opthalmology Vis Sci.
2019;60(3):M20.

94.

Hardy R, Hillis A, Mutti D, et al. Myopia stabilization and associated factors among
participants in the correction of myopia evaluation trial (COMET). Investig Ophthalmol Vis Sci.
2013;54(13):7871-7883.

95.

Wojciechowski R, Congdon N, Bowie H, Munoz B, Gilbert D, West SK. Heritability of Refractive
Error and Familial Aggregation of Myopia in an Elderly American Population. Investig
Opthalmology Vis Sci. 2005;46(5):1588.

96.

Grasby KL, Verweij KJH, Mosing MA, Zietsch BP, Medland SE. Estimating heritability from twin
studies. Methods Mol Biol. 2017;1666:171-194.

97.

Hammond CJ, Snieder H, Gilbert CE, Spector TD. Genes and environment in refractive error:
The twin eye study. Investig Ophthalmol Vis Sci. 2001;42(6):1232-1236.

233

98.

Lin LL, Chen C ‐J. A twin study on myopia in Chinese school children. Acta Ophthalmol.
1988;66(185 S):51-53.

99.

Teikari JM, Kaprio J, Koskenvuo MK, Vannas A. Heritability estimate for refractive errors—a
population-based sample of adult twins. Genet Epidemiol. 1988;5(3):171-181.

100.

Klein AP, Suktitipat B, Duggal P, et al. Heritability analysis of spherical equivalent, axial length,
corneal curvature, and anterior chamber depth in the Beaver Dam Eye Study. Arch
Ophthalmol (Chicago, Ill 1960). 2009;127(5):649-655.

101.

Guggenheim JA, Zhou X, Evans DM, et al. Coordinated genetic scaling of the human eye:
Shared determination of axial eye length and corneal curvature. Investig Ophthalmol Vis Sci.
2013;54(3):1715-1721.

102.

Kim MH, Zhao D, Kim W, et al. Heritability of myopia and ocular biometrics in Koreans: the
healthy twin study. Invest Ophthalmol Vis Sci. 2013;54(5):3644-3649.

103.

Tedja MS, Haarman AEG, Meester-Smoor MA, et al. IMI – Myopia genetics report. Investig
Ophthalmol Vis Sci. 2019;60(3):M89-M105.

104.

Verhoeven VJM, Hysi PG, Wojciechowski R, et al. Genome-wide meta-analyses of
multiancestry cohorts identify multiple new susceptibility loci for refractive error and myopia.
Nat Genet. 2013;45(3):314-318.

105.

Kiefer AK, Tung JY, Do CB, et al. Genome-Wide Analysis Points to Roles for Extracellular
Matrix Remodeling, the Visual Cycle, and Neuronal Development in Myopia. PLoS Genet.
2013;9(2).

106.

Manolio TA, Collins FS, Cox NJ, et al. Finding the missing heritability of complex diseases.
Nature. 2009;461(7265):747-753.

234

107.

Verhoeven VJM, Buitendijk GHS, Rivadeneira F, et al. Education influences the role of genetics
in myopia. Eur J Epidemiol. 2013;28(12):973-980.

108.

Strang NC, Schmid KL, Carney LG. Hyperopia is predominantly axial in nature. Curr Eye Res.
1998;17(4):380-383.

109.

Llorente L, Barbero S, Cano D, Dorronsoro C, Marcos S. Myopic versus hyperopic eyes: Axial
length, corneal shape and optical aberrations. J Vis. 2004;4(4):288-298.

110.

Choong YF, Chen AH, Goh PP. A Comparison of Autorefraction and Subjective Refraction With
and Without Cycloplegia in Primary School Children. Am J Ophthalmol. 2006;142(1).

111.

Congdon N, Burnett A, Frick K. The impact of uncorrected myopia on individuals and society.
Community Eye Heal J. 2019;32(105):7-8.

112.

Harrington S, Davison PA, O’Dwyer V. School performance and undetected and untreated
visual problems in schoolchildren in Ireland; a population-based cross-sectional study. Irish
Educ Stud. 2021;0(0):1-22.

113.

Kulp MT, Ciner E, Maguire M, et al. Uncorrected hyperopia and preschool early literacy:
Results of the Vision in Preschoolers-Hyperopia in Preschoolers (VIP-HIP) study.
Ophthalmology. 2016;123(4):681-689.

114.

Haarman AEG, Enthoven CA, Tideman JWL, Tedja MS, Verhoeven VJM, Klaver CCW. The
Complications of Myopia: A Review and Meta-Analysis. Invest Ophthalmol Vis Sci.
2020;61(4):49.

115.

Saunders KJ. Early refractive development in humans. Surv Ophthalmol. 1995;40(3):207-216.

116.

Mayer DL, Hansen RM, Moore BD, Kim S, Fulton AB. Cycloplegic refractions in healthy
children aged 1 through 48 months. Arch Ophthalmol. 2001;119(11):1625-1628.
235

117.

Varghese RM, Sreenivas V, Puliyel JM, Varughese S. Refractive status at birth: Its relation to
newborn physical parameters at birth and gestational age. PLoS One. 2009;4(2):1-6.

118.

Semeraro F, Forbice E, Nascimbeni G, et al. Ocular Refraction at Birth and Its Development
During the First Year of Life in a Large Cohort of Babies in a Single Center in Northern Italy.
Front Pediatr. 2020;7(January):1-6.

119.

Saunders KJ, McCulloch DL, Shepherd AJ, Wilkinson AG. Emmetropisation following preterm
birth. Br J Ophthalmol. 2002;86(9):1035-1040.

120.

Guzowski M, Wang JJ, Rochtchina E, Rose KA, Mitchell P. Five-year refractive changes in an
older population: The Blue Mountains Eye Study. Ophthalmology. 2003;110(7):1364-1370.

121.

Gudmundsdottir E, Arnarsson A, Jonasson F. Five-year refractive changes in an adult
population: Reykjavik eye study. Ophthalmology. 2005;112(4):672-677.

122.

Hashemi H, Iribarren R, Morgan IG, Khabazkhoob M, Mohammad K, Fotouhi A. Increased
hyperopia with ageing based on cycloplegic refractions in adults: The Tehran Eye Study. Br J
Ophthalmol. 2010;94(1):20-23.

123.

Read SA, Collins MJ, Carney LG. A review of astigmatism and its possible genesis: Invited
review. Clin Exp Optom. 2007;90(1):5-19.

124.

Isenberg SJ, Del Signore M, Chen A, Wei J, Christenson PD. Corneal topography of neonates
and infants. Arch Ophthalmol. 2004;122(12):1767-1771.

125.

Rozema JJ, Hershko S, Tassignon MJ, et al. The components of adult astigmatism and their
age-related changes. Ophthalmic Physiol Opt. 2019;39(3):183-193.

126.

Mutti DO, Mitchell GL, Jones LA, et al. Refractive astigmatism and the toricity of ocular
components in human infants. Optom Vis Sci. 2004;81(10):753-761.
236

127.

Read SA, Collins MJ, Carney LG. The influence of eyelid morphology on normal corneal shape.
Investig Ophthalmol Vis Sci. 2007;48(1):112-119.

128.

Wilson G, Bell C, Chotai S. The effect of lifting the lids on corneal astigmatism. Optom Vis Sci.
1982;59(8):670-674.

129.

Heidary G, Ying GS, Maguire MG, Young TL. The association of astigmatism and spherical
refractive error in a high myopia cohort. Optom Vis Sci. 2005;82(4):244-247.

130.

Tong L, Saw SM, Carkeet A, Chan WY, Wu HM, Tan D. Prevalence rates and epidemiological
risk factors for astigmatism in Singapore school children. Optom Vis Sci. 2002;79(9):606-613.

131.

Farbrother JE, Welsby JW, Guggenheim JA. Astigmatic Axis is Related to the Level of Spherical
Ametropia. Optom Vis Sci. 2004;81(1):18-26.

132.

Pärssinen O. Astigmatism and school myopia. Acta Ophthalmol. 1991;69(6):786-790.

133.

Valluri S, Minkovitz JB, Budak K, et al. Comparative corneal topography and refractive
variables in monozygotic and dizygotic twins. Am J Ophthalmol. 1999;127(2):158-163.

134.

Wolffsohn JS, Davies LN. Presbyopia: Effectiveness of correction strategies. Prog Retin Eye
Res. 2019;68:124-143.

135.

Schachar RA. The Mechanism of Accommodation and Presbyopia. Int Ophthalmol Clin.
2006;46(3):39-61.

136.

Charman WN. Virtual Issue Editorial: Presbyopia – grappling with an age-old problem.
Ophthalmic Physiol Opt. 2017;37(6):655-660.

137.

Sheppard AL, John Evans C, Singh KD, Wolffsohn JS, Dunne MCM, Davies LN. Threedimensional magnetic resonance imaging of the phakic crystalline lens during
accommodation. Investig Ophthalmol Vis Sci. 2011;52(6):3689-3697.
237

138.

Laughton DS, Sheppard AL, Mallen EAH, Read SA, Davies LN. Does transient increase in axial
length during accommodation attenuate with age? Clin Exp Optom. 2017;100(6):676-682.

139.

Miranda MN. The geographic factor in the onset of presbyopia. Trans Am Ophthalmol Soc.
1979;VOL. 77:603-621.

140.

Patel I, West SK. Presbyopia: prevalence, impact, and interventions. Community eye Heal.
2007;20(63):40-41.

141.

Heys KR, Cram SL, Truscott RJW. Massive increase in the stiffness of the human lens nucleus
with age: The basis for presbyopia? Mol Vis. 2004;10(June):956-963.

142.

Pointer JS. The presbyopic add. III. Influence of the distance refractive type. Ophthalmic
Physiol Opt. 1995;15(4):249-253.

143.

Abraham LM, Kuriakose T, Sivanandam V, Venkatesan N, Thomas R, Muliyil J. Amplitude of
accommodation and its relation to refractive errors. Indian J Ophthalmol. 2005;53(2):105108.

144.

Spierer A, Shalev B. Presbyopia among normal individuals. Graefe’s Arch Clin Exp Ophthalmol.
2003;241(2):101-105.

145.

Weale RA. Human ocular aging and ambient temperature. Br J Ophthalmol. 1981;65(12):869870.

146.

Pointer JS. Gender-related optical aspects of the onset of presbyopia. Ophthalmic Physiol
Opt. 2002;22(2):126-129.

147.

Pointer JS. The presbyopic add. II. Age-related trend and a gender difference. Ophthalmic
Physiol Opt. 1995;15(4):241-248.

148.

Edwards MH, Law LF, Lee CM, Leung KM, Lui WO. Clinical norms for amplitude of
238

accommodation in Chinese. Ophthalmic Physiol Opt. 1993;13(2):199-204.
149.

Carnevali T, Southaphanh P. A retrospective study on presbyopia onset and progression in a
Hispanic population. Optometry. 2005;76(1):37-46.

150.

Weale RA. Epidemiology of refractive errors and presbyopia. Surv Ophthalmol.
2003;48(5):515-543.

151.

Lin LLK, Shih YF, Hsiao CK, Chen CJ. Prevalence of myopia in Taiwanese schoolchildren: 1983
to 2000. Ann Acad Med Singapore. 2004;33(1):27-33.

152.

Anton A, Andrada M, Mayo A, Portela J, Merayo J. Epidemiology of Refractive Errors in an
Adult European Population: The Segovia Study. Ophthalmic Epidemiol. 2009;16(4):231-237.

153.

Yotsukura E, Torii H, Inokuchi M, et al. Current Prevalence of Myopia and Association of
Myopia with Environmental Factors among Schoolchildren in Japan. JAMA Ophthalmol.
2019;137(11):1233-1239.

154.

Williams KM, Verhoeven VJM, Cumberland P, et al. Prevalence of refractive error in Europe:
the European Eye Epidemiology (E3) Consortium. Eur J Epidemiol. 2015;30(4):305-315.

155.

Rahi JS, Cumberland PM, Peckham CS. Myopia over the lifecourse: prevalence and early life
influences in the 1958 British birth cohort. Ophthalmology. 2011;118(5):797-804.

156.

Rim TH, Kim S-H, Lim KH, Choi M, Kim HY, Baek S-H. Refractive Errors in Koreans: The Korea
National Health and Nutrition Examination Survey 2008-2012. Korean J Ophthalmol.
2016;30(3):214.

157.

Yoon K, Mun G, Kim S-D, et al. Prevalence of Eye Diseases in South Korea: Data from the
Korea National Health and Nutrition Examination Survey 2008-2009. Korean J Ophthalmol.
2011;25(6):421.
239

158.

Vitale S, Ellwein L, Cotch MF, Ferris FL, Sperduto R. Prevalence of refractive error in the
United States, 1999-2004. Arch Ophthalmol (Chicago, Ill 1960). 2008;126(8):1111-1119.

159.

Cumberland PM, Bao Y, Hysi PG, et al. Frequency and Distribution of Refractive Error in Adult
Life: Methodology and Findings of the UK Biobank Study. Pan C-W, ed. PLoS One.
2015;10(10):e0139780.

160.

Jonas JB, Xu L, Wang YX. The Beijing Eye Study. Acta Ophthalmol. 2009;87(3):247-261.

161.

Cumberland PM, Bountziouka V, Rahi JS. Impact of varying the definition of myopia on
estimates of prevalence and associations with risk factors: time for an approach that serves
research, practice and policy. Br J Ophthalmol. 2018;102(10):1407-1412.

162.

Young G, Sulley A, Hunt C. Prevalence of Astigmatism in Relation to Soft Contact Lens Fitting.
Eye Contact Lens Sci Clin Pract. 2011;37(1):20-25.

163.

Holden BA, Fricke TR, Ho SM, et al. Global vision impairment due to uncorrected presbyopia.
Arch Ophthalmol (Chicago, Ill 1960). 2008;126(12):1731-1739.

164.

Hu YY, Wu JF, Lu TL, et al. Effect of cycloplegia on the refractive status of children: The
shandong children eye study. PLoS One. 2015;10(2):1-10.

165.

Sanfilippo PG, Chu BS, Bigault O, et al. What is the appropriate age cut-off for cycloplegia in
refraction? Acta Ophthalmol. 2014;92(6):458-462.

166.

Morgan IG, Iribarren R, Fotouhi A, Grzybowski A. Cycloplegic refraction is the gold standard
for epidemiological studies. Acta Ophthalmol. 2015;93(6):581-585.

167.

Mimouni M, Zoller L, Horowitz J, Wygnanski-Jaffe T, Morad Y, Mezer E. Cycloplegic
autorefraction in young adults: is it mandatory? Graefe’s Arch Clin Exp Ophthalmol.
2016;254(2):395-398.
240

168.

Yazdani N, Sadeghi R, Momeni-Moghaddam H, Zarifmahmoudi L, Ehsaei A. Comparison of
cyclopentolate versus tropicamide cycloplegia: A systematic review and meta-analysis. J
Optom. 2018;11(3):135-143.

169.

Wolffsohn JS, Kollbaum PS, Berntsen DA, et al. IMI – Clinical Myopia Control Trials and
Instrumentation Report. Investig Opthalmology Vis Sci. 2019;60(3):M132.

170.

McCullough SJ, Doyle L, Saunders KJ. Intra- and inter- examiner repeatability of cycloplegic
retinoscopy among young children. Ophthalmic Physiol Opt. 2017;37(1):16-23.

171.

Pesudovs K, Parker KE, Cheng H, Applegate RA. The precision of wavefront refraction
compared to subjective refraction and autorefraction. Optom Vis Sci. 2007;84(5):387-392.

172.

Walline JJ. Myopia control: A review. Eye Contact Lens. 2016;42(1):3-8.

173.

Bradley JC, Cohn CD, Wu PW, Brown SM. Comparison of a monocular pupillometer and the
pupillometry function of a binocular free-viewing autorefractor. J Cataract Refract Surg.
2011;37(7):1257-1262.

174.

Donovan L, Sankaridurg P, Ho A, Naduvilath T, Smith EL, A. Holden B. Myopia Progression
Rates in Urban Children Wearing Single-Vision Spectacles. Optom Vis Sci. 2012;89(1):27-32.

175.

Brown NAP, Hill AR. Cataract: the relation between myopia and cataract morphology. Br J
Ophthalmol. 1987;71(6):405-414.

176.

Saw SM, Gazzard G, Koh D, et al. Prevalence rates of refractive errors in Sumatra, Indonesia.
Investig Ophthalmol Vis Sci. 2002;43(10):3174-3180.

177.

Sawada A, Tomidokoro A, Araie M, Iwase A, Yamamoto T. Refractive Errors in an Elderly
Japanese Population. Ophthalmology. 2008;115(2):363-370.e3.

178.

Kim EC, Morgan IG, Kakizaki H, Kang S, Jee D. Prevalence and risk factors for refractive errors:
241

Korean National Health and Nutrition Examination Survey 2008-2011. PLoS One.
2013;8(11):11-15.
179.

Nakao S ya, Miyake M, Hosoda Y, et al. Myopia Prevalence and Ocular Biometry Features in a
General Japanese Population: The Nagahama Study. Ophthalmology. Published online
2020:1-10.

180.

Gupta A, Casson RJ, Newland HS, et al. Prevalence of Refractive Error in Rural Myanmar. The
Meiktila Eye Study. Ophthalmology. 2008;115(1):26-34.

181.

Xu L, Li J, Cui T, et al. Refractive error in urban and rural adult Chinese in Beijing.
Ophthalmology. 2005;112(10):1676-1683.

182.

Bourne RRA, Dineen BP, Ali SM, Noorul Huq DM, Johnson GJ. Prevalence of refractive error in
Bangladeshi adults: Results of the national blindness and low vision survey of Bangladesh.
Ophthalmology. 2004;111(6):1150-1160.

183.

Nangia V, Jonas JB, Sinha A, Matin A, Kulkarni M. Refractive Error in Central India. The Central
India Eye and Medical Study. Ophthalmology. 2010;117(4):693-699.

184.

Krishnaiah S, Srinivas M, Khanna RC, Rao GN. Prevalence and risk factors for refractive errors
in the South Indian adult population: The Andhra Pradesh Eye disease study. Clin Ophthalmol.
2009;3:17-27.

185.

Hashemi H, Khabazkhoob M, Jafarzadehpur E, et al. High prevalence of myopia in an adult
population, Shahroud, Iran. Optom Vis Sci. 2012;89(7):993-999.

186.

Wong TY, Foster PJ, Hee J, et al. Prevalence and risk factors for refractive errors in adult
Chinese in Singapore. Invest Ophthalmol Vis Sci. 2000;41(9):2486-2494.

187.

Attebo K, Ivers R, Mitchell P. Refractive Errors in an Older Population - The Blue Mountains
242

Study. Ophthalmology. 1999;1066(6):1066-1072.
188.

Mitchell JP, Williams N, Martin R, et al. The Venezuela Eye Evaluation Study. J Natl Med
Assoc. 2008;100(4):435-438.

189.

Jiménez JR, Bermúdez J, Rubiño M, Gómez L, Anera RG. Prevalence of myopia in an adult
population of two different ethnic groups in the Ecuadorian Amazon. Jpn J Ophthalmol.
2004;48(2):163-165.

190.

Galvis V, Tello A, Otero J, et al. Prevalence of refractive errors in Colombia: Miopur study. Br J
Ophthalmol. 2018;102(10):1320-1323.

191.

Cortinez MF, Chiappe JP, Iribarren R. Prevalence of Refractive Errors in a Population of OfficeWorkers in Buenos Aires, Argentina. Ophthalmic Epidemiol. 2008;15(1):10-16.

192.

Chan VF, Mebrahtu G, Ramson P, Wepo M, Naidoo KS. Prevalence of Refractive Error and
Spectacle Coverage in Zoba Ma’ekel Eritrea: A Rapid Assessment of Refractive Error.
Ophthalmic Epidemiol. 2013;20(3):131-137.

193.

Bright T, Kuper H, Macleod D, Musendo D, Irunga P, Yip JLY. Population need for primary eye
care in Rwanda: A national survey. Tsai D-C, ed. PLoS One. 2018;13(5):e0193817.

194.

Ezelum C, Razavi H, Sivasubramaniam S, et al. Refractive Error in Nigerian Adults: Prevalence,
Type, and Spectacle Coverage. Investig Opthalmology Vis Sci. 2011;52(8):5449.

195.

Mashige KP, Jaggernath J, Ramson P, Martin C, Chinanayi FS, Naidoo KS. Prevalence of
Refractive Errors in the INK Area, Durban, South Africa. Optom Vis Sci. 2016;93(3):243-250.

196.

He M, Zheng Y, Xiang F. Prevalence of myopia in urban and rural children in mainland China.
Optom Vis Sci. 2009;86(1):40-44.

197.

Tan CSH, Chan YH, Wong TY, et al. Prevalence and risk factors for refractive errors and ocular
243

biometry parameters in an elderly Asian population: The Singapore Longitudinal Aging Study
(SLAS). Eye. 2011;25(10):1294-1301.
198.

Liang YB, Wong TY, Sun LP, et al. Refractive Errors in a Rural Chinese Adult Population. The
Handan Eye Study. Ophthalmology. 2009;116(11):2119-2127.

199.

Yoo YC, Kim JM, Park KH, Kim CY, Kim TW. Refractive errors in a rural Korean adult
population: The Namil Study. Eye. 2013;27(12):1368-1375.

200.

Nowak MS, Jurowski P, Grzybowski A, Smigielski J. Characteristics of Refractive Errors in a
Population of Adults in the Central Region of Poland. Int J Environ Res Public Health.
2018;15(1):10-14.

201.

Sherwin JC, Khawaja AP, Broadway D, et al. Uncorrected refractive error in older British
adults: The EPIC-Norfolk eye study. Br J Ophthalmol. 2012;96(7):991-996.

202.

Wang Q, Klein BEK, Klein R, Moss SE. Refractive status in the Beaver Dam eye study. Investig
Ophthalmol Vis Sci. 1994;35(13):4344-4347.

203.

Attebo K, Ivers RQ, Mitchell P. Refractive errors in an older population: the Blue Mountains
Eye Study. Ophthalmology. 1999;106(6):1066-1072.

204.

Hendricks TJW, de Brabander J, Vankan-Hendricks MHP, van der Horst FG, Hendrikse F,
Knottnerus JA. Prevalence of habitual refractive errors and anisometropia among Dutch
schoolchildren and hospital employees. Acta Ophthalmol. 2009;87(5):538-543.

205.

Varma R, Torres M, McKean-Cowdin R, et al. Prevalence and Risk Factors for Refractive Error
in Adult Chinese Americans: The Chinese American Eye Study. Am J Ophthalmol.
2017;175:201-212.

206.

Hashemi H, Khabazkhoob M, Yekta A, et al. High prevalence of astigmatism in the 40- to 64244

year-old population of Shahroud, Iran. Clin Exp Ophthalmol. 2012;40(3):247-254.
207.

Fricke TR, Tahhan N, Resnikoff S, et al. Global Prevalence of Presbyopia and Vision
Impairment from Uncorrected Presbyopia: Systematic Review, Meta-analysis, and Modelling.
Ophthalmology. 2018;125(10):1492-1499.

208.

Wang J, Ying GS, Fu X, et al. Prevalence of myopia and vision impairment in school students in
Eastern China. BMC Ophthalmol. 2020;20(1):1-10.

209.

Negrel AD, Maul E, Pokharel GP, Zhao J, Ellwein LB. Refractive error study in children:
Sampling and measurement methods for a multi-country survey. Am J Ophthalmol.
2000;129(4):421-426.

210.

Zhao J, Pan X, Sui R, Munoz SR, Sperduto RD, Ellwein LB. Refractive error study in children:
Results from Shunyi District, China. Am J Ophthalmol. 2000;129(4):427-435.

211.

Maul E, Barroso S, Munoz SR, Sperduto RD, Ellwein LB. Refractive Error Study in Children:
results from La Florida, Chile. Am J Ophthalmol. 2000;129(4):445-454.

212.

Murthy GVS, Gupta SK, Ellwein LB, et al. Refractive error in children in an urban population in
New Delhi. Investig Ophthalmol Vis Sci. 2002;43(3):623-631.

213.

He M, Zeng J, Liu Y, Xu J, Pokharel GP, Ellwein LB. Refractive Error and Visual Impairment in
Urban Children in Southern China. Investig Opthalmology Vis Sci. 2004;45(3):793.

214.

Goh PP, Abqariyah Y, Pokharel GP, Ellwein LB. Refractive error and visual impairment in
school-age children in Gombak District, Malaysia. Ophthalmology. 2005;112(4):678-685.

215.

O’Donoghue L, McClelland JF, Logan NS, Rudnicka AR, Owen CG, Saunders KJ. Refractive error
and visual impairment in school children in Northern Ireland. Br J Ophthalmol.
2010;94(9):1155-1159.
245

216.

Harrington SC, Stack J, Saunders K, O’Dwyer V. Refractive error and visual impairment in
Ireland schoolchildren. Br J Ophthalmol. 2019;103(8):1112-1118.

217.

Naidoo KS, Raghunandan A, Mashige KP, et al. Refractive error and visual impairment in
African children in South Africa. Investig Ophthalmol Vis Sci. 2003;44(9):3764-3770.

218.

Moraes Ibrahim F, Moraes Ibrahim M, Pomepo de Camargo JR, Veronese Rodrigues M de L,
Scott IU, Silva Paula J. Visual impairment and myopia in Brazilian children: a population-based
study. Optom Vis Sci. 2013;90(3):223-227.

219.

Jung S, Lee JH, Kakizaki H, Jee D. Prevalence of Myopia and its Association with Body Stature
and Educational Level in 19-Year-Old Male Conscripts in Seoul, South Korea. Investig
Opthalmology Vis Sci. 2012;53(9):5579.

220.

Semanyenzi SE, Karimurio J, Nzayirambaho M. Prevalence and pattern of refractive errors in
high schools of Nyarugenge district. Rwanda Med J. 2015;72(3):8-13.

221.

Mehari ZA, Yimer AW. Prevalence of refractive errors among schoolchildren in rural central
Ethiopia. Clin Exp Optom. 2013;96(1):65-69.

222.

Zhou W, Zhang Y, Li H, et al. Five-Year Progression of Refractive Errors and Incidence of
Myopia in School-Aged Children in Western China. J Epidemiol. 2016;26(7):386-395.

223.

Ma Y, Qu X, Zhu X, et al. Age-specific prevalence of visual impairment and refractive error in
children aged 3–10 years in Shanghai, China. Investig Ophthalmol Vis Sci. 2016;57(14):61886196.

224.

Logan NS, Shah P, Rudnicka AR, Gilmartin B, Owen CG. Childhood ethnic differences in
ametropia and ocular biometry: the Aston Eye Study. Ophthalmic Physiol Opt.
2011;31(5):550-558.

246

225.

French AN, O’Donoghue L, Morgan IG, Saunders KJ, Mitchell P, Rose KA. Comparison of
Refraction and Ocular Biometry in European Caucasian Children Living in Northern Ireland
and Sydney, Australia. Investig Opthalmology Vis Sci. 2012;53(7):4021.

226.

Ovenseri-Ogbomo G, Dr V Omuemu. Prevalence of refractive error among school children in
the Cape Coast Municipality, Ghana. Clin Optom. Published online 2010:59.

227.

Dolgin E. The myopia boom. Nature. 2015;519(7543):276-278.

228.

Hagen LA, Gjelle JVB, Arnegard S, Pedersen HR, Gilson SJ, Baraas RC. Prevalence and Possible
Factors of Myopia in Norwegian Adolescents. Sci Rep. 2018;8(1):1-10.

229.

Theophanous C, Modjtahedi BS, Batech M, Marlin DS, Luong TQ, Fong DS. Myopia prevalence
and risk factors in children. Clin Ophthalmol. 2018;12:1581-1587.

230.

De Amorim Garcia CA, Oréfice F, Dutra Nobre GF, De Brito Souza D, Ramalho Rocha ML,
Garrido Vianna RN. Prevalence of refractive errors in students in Northeastern Brazil. Arq
Bras Oftalmol. 2005;68(3):321-325.

231.

Quek TPL, Chua CG, Chong CS, et al. Prevalence of refractive errors in teenage high school
students in Singapore. Ophthalmic Physiol Opt. 2004;24(1):47-55.

232.

Hashemi H, Rezvan F, Beiranvand A, et al. Prevalence of Refractive Errors among High School
Students in Western Iran. J Ophthalmic Vis Res. 2014;9(2):232-239.

233.

Shapira Y, Mimouni M, Machluf Y, Chaiter Y, Saab H, Mezer E. The Increasing Burden of
Myopia in Israel among Young Adults over a Generation: Analysis of Predisposing Factors.
Ophthalmology. 2019;126(12):1617-1626.

234.

Czepita D, Żejmo M, Mojsa A. Prevalence of myopia and hyperopia in a population of Polish
schoolchildren. Ophthalmic Physiol Opt. 2006;27(1):60-65.
247

235.

Taylor HR, Robin TA, Lansingh VC, Weih LM, Keeffe JE. A myopic shift in Australian
Aboriginals: 1977-2000. Trans Am Ophthalmol Soc. 2003;101:107-110; discussion 110-2.

236.

Bar Dayan Y, Levin A, Morad Y, et al. The changing prevalence of myopia in young adults: a
13-year series of population-based prevalence surveys. Invest Ophthalmol Vis Sci.
2005;46(8):2760-2765.

237.

Chen M, Wu A, Zhang L, et al. The increasing prevalence of myopia and high myopia among
high school students in Fenghua city, eastern China: a 15-year population-based survey. BMC
Ophthalmol. 2018;18(1):159.

238.

Liang YB, Lin Z, Vasudevan B, et al. Generational difference of refractive error in the baseline
study of the Beijing Myopia Progression Study. Br J Ophthalmol. 2013;97(6):765-769.

239.

Dong L, Kang YK, Li Y, Wei W Bin, Jonas JB. PREVALENCE AND TIME TRENDS OF MYOPIA IN
CHILDREN AND ADOLESCENTS IN CHINA. Retina. 2020;40(3):399-411.

240.

Priscilla JJ, Verkicharla PK. Time trends on the prevalence of myopia in India – A prediction
model for 2050. Ophthalmic Physiol Opt. 2021;41(3):466-474.

241.

WHO. World report on vision. World Heal Organ. 2019;214(14):1-160.

242.

Resnikoff S, Pascolini D, Etya’ale D, et al. Global data on visual impairment in the year 2002.
Bull World Health Organ. 2004;82(11):844-851.

243.

Tseng YC, Liu SHY, Lou MF, Huang GS. Quality of life in older adults with sensory impairments:
a systematic review. Qual Life Res. 2018;27(8):1957-1971.

244.

Hassell JB, Lamoureux EL, Keeffe JE. Impact of age related macular degeneration on quality of
life. Br J Ophthalmol. 2006;90(5):593-596.

245.

Lamoreux EL, Chong E, Wang JJ, et al. Visual impairment, causes of vision loss, and falls: The
248

singapore malay eye study. Investig Ophthalmol Vis Sci. 2008;49(2):528-533.
246.

Lamoureux EL, Hassell JB, Keeffe JE. The Impact of Diabetic Retinopathy on Participation in
Daily Living. Arch Ophthalmol. 2004;122(1):84-88.

247.

West SK, Munoz B, Rubin GS, et al. Function and visual impairment in a population-based
study of older adults: The SEE project. Investig Ophthalmol Vis Sci. 1997;38(1):72-82.

248.

Klein BEK, Klein R, Lee KE, Cruickshanks KJ. Performance-based and self-assessed measures of
visual function as related to history of falls, hip fractures, and measured gait time: The Beaver
Dam Eye Study. Ophthalmology. 1998;105(1):160-164.

249.

Frank CR, Xiang X, Stagg BC, Ehrlich JR. Longitudinal Associations of Self-reported Vision
Impairment with Symptoms of Anxiety and Depression among Older Adults in the United
States. JAMA Ophthalmol. 2019;137(7):793-800.

250.

Rovner BW, Ganguli M. Depression and disability associated with impaired vision: The
moVIES project. J Am Geriatr Soc. 1998;46(5):617-619.

251.

Evans JR, Fletcher AE, Wormald RPL. Depression and Anxiety in Visually Impaired Older
People. Ophthalmology. 2007;114(2):283-288.

252.

Cosh S, von Hanno T, Helmer C, Bertelsen G, Delcourt C, Schirmer H. The association amongst
visual, hearing, and dual sensory loss with depression and anxiety over 6 years: The Tromsø
Study. Int J Geriatr Psychiatry. 2018;33(4):598-605.

253.

Ehrlich JR, Ramke J, Macleod D, et al. Association between vision impairment and mortality: a
systematic review and meta-analysis. Lancet Glob Heal. 2021;9(4):e418-e430.

254.

Smith TST, Frick KD, Holden BA, Fricke TR, Naidoo KS. Potential lost productivity resulting
from the global burden of uncorrected refractive error. Bull World Health Organ.
249

2009;87(6):431-437.
255.

Deloitte Access Economics. The Cost of Sight Loss: The Economic Impact of Vision Impairment
and Blindness in the Republic of Ireland. Deloitte Access Econ. 2011;(May).

256.

Steinmetz JD, Bourne RRA, Briant PS, et al. Causes of blindness and vision impairment in 2020
and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020:
the Right to Sight: an analysis for the Global Burden of Disease Study. Lancet Glob Heal.
2021;9(2):e144-e160.

257.

European Council of Optometry and Optics. Blue Book 2020 Trends in Optics and Optometry Comparative European Data.; 2020.

258.

Resnikoff S, Lansingh VC, Washburn L, et al. Estimated number of ophthalmologists
worldwide (International Council of Ophthalmology update): Will we meet the needs? Br J
Ophthalmol. 2020;104(4):588-592.

259.

Kelliher C, Kenny D, O’Brien C. Trends in blind registration in the adult population of the
Republic of Ireland 1996-2003. Br J Ophthalmol. 2006;90(3):367-371.

260.

Munier A, Gunning T, Kenny D, O’Keefe M. Causes of blindness in the adult population of the
Republic of Ireland. Br J Ophthalmol. 1998;82(6):630-633.

261.

Robinson R, Deutsch J, Jones HS, et al. Unrecognised and unregistered visual impairment. Br J
Ophthalmol. 1994;78(10):736-740.

262.

Tracey ML, McHugh SM, Fitzgerald AP, Buckley CM, Canavan RJ, Kearney PM. Trends in
blindness due to diabetic retinopathy among adults aged 18–69 years over a decade in
Ireland. Diabetes Res Clin Pract. 2016;121:1-8.

263.

Solomon SD, Lindsley K, Vedula SS, Krzystolik MG, Hawkins BS. Anti-vascular endothelial
250

growth factor for neovascular age-related macular degeneration. Cochrane Database Syst
Rev. 2014;35(10):1957-1963.
264.

Pandey R, Morgan MM, Murphy C, et al. Irish National Diabetic RetinaScreen Programme:
Report on five rounds of retinopathy screening and screen-positive referrals. (INDEAR study
report no. 1). Br J Ophthalmol. 2020;(1):1-6.

265.

Goggin M, O’Keefe M. Childhood blindness in the Republic of Ireland: A national survey. Br J
Ophthalmol. 1991;75(7):425-429.

266.

Khan RI, O’Keefe M, Nolan L, Kenny D. Changing pattern of childhood blindness. Ir Med J.
2007;100(5):82-85.

267.

Verhoeven VJM, Wong KT, Buitendijk GHS, Hofman A, Vingerling JR, Klaver CCW. Visual
consequences of refractive errors in the general population. Ophthalmology.
2015;122(1):101-109.

268.

McCrann S, Flitcroft I, Lalor K, Butler J, Bush A, Loughman J. Parental attitudes to myopia: a
key agent of change for myopia control? Ophthalmic Physiol Opt. 2018;38(3):298-308.

269.

Ruiz-Medrano J, Montero JA, Flores-Moreno I, Arias L, García-Layana A, Ruiz-Moreno JM.
Myopic maculopathy: Current status and proposal for a new classification and grading system
(ATN). Prog Retin Eye Res. 2019;69(November 2018):80-115.

270.

Curtin BJ, Karlin DB. Axial length measurements and fundus changes of the myopic eye. I. The
posterior fundus. Trans Am Ophthalmol Soc. 1970;68:312-334.

271.

Ohno-Matsui K, Kawasaki R, Jonas JB, et al. International photographic classification and
grading system for myopic maculopathy. Am J Ophthalmol. 2015;159(5):877-883.e7.

272.

Hayashi K, Ohno-Matsui K, Shimada N, et al. Long-term pattern of progression of myopic
251

maculopathy: A natural history study. Ophthalmology. 2010;117(8):1595-1611.e4.
273.

Vongphanit J, Mitchell P, Wang JJ. Prevalence and progression of myopic retinopathy in an
older population. Ophthalmology. 2002;109(4):704-711.

274.

Ohno-Matsui K. Proposed classification of posterior staphylomas based on analyses of eye
shape by three-dimensional magnetic resonance imaging and wide-field fundus imaging.
Ophthalmology. 2014;121(9):1798-1809.

275.

Ikuno Y. Overview of the complications of high myopia. Retina. 2017;37(12):2347-2351.

276.

Mitry D, Chalmers J, Anderson K, et al. Temporal trends in retinal detachment incidence in
Scotland between 1987 and 2006. Br J Ophthalmol. 2011;95(3):365-369.

277.

Van Leeuwen R, Haarman AEG, Van De Put MAJ, Klaver CCW, Los LI. Association of
Rhegmatogenous Retinal Detachment Incidence with Myopia Prevalence in the Netherlands.
JAMA Ophthalmol. 2021;139(1):85-92.

278.

Park SJ, Choi NK, Park KH, Woo SJ. Five year nationwide incidence of rhegmatogenous retinal
detachment requiring surgery in Korea. PLoS One. 2013;8(11).

279.

Tan NYQ, Sng CCA, Jonas JB, Wong TY, Jansonius NM, Ang M. Glaucoma in myopia: Diagnostic
dilemmas. Br J Ophthalmol. 2019;103(10):1347-1355.

280.

Marcus MW, De Vries MM, Junoy Montolio FG, Jansonius NM. Myopia as a risk factor for
open-angle glaucoma: A systematic review and meta-analysis. Ophthalmology.
2011;118(10):1989-1994.e2.

281.

Cedrone C, Mancino R, Ricci F, Cerulli A, Culasso F, Nucci C. The 12-year incidence of
glaucoma and glaucoma-related visual field loss in Italy: The Ponza eye study. J Glaucoma.
2012;21(1):1-6.
252

282.

Hsu CH, Chen RI, Lin SC. Myopia and glaucoma: Sorting out the difference. Curr Opin
Ophthalmol. 2015;26(2):90-95.

283.

Pan CW, Cheng CY, Saw SM, Wang JJ, Wong TY. Myopia and age-related cataract: A
systematic review and meta-analysis. Am J Ophthalmol. 2013;156(5):1021-1033.e1.

284.

Lim R, Mitchell P, Cumming RG. Refractive associations with cataract: the Blue Mountains Eye
Study. Invest Ophthalmol Vis Sci. 1999;40(12):3021-3026.

285.

Pan CW, Ikram MK, Cheung CY, et al. Refractive errors and age-related macular degeneration:
A systematic review and meta-analysis. Ophthalmology. 2013;120(10):2058-2065.

286.

Pallikaris IG, Kymionis GD, Ginis HS, Kounis GA, Christodoulakis E, Tsilimbaris MK. Ocular
rigidity in patients with age-related macular degeneration. Am J Ophthalmol. 2006;141(4).

287.

Lowe RF. Aetiology of the anatomical basis for primary angle-closure glaucoma. Biometrical
comparisons between normal eyes and eyes with primary angle-closure glaucoma. Br J
Ophthalmol. 1970;54(3):161-169.

288.

Xu L, Cao WF, Wang YX, Chen CX, Jonas JB. Anterior Chamber Depth and Chamber Angle and
Their Associations with Ocular and General Parameters: The Beijing Eye Study. Am J
Ophthalmol. 2008;145(5).

289.

Vijaya L, George R, Arvind H, et al. Prevalence of Primary Angle-Closure Disease in an Urban
South Indian Population and Comparison with a Rural Population. The Chennai Glaucoma
Study. Ophthalmology. 2008;115(4):655-661.

290.

Van Romunde SHM, Thepass G, Lemij HG. Is hyperopia an important risk factor for PACG in
the dutch population? - A case control study. J Ophthalmol. 2013;2013.

291.

Hopf S, Korb C, Nickels S, et al. Prevalence of myopic maculopathy in the German population:
253

Results from the Gutenberg health study. Br J Ophthalmol. 2020;104(9):1254-1259.
292.

Xiao O, Guo X, Wang D, et al. Distribution and severity of myopic maculopathy among highly
myopic eyes. Investig Ophthalmol Vis Sci. 2018;59(12):4880-4885.

293.

Koh V, Tan C, Tan PT, et al. Myopic Maculopathy and Optic Disc Changes in Highly Myopic
Young Asian Eyes and Impact on Visual Acuity. Am J Ophthalmol. 2016;164:69-79.

294.

Tideman JWL, Snabel MCC, Tedja MS, et al. Association of axial length with risk of
uncorrectable visual impairment for europeans with myopia. JAMA Ophthalmol.
2016;134(12):1355-1363.

295.

Leveziel N, Marillet S, Dufour Q, et al. Prevalence of macular complications related to myopia
– Results of a multicenter evaluation of myopic patients in eye clinics in France. Acta
Ophthalmol. 2020;98(2):e245-e251.

296.

Bullimore MA, Ritchey ER, Shah S, Leveziel N, Bourne RRA, Flitcroft DI. The Risks and Benefits
of Myopia Control. Ophthalmology. 2021;128(11):1561-1579.

297.

Fricke TR, Jong M, Naidoo KS, et al. Global prevalence of visual impairment associated with
myopic macular degeneration and temporal trends from 2000 through 2050: Systematic
review, meta-analysis and modelling. Br J Ophthalmol. 2018;102(7):855-862.

298.

Frick KD, Joy SM, Wilson DA, Naidoo KS, Holden BA. The Global Burden of Potential
Productivity Loss from Uncorrected Presbyopia. Ophthalmology. 2015;122(8):1706-1710.

299.

Chan VF, MacKenzie GE, Kassalow J, Gudwin E, Congdon N. Impact of presbyopia and its
correction in low- And middle-income countries. Asia-Pacific J Ophthalmol. 2018;7(6):370374.

300.

Naidoo KS, Jaggernath J, Chinanayi FS, Chan VF. Near vision correction and work productivity
254

among textile workers. African Vis Eye Heal. 2016;75(1):1-6.
301.

Reddy PA, Congdon N, MacKenzie G, et al. Effect of providing near glasses on productivity
among rural Indian tea workers with presbyopia (PROSPER): a randomised trial. Lancet Glob
Heal. 2018;6(9):e1019-e1027.

302.

The Economist. The world’s most valuable resource is no longer oil, but data. Econ.
2017;423:5-8.

303.

Scheetz J, He M, van Wijngaarden P. Ophthalmology and the emergence of artificial
intelligence. Med J Aust. 2021;214(4):155-157.e1.

304.

Baro E, Degoul S, Beuscart R, Chazard E. Toward a literature-driven definition of big data in
healthcare. Biomed Res Int. 2015;2015.

305.

Andreu-Perez J, Poon CCY, Merrifield RD, Wong STC, Yang GZ. Big Data for Health. IEEE J
Biomed Heal Informatics. 2015;19(4):1193-1208.

306.

Reeves SW, Sloan FA, Lee PP, Jaffe GJ. Uveitis in the elderly: Epidemiological data from the
National Long-term Care Survey medicare cohort. Ophthalmology. 2006;113(2):302-308.

307.

Liu Y, Wang H, Zhao W, Zhang M, Qin H, Xie Y. Flexible, stretchable sensors for wearable
health monitoring: Sensing mechanisms, materials, fabrication strategies and features.
Sensors (Switzerland). 2018;18(2).

308.

Schoen C, Osborn R, Squires D, et al. A Survey Of Primary Care Doctors In Ten Countries
Shows Progress In Use Of Health Information Technology, Less In Other Areas. Health Aff.
2012;31(12):2805-2816.

309.

Moore M, Loughman J, Butler JS, Ohlendorf A, Wahl S, Flitcroft DI. Application of big-data for
epidemiological studies of refractive error. Mimouni M, ed. PLoS One. 2021;16(4):e0250468.
255

310.

Willis JR, Vitale S, Morse L, et al. The Prevalence of Myopic Choroidal Neovascularization in
the United States: Analysis of the IRIS®Data Registry and NHANES. Ophthalmology.
2016;123(8):1771-1782.

311.

Donthineni PR, Kammari P, Shanbhag SS, Singh V, Das AV, Basu S. Incidence, demographics,
types and risk factors of dry eye disease in India: Electronic medical records driven big data
analytics report I. Ocul Surf. 2019;17(2):250-256.

312.

Das AV, Donthineni PR, Sai Prashanthi G, Basu S. Allergic eye disease in children and
adolescents seeking eye care in India: Electronic medical records driven big data analytics
report II. Ocul Surf. 2019;17(4):683-689.

313.

Johnston RL, Lee AY, Buckle M, et al. UK Age-Related Macular Degeneration Electronic
Medical Record System (AMD EMR) Users Group Report IV: Incidence of Blindness and Sight
Impairment in Ranibizumab-Treated Patients. Ophthalmology. 2016;123(11):2386-2392.

314.

Willis J, Morse L, Vitale S, et al. Treatment Patterns for Myopic Choroidal Neovascularization
in the United States: Analysis of the IRIS Registry. Ophthalmology. 2017;124(7):935-943.

315.

Coleman AL. How Big Data Informs Us about Cataract Surgery: The LXXII Edward Jackson
Memorial Lecture. Am J Ophthalmol. 2015;160(6):1091-1103.e3.

316.

Lin H, Long E, Ding X, et al. Prediction of myopia development among Chinese school-aged
children using refraction data from electronic medical records: A retrospective, multicentre
machine learning study. PLoS Med. 2018;15(11):1-17.

317.

Shuldiner SR, Boland M V, Ramulu PY, et al. Predicting eyes at risk for rapid glaucoma
progression based on an initial visual field test using machine learning. Le KNQ, ed. PLoS One.
2021;16(4):e0249856.

318.

Bommakanti NK, Zhou Y, Ehrlich JR, et al. Application of the Sight Outcomes Research
256

Collaborative Ophthalmology Data Repository for Triaging Patients with Glaucoma and Clinic
Appointments during Pandemics Such as COVID-19. JAMA Ophthalmol. 2020;138(9):974-980.
319.

Jones L, Bryan SR, Miranda MA, Crabb DP, Kotecha A. Example of monitoring measurements
in a virtual eye clinic using “big data.” Br J Ophthalmol. 2018;102(7):911-915.

320.

Parke DW, Rich WL, Sommer A, Lum F. The American Academy of Ophthalmology’s IRIS ®
Registry (Intelligent Research in Sight Clinical Data): A Look Back and a Look to the Future.
Ophthalmology. 2017;124(11):1572-1574.

321.

Vanner EA, Sun CQ, McSoley MJ, et al. Tube Versus Trabeculectomy IRIS registry 1-Year
Composite Outcome Analysis with Comparisons to the Randomized Controlled Trial. Am J
Ophthalmol. 2021;227:87-99.

322.

Pershing S, Lum F, Hsu S, et al. Endophthalmitis after Cataract Surgery in the United States: A
Report from the Intelligent Research in Sight Registry, 2013–2017. Ophthalmology.
2020;127(2):151-158.

323.

Repka MX. Amblyopia Outcomes Through Clinical Trials and Practice Measurement: Room for
Improvement: The LXXVII Edward Jackson Memorial Lecture. Am J Ophthalmol. 2020;219:A1A26.

324.

Cantrell RA, Lum F, Chia Y, et al. Treatment Patterns for Diabetic Macular Edema: An
Intelligent Research in Sight (IRIS®) Registry Analysis. Ophthalmology. 2020;127(3):427-429.

325.

Stein JD, Rahman M, Andrews C, et al. Evaluation of an Algorithm for Identifying Ocular
Conditions in Electronic Health Record Data. JAMA Ophthalmol. 2019;137(5):491-497.

326.

Javitt JC, Vitale S, Canner JK, et al. National Outcomes of Cataract Extraction: Endophthalmitis
Following Inpatient Surgery. Arch Ophthalmol. 1991;109(8):1085-1089.

257

327.

Clark A, Ng JQ, Morlet N, Semmens JB. Big data and ophthalmic research. Surv Ophthalmol.
2016;61(4):443-465.

328.

Cassard SD, Quigley HA, Gower EW, Friedman DS, Ramulu PY, Jampel HD. Regional variations
and trends in the prevalence of diagnosed glaucoma in the medicare population.
Ophthalmology. 2012;119(7):1342-1351.

329.

Gritz DC, Wong IG. Incidence and prevalence of uveitis in Northern California: The Northern
California Epidemiology of Uveitis Study. Ophthalmology. 2004;111(3):491-500.

330.

Rim TH, Kim SS, Ham D Il, Yu SY, Chung EJ, Lee SC. Incidence and prevalence of uveitis in
South Korea: A nationwide cohort study. Br J Ophthalmol. Published online 2017:1-5.

331.

Hwang DK, Chou YJ, Pu CY, Chou P. Epidemiology of uveitis among the Chinese population in
Taiwan: A population-based study. Ophthalmology. 2012;119(11):2371-2376.

332.

Dahrouj M, Miller JB. Artificial Intelligence (AI) and Retinal Optical Coherence Tomography
(OCT). Semin Ophthalmol. 2021;00(00):1-5.

333.

Ting DSW, Peng L, Varadarajan A V., et al. Deep learning in ophthalmology: The technical and
clinical considerations. Prog Retin Eye Res. 2019;72(December 2018):100759.

334.

Ting DSW, Pasquale LR, Peng L, et al. Artificial intelligence and deep learning in
ophthalmology. Br J Ophthalmol. 2019;103(2):167-175.

335.

Budai A, Bock R, Maier A, Hornegger J, Michelson G. Robust vessel segmentation in fundus
images. Int J Biomed Imaging. 2013;2013.

336.

Carmona EJ, Rincón M, García-Feijoó J, Martínez-de-la-Casa JM. Identification of the optic
nerve head with genetic algorithms. Artif Intell Med. 2008;43(3):243-259.

337.

Kauppi T, Kämäräinen J-K, Lensu L, et al. Constructing Benchmark Databases and Protocols for
258

Medical Image Analysis: Diabetic Retinopathy. Comput Math Methods Med. 2013;2013:1-15.
338.

Abràmoff MD, Folk JC, Han DP, et al. Automated Analysis of Retinal Images for Detection of
Referable Diabetic Retinopathy. JAMA Ophthalmol. 2013;131(3):351.

339.

Farsiu S, Chiu SJ, O’Connell R V., et al. Quantitative classification of eyes with and without
intermediate age-related macular degeneration using optical coherence tomography.
Ophthalmology. 2014;121(1):162-172.

340.

Kermany DS, Goldbaum M, Cai W, et al. Identifying Medical Diagnoses and Treatable Diseases
by Image-Based Deep Learning. Cell. 2018;172(5):1122-1131.e9.

341.

Sudlow C, Gallacher J, Allen N, et al. UK Biobank: An Open Access Resource for Identifying the
Causes of a Wide Range of Complex Diseases of Middle and Old Age. PLoS Med. 2015;12(3):110.

342.

McKibbin M, Farragher T, Shickle D. Vitreoretinal interface abnormalities in middle-aged
adults with visual impairment in the UK Biobank study: Prevalence, impact on visual acuity
and associations. BMJ Open Ophthalmol. 2017;1(1).

343.

Chan MPY, Grossi CM, Khawaja AP, et al. Associations with intraocular pressure in a large
cohort: Results from the UK Biobank. Ophthalmology. 2016;123(4):771-782.

344.

Patel PJ, Foster PJ, Grossi CM, et al. Spectral-domain optical coherence tomography imaging
in 67 321 adults: Associations with macular thickness in the UK biobank study.
Ophthalmology. 2016;123(4):829-840.

345.

Plotnikov D, Williams C, Atan D, Davies NM, Mojarrad NG, Guggenheim JA. Effect of
education on myopia: Evidence from the United Kingdom ROSLA 1972 Reform. Investig
Ophthalmol Vis Sci. 2020;61(11).

259

346.

Chua SYL, Warwick A, Peto T, et al. Association of ambient air pollution with age-related
macular degeneration and retinal thickness in UK Biobank. Br J Ophthalmol. Published online
2021:1-7.

347.

Cumberland PM, Rahi JS. Visual function, social position, and health and life chances the UK
Biobank study. JAMA Ophthalmol. 2016;134(9):959-966.

348.

Wen L, Cheng Q, Lan W, et al. An objective comparison of light intensity and near-visual tasks
between rural and urban school children in China by a wearable device clouclip. Transl Vis Sci
Technol. 2019;8(6).

349.

Wen L, Cheng Q, Cao Y, et al. The Clouclip, a wearable device for measuring near-work and
outdoor time: validation and comparison of objective measures with questionnaire
estimates. Acta Ophthalmol. Published online 2021:1-14.

350.

Cao Y, Lan W, Wen L, et al. An effectiveness study of a wearable device (Clouclip) intervention
in unhealthy visual behaviors among school-age children: A pilot study. Med (United States).
2020;99(2).

351.

Mansouri K. The road ahead to continuous 24-hour intraocular pressure monitoring in
glaucoma. J Ophthalmic Vis Res. 2014;9(2):260-268.

352.

Perakakis N, Yazdani A, Karniadakis GE, Mantzoros C. Omics, big data and machine learning as
tools to propel understanding of biological mechanisms and to discover novel diagnostics and
therapeutics. Metabolism. 2018;87:A1-A9.

353.

Haines JL, Hauser MA, Schmidt S, et al. Complement factor H variant increases the risk of agerelated macular degeneration. Science (80- ). 2005;308(5720):419-421.

354.

Corvin A, Craddock N, Sullivan PF. Genome-wide association studies: A primer. Psychol Med.
2010;40(7):1063-1077.
260

355.

Choquet H, Paylakhi S, Kneeland SC, et al. A multiethnic genome-wide association study of
primary open-angle glaucoma identifies novel risk loci. Nat Commun. 2018;9(1).

356.

Wiggs JL, Pasquale LR. Genetics of glaucoma. Hum Mol Genet. 2017;26(R1):R21-R27.

357.

Graham PS, Kaidonis G, Abhary S, et al. Genome-wide association studies for diabetic macular
edema and proliferative diabetic retinopathy. BMC Med Genet. 2018;19(1):1-8.

358.

Huang YC, Lin JM, Lin HJ, et al. Genome-wide association study of diabetic retinopathy in a
Taiwanese population. Ophthalmology. 2011;118(4):642-648.

359.

Fritsche LG, Igl W, Bailey JNC, et al. A large genome-wide association study of age-related
macular degeneration highlights contributions of rare and common variants. Nat Genet.
2016;48(2):134-143.

360.

Holliday EG, Smith A V., Cornes BK, et al. Insights into the Genetic Architecture of Early Stage
Age-Related Macular Degeneration: A Genome-Wide Association Study Meta-Analysis. PLoS
One. 2013;8(1).

361.

Chen W, Stambolian D, Edwards AO, et al. Genetic variants near TIMP3 and high-density
lipoprotein-associated loci influence susceptibility to age-related macular degeneration. Proc
Natl Acad Sci U S A. 2010;107(16):7401-7406.

362.

Verhoeven VJM, Hysi PG, Saw SM, et al. Large scale international replication and metaanalysis study confirms association of the 15q14 locus with myopia. The CREAM consortium.
Hum Genet. 2012;131(9):1467-1480.

363.

Hysi PG, Young TL, MacKey DA, et al. A genome-wide association study for myopia and
refractive error identifies a susceptibility locus at 15q25. Nat Genet. 2010;42(10):902-905.

364.

Hysi PG, Mahroo OA, Cumberland P, et al. Common mechanisms underlying refractive error
261

identified in functional analysis of gene lists from genome-wide association study results in 2
European British cohorts. JAMA Ophthalmol. 2014;132(1):50-56.
365.

Guggenheim JA, McMahon G, Kemp JP, et al. A genome-wide association study for corneal
curvature identifies the platelet-derived growth factor receptor alpha gene as a quantitative
trait locus for eye size in white Europeans. Mol Vis. 2013;19(February):243-253.

366.

Cheng CY, Schache M, Ikram MK, et al. Nine loci for ocular axial length identified through
genome-wide association studies, including shared loci with refractive error. Am J Hum
Genet. 2013;93(2):264-277.

367.

Ozel AB, Moroi SE, Reed DM, et al. Genome-wide association study and meta-analysis of
intraocular pressure. Hum Genet. 2014;133(1):41-57.

368.

MacGregor S, Ong JS, An J, et al. Genome-wide association study of intraocular pressure
uncovers new pathways to glaucoma. Nat Genet. 2018;50(8):1067-1071.

369.

Sedgwick P. Bias in observational study designs: Prospective cohort studies. BMJ.
2014;349(December):1-3.

370.

MacKey DA, Hewitt AW. Genome-wide association study success in ophthalmology. Curr Opin
Ophthalmol. 2014;25(5):386-393.

371.

Swift A, Heale R, Twycross A. What are sensitivity and specificity? Evid Based Nurs.
2020;23(1):2019-2021.

372.

Streiner DL, Cairney J. What’s under the ROC? An Introduction to Receiver Operating
Characteristics Curves. Can J Psychiatry. 2007;52(2):121-128.

373.

Ganley JP. Longitudinal prevalence of major eye diseases. Evidence-Based Eye Care.
2004;5(1).
262

374.

Sloan FA, Belsky D, Ruiz D, Lee P. Changes in incidence of diabetes mellitus-related eye
disease among US elderly persons, 1994-2005. Arch Ophthalmol. 2008;126(11):1548-1553.

375.

Martinez-Thompson JM, Diehl NN, Holmes JM, Mohney BG. Incidence, types, and lifetime risk
of adult-onset strabismus. Ophthalmology. 2014;121(4):877-882.

376.

Stein JD, Kim DS, Niziol LM, et al. Differences in rates of glaucoma among Asian Americans
and other racial groups, and among various Asian ethnic groups. Ophthalmology.
2011;118(6):1031-1037.

377.

Jammal AA, Thompson AC, Mariottoni EB, et al. Rates of Glaucomatous Structural and
Functional Change From a Large Clinical Population: The Duke Glaucoma Registry Study. Am J
Ophthalmol. 2021;222:238-247.

378.

Cedrone C, Ricci F, Regine F, Cerulli A, Palma S, Culasso F. Nationwide incidence of
endophthalmitis among the general population and the subjects at risk of endophthalmitis in
Italy. Ophthalmic Epidemiol. 2008;15(6):366-371.

379.

Sarah Wild, Gojka Roglic, Anders Green, Richard Sicree HK. Estimates for the year 2000 and
projections for 2030. World Health. 2004;27(5):1047-1053.

380.

Beede E, Baylor E, Hersch F, et al. A Human-Centered Evaluation of a Deep Learning System
Deployed in Clinics for the Detection of Diabetic Retinopathy. Conf Hum Factors Comput Syst
- Proc. Published online 2020:1-12.

381.

Gulshan V, Peng L, Coram M, et al. Development and validation of a deep learning algorithm
for detection of diabetic retinopathy in retinal fundus photographs. JAMA - J Am Med Assoc.
2016;316(22):2402-2410.

382.

Gulshan V, Rajan RP, Widner K, et al. Performance of a Deep-Learning Algorithm vs Manual
Grading for Detecting Diabetic Retinopathy in India. JAMA Ophthalmol. 2019;137(9):987-993.
263

383.

Sayres R, Taly A, Rahimy E, et al. Using a Deep Learning Algorithm and Integrated Gradients
Explanation to Assist Grading for Diabetic Retinopathy. Ophthalmology. 2019;126(4):552-564.

384.

Ran AR, Tham CC, Chan PP, et al. Deep learning in glaucoma with optical coherence
tomography: a review. Eye. 2021;35(1):188-201.

385.

Muhammad H, Fuchs TJ, De Cuir N, et al. Hybrid Deep Learning on Single Wide-field Optical
Coherence tomography Scans Accurately Classifies Glaucoma Suspects. J Glaucoma.
2017;26(12):1086-1094.

386.

Lee J, Kim YK, Park KH, Jeoung JW. Diagnosing Glaucoma with Spectral-domain Optical
Coherence Tomography Using Deep Learning Classifier. J Glaucoma. 2020;29(4):287-294.

387.

Thompson AC, Jammal AA, Berchuck SI, Mariottoni EB, Medeiros FA. Assessment of a
Segmentation-Free Deep Learning Algorithm for Diagnosing Glaucoma from Optical
Coherence Tomography Scans. JAMA Ophthalmol. 2020;138(4):333-339.

388.

Ran AR, Cheung CY, Wang X, et al. Detection of glaucomatous optic neuropathy with spectraldomain optical coherence tomography: a retrospective training and validation deep-learning
analysis. Lancet Digit Heal. 2019;1(4):e172-e182.

389.

Thompson AC, Jammal AA, Medeiros FA. A Deep Learning Algorithm to Quantify Neuroretinal
Rim Loss From Optic Disc Photographs. Am J Ophthalmol. 2019;201:9-18.

390.

Li Z, He Y, Keel S, Meng W, Chang RT, He M. Efficacy of a Deep Learning System for Detecting
Glaucomatous Optic Neuropathy Based on Color Fundus Photographs. Ophthalmology.
2018;125(8):1199-1206.

391.

Jampel HD, Friedman D, Quigley H, et al. Agreement Among Glaucoma Specialists in Assessing
Progressive Disc Changes From Photographs in Open-Angle Glaucoma Patients. Am J
Ophthalmol. 2009;147(1):39-44.
264

392.

Medeiros FA, Jammal AA, Mariottoni EB. Detection of Progressive Glaucomatous Optic Nerve
Damage on Fundus Photographs with Deep Learning. Ophthalmology. 2021;128(3):383-392.

393.

Bullimore MA, Brennan NA. Myopia Control: Why Each Diopter Matters. Optom Vis Sci.
2019;96(6):463-465.

394.

Brennan NA, Toubouti YM, Cheng X, Bullimore MA. Efficacy in myopia control. Prog Retin Eye
Res. 2020;(xxxx):100923.

395.

Varadarajan A V., Poplin R, Blumer K, et al. Deep Learning for Predicting Refractive Error From
Retinal Fundus Images. Investig Opthalmology Vis Sci. 2018;59(7):2861.

396.

Goh JHL, Lim ZW, Fang X, et al. Artificial intelligence for cataract detection and management.
Asia-Pacific J Ophthalmol. 2020;9(2):88-95.

397.

Pead E, Megaw R, Cameron J, et al. Automated detection of age-related macular
degeneration in color fundus photography: a systematic review. Surv Ophthalmol.
2019;64(4):498-511.

398.

Scruggs BA, Paulchan R V., Kalpathy-Cramer J, Chiang MF, Peter Campbell J. Artificial
intelligence in retinopathy of prematurity diagnosis. Transl Vis Sci Technol. 2020;9(2):1-10.

399.

Poplin R, Varadarajan A V., Blumer K, et al. Prediction of cardiovascular risk factors from
retinal fundus photographs via deep learning. Nat Biomed Eng. 2018;2(3):158-164.

400.

Blonde L, Khunti K, Harris SB, Meizinger C, Skolnik NS. Interpretation and Impact of RealWorld Clinical Data for the Practicing Clinician. Adv Ther. 2018;35(11):1763-1774.

401.

Anglemyer A, Horvath HT, Bero L. Healthcare outcomes assessed with observational study
designs compared with those assessed in randomized trials. Cochrane Database Syst Rev.
2014;2014(4).
265

402.

Lee AY, Lee CS, Butt T, et al. UK AMD EMR Users Group Report V: Benefits of initiating
ranibizumab therapy for neovascular AMD in eyes with vision better than 6/12. Br J
Ophthalmol. 2015;99(8):1045-1050.

403.

Repka MX, Lum F, Burugapalli B. Strabismus, Strabismus Surgery, and Reoperation Rate in the
United States: Analysis from the IRIS Registry. Ophthalmology. 2018;125(10):1646-1653.

404.

Ting DSW, Lee AY, Wong TY. An Ophthalmologist’s Guide to Deciphering Studies in Artificial
Intelligence. Ophthalmology. 2019;126(11):1475-1479.

405.

Zarbin MA, Lee AY, Keane PA, Chiang MF. Data Science in Translational Vision Science and
Technology. Transl Vis Sci Technol. 2021;10(8):20.

406.

Challen R, Denny J, Pitt M, Gompels L, Edwards T, Tsaneva-Atanasova K. Artificial intelligence,
bias and clinical safety. BMJ Qual Saf. 2019;28(3):231-237.

407.

Chang J, Lee J, Ha A, et al. Explaining the Rationale of Deep Learning Glaucoma Decisions with
Adversarial Examples. Ophthalmology. 2021;128(1):78-88.

408.

Parasuraman R, Manzey DH. Complacency and bias in human use of automation: An
attentional integration. Hum Factors. 2010;52(3):381-410.

409.

Tahvildari M, Singh RB, Saeed HN. Application of Artificial Intelligence in the Diagnosis and
Management of Corneal Diseases. Semin Ophthalmol. 2021;00(00):1-8.

410.

Central Statistics Office Ireland. Age and sex composition. Census 2016 Rep. 2016;Chapter
3:19-25.

411.

Nguyen L, Bellucci E, Nguyen LT. Electronic health records implementation: An evaluation of
information system impact and contingency factors. Int J Med Inform. 2014;83(11):779-796.

412.

Fujiwara M, Hasebe S, Nakanishi R, Tanigawa K, Ohtsuki H. Seasonal variation in myopia
266

progression and axial elongation: An evaluation of Japanese children participating in a myopia
control trial. Jpn J Ophthalmol. 2012;56(4):401-406.
413.

Gwiazda J, Deng L, Manny R, et al. Seasonal variations in the progression of myopia in
children enrolled in the correction of myopia evaluation trial. Investig Ophthalmol Vis Sci.
2014;55(2):752-758.

414.

Central Statistics Office Ireland. Geographical Distribution. Census 2016 Rep. 2016;Chapter
2:5.

415.

Central Statistics Office Ireland. Census 2016 Summary Results.; 2017.

416.

Smith W, Assink J, Klein R, et al. Risk factors for age-related macular degeneration.
Ophthalmology. 2001;108(4):697-704.

417.

Coleman AL, Miglior S. Risk Factors for Glaucoma Onset and Progression. Surv Ophthalmol.
2008;53(6 SUPPL.):3-10.

418.

Cook EJ, Sharp C, Randhawa G, Guppy A, Gangotra R, Cox J. Who uses NHS health checks?
Investigating the impact of ethnicity and gender and method of invitation on uptake of NHS
health checks. Int J Equity Health. 2016;15(1):1-11.

419.

Bourne RRA, Stevens GA, White RA, et al. Causes of vision loss worldwide, 1990–2010: a
systematic analysis. Lancet Glob Heal. 2013;1(6):e339-e349.

420.

Xu L, Wang Y, Li Y, et al. Causes of Blindness and Visual Impairment in Urban and Rural Areas
in Beijing. The Beijing Eye Study. Ophthalmology. 2006;113(7):1134.e1-1134.e11.

421.

Lavanya R, Kawasaki R, Tay WT, et al. Hyperopic refractive error and shorter axial length are
associated with age-related macular degeneration: The Singapore Malay eye study. Investig
Ophthalmol Vis Sci. 2010;51(12):6247-6252.
267

422.

Pan C, Ramamurthy D, Saw S. Worldwide prevalence and risk factors for myopia. Ophthalmic
Physiol Opt. 2012;32(1):3-16.

423.

Ferraz FH, Corrente JE, Opromolla P, Padovani CR, Schellini SA. Refractive errors in a Brazilian
population: age and sex distribution. Ophthalmic Physiol Opt. 2015;35(1):19-27.

424.

Claxton K, Posnett J. An economic approach to clinical trial design and research prioritysetting. Health Econ. 1996;5(6):513-524.

425.

Phillips C V. The economics of “more research is needed.” Int J Epidemiol. 2001;30(4):771776.

426.

Mooney SJ, Westreich DJ, El-Sayed AM. Epidemiology in the era of big data. Epidemiology.
2015;26(3):390-394.

427.

US Food and Drug Administration. Examining the Impact of Real-World Evidence on Medical
Product Development. Natl Acad Sci Eng Med. 2018;(February).

428.

Huwaldt J. Plot Digitizer.

429.

Sullivan CM, Fowler CW. Analysis of a progressive addition lens population. Ophthalmic
Physiol Opt. 1989;9(2):163-170.

430.

Ritz C, Baty F, Streibig JC, Gerhard D. Dose-response analysis using R. PLoS One.
2015;10(12):1-13.

431.

Grossniklaus H, Green W. Pathologic Findings in Pathologic Myopia. Retina. 1992;12(2):127133.

432.

Sedgwick P. Bias in observational study designs: Cross sectional studies. BMJ.
2015;350(March):2-3.

433.

Kaplan RM, Chambers DA, Glasgow RE. Big data and large sample size: A cautionary note on
268

the potential for bias. Clin Transl Sci. 2014;7(4):342-346.
434.

Department of Employment Affairs and Social Protection. Almost 1.2 Million Claims for PRSI
Treatment Benefit Supports. Published online 2020:1-5.

435.

Health Service Executive. PCRS Optical Report. PCRS Opt Rep. Published online 2018:1-2.

436.

The College of Optometrists. Britain’s Eye Health in Focus. A Snapshot of Consumer Attitudes
and Behaviour towards Eye Health.; 2013.

437.

Hrynchak P. Prescribing spectacles: Reasons for failure of spectacle lens acceptance.
Ophthalmic Physiol Opt. 2006;26(1):111-115.

438.

Freeman CE, Evans BJW. Investigation of the causes of non-tolerance to optometric
prescriptions for spectacles. Ophthalmic Physiol Opt. 2010;30(1):1-11.

439.

Attebo K, Mitchell P, Cumming R, Smith W. Knowledge and beliefs about common eye
diseases. Aust N Z J Ophthalmol. 1997;25(4):283-287.

440.

Pascual M, Huang J, Maguire MG, et al. Risk factors for amblyopia in the vision in
preschoolers study. Ophthalmology. 2014;121(3):622-629.e1.

441.

Wong TY, Klein BEK, Klein R, Knudtson M, Lee KE. Refractive errors, intraocular pressure, and
glaucoma in a white population. Ophthalmology. 2003;110(1):211-217.

442.

Kanthan GL, Mitchell P, Rochtchina E, Cumming RG, Wang JJ. Myopia and the long-term
incidence of cataract and cataract surgery: The Blue Mountains Eye Study. Clin Exp
Ophthalmol. 2014;42(4):347-353.

443.

Yannuzzi L. Risk Factors for Idiopathic Rhegmatogenous Retinal Detachment. Am J Epidemiol.
1993;137(7):749-757.

444.

Vu HTV, Keeffe JE, McCarty CA, Taylor HR. Impact of unilateral and bilateral vision loss on
269

quality of life. Br J Ophthalmol. 2005;89(3):360-363.
445.

Chia EM, Wang JJ, Rochtchina E, Smith W, Cumming RR, Mitchell P. Impact of Bilateral Visual
Impairment on Health-Related Quality of Life: The Blue Mountains Eye Study. Investig
Ophthalmol Vis Sci. 2004;45(1):71-76.

446.

Finger RP, Fenwick E, Marella M, et al. The impact of vision impairment on vision-specific
quality of life in Germany. Investig Ophthalmol Vis Sci. 2011;52(6):3613-3619.

447.

Chen M, Wu A, Zhang L, et al. The increasing prevalence of myopia and high myopia among
high school students in Fenghua city, eastern China: A 15-year population-based survey. BMC
Ophthalmol. 2018;18(1):1-10.

448.

Hrynchak PK, Mittelstaedt A, Machan CM, Bunn C, Irving EL. Increase in Myopia Prevalence in
Clinic-Based Populations Across a Century. Optom Vis Sci. 2013;90(11):1331-1341.

449.

Bland JM, Altman DG. Statistics Notes: Bootstrap resampling methods. BMJ. 2015;350(jun02
13):h2622-h2622.

450.

Carpenter J, Bithell J. Bootstrap confidence intervals: When, which, what? A practical guide
for medical statisticians. Stat Med. 2000;19(9):1141-1164.

451.

Chalmers RL, Wagner H, Kinoshita B, et al. Is purchasing lenses from the prescriber associated
with better habits among soft contact lens wearers? Contact Lens Anterior Eye.
2016;39(6):435-441.

452.

Gollogly HE, Hodge DO, St. Sauver JL, Erie JC. Increasing incidence of cataract surgery:
Population-based study. J Cataract Refract Surg. 2013;39(9):1383-1389.

453.

Daien V, Le Pape A, Heve D, Carriere I, Villain M. Incidence and Characteristics of Cataract
Surgery in France from 2009 to 2012: A National Population Study. Ophthalmology.
270

2015;122(8):1633-1638.
454.

Eurostat. Surgical operations and procedures performed in hospitals by ICD-9-CM Source of
data. Eurostat Database. Published 2021. Accessed April 28, 2021.
https://appsso.eurostat.ec.europa.eu/nui/submitViewTableAction.do

455.

Wang W, Yan W, Fotis K, et al. Cataract surgical rate and socioeconomics: A global study.
Investig Ophthalmol Vis Sci. 2016;57(14):5872-5881.

456.

Anstey KJ, Wood J, Lord S, Walker JG. Cognitive, sensory and physical factors enabling driving
safety in older adults. Clin Psychol Rev. 2005;25(1):45-65.

457.

Gresset JA, Meyer FM. Risk of accidents among elderly car drivers with visual acuity equal to
6/12 or 6/15 and lack of binocular vision. Ophthalmic Physiol Opt. 1994;14(1):33-37.

458.

Owsley C, Ball K, McGwin G, et al. Visual processing impairment and risk of motor vehicle
crash among older adults. J Am Med Assoc. 1998;279(14):1083-1088.

459.

Chen SP, Bhattacharya J, Pershing S. Association of vision loss with cognition in older adults.
JAMA Ophthalmol. 2017;135(9):963-970.

460.

Reger MA, Welsh RK, Watson GS, Cholerton B, Baker LD, Craft S. The Relationship between
Neuropsychological Functioning and Driving Ability in Dementia: A Meta-Analysis.
Neuropsychology. 2004;18(1):85-93.

461.

Ivers RQ, Mitchell P, Cumming RG. Sensory impairment and driving: The Blue Mountains Eye
Study. Am J Public Health. 1999;89(1):85-87.

462.

Margolis KL, Kerani RP, McGovern P, Songer T, Cauley JA, Ensrud KE. Risk factors for motor
vehicle crashes in older women. Journals Gerontol - Ser A Biol Sci Med Sci. 2002;57(3):M186M191.
271

463.

Desapriya E, Harjee R, Brubacher J, et al. Vision screening of older drivers for preventing road
traffic injuries and fatalities. Cochrane Database Syst Rev. 2014;2014(2).

464.

European Commission. Commission Directive 2009/113/EC Amending Directive 2006/126/EC.;
2009:31-35.

465.

ECOO Working Group on Vision and Driving. Visual Standards for Driving in Europe.; 2017.

466.

Latham K, Katsou MF, Rae S. Advising patients on visual fitness to drive: Implications of
revised DVLA regulations. Br J Ophthalmol. 2015;99(4):545-548.

467.

Pointer JS. Poor recognition of the UK minimum driving vision standard by motorists
attending optometric practice. Ophthalmic Physiol Opt. 2007;27(3):238-244.

468.

O’Neill D. Medical screening of older drivers is not evidence based. BMJ.
2012;345(September):6371.

469.

Desapriya E, Ranatunga Y, Pike I. We need evidence based tools to identify medically at risk
drivers. BMJ. 2012;345(7880):7087.

470.

Smith G. Relation between Spherical Refractive Error and Visual Acuity. Optom Vis Sci.
1991;68(8):591-598.

471.

Chihuri S, Mielenz TJ, Dimaggio CJ, et al. Driving cessation and health outcomes in older
adults. J Am Geriatr Soc. 2016;64(2):332-341.

472.

Ragland DR, Satariano WA, MacLeod KE. Driving cessation and increased depressive
symptoms. Journals Gerontol - Ser A Biol Sci Med Sci. 2005;60(3):399-403.

473.

Edwards JD, Lunsman M, Perkins M, Rebok GW, Roth DL. Driving cessation and health
trajectories in older adults. Journals Gerontol - Ser A Biol Sci Med Sci. 2009;64(12):1290-1295.

474.

Wood JM, Tyrrell RA, Chaparro A, Marszalek RP, Carberry TP, Chu BS. Even moderate visual
272

impairments degrade drivers’ ability to see pedestrians at night. Investig Ophthalmol Vis Sci.
2012;53(6):2586-2592.
475.

Rubin GS, Ng ESW, Bandeen-Roche K, et al. A prospective, population-based study of the role
of visual impairment in motor vehicle crashes among older drivers: The SEE study. Investig
Ophthalmol Vis Sci. 2007;48(4):1483-1491.

476.

Cross JM, McGwin G, Rubin GS, et al. Visual and medical risk factors for motor vehicle
collision involvement among older drivers. Br J Ophthalmol. 2009;93(3):400-404.

477.

Marottoli RA, Richardson ED, Stowe MH, et al. Development of a test battery to identify older
drivers at risk for self-reported adverse driving events. J Am Geriatr Soc. 1998;46(5):562-568.

478.

Piyasena P, Olvera-Herrera VO, Chan VF, et al. Vision impairment and traffic safety outcomes
in low-income and middle-income countries: a systematic review and meta-analysis. Lancet
Glob Heal. 2021;9(10):e1411-e1422.

479.

Owsley C, McGwin G. Vision and driving. Vision Res. 2010;50(23):2348-2361.

480.

Freeman EE, Muñoz B, Turano KA, West SK. Measures of visual function and their association
with driving modification in older adults. Investig Ophthalmol Vis Sci. 2006;47(2):514-520.

481.

Higgins KE, Wood JM. Predicting components of closed road driving performance from vision
tests. Optom Vis Sci. 2005;82(8):647-656.

482.

European Transport Safety Council. Ranking EU Progress on Road Safety 14th Road Safety
Performance Index Report.; 2020.

483.

Patoine A, Mikula L, Mejía-Romero S, et al. Increased visual and cognitive demands
emphasize the importance of meeting visual needs at all distances while driving. Chen F, ed.
PLoS One. 2021;16(3):e0247254.
273

484.

Polling JR, Klaver C, Tideman JW. Myopia progression from wearing first glasses to adult age:
The DREAM Study. Br J Ophthalmol. Published online 2021:1-5.

485.

Brake. Driver Eyesight Survey 2014.; 2014.

486.

Johnson MA, Choy D. On the definition of age-related norms for visual function testing. Appl
Opt. 1987;26(8):1449.

487.

Wright DM, O’Reilly D, Azuara-Blanco A, Curran R, McMullan M, Hogg RE. Delayed
attendance at routine eye examinations is associated with increased probability of general
practitioner referral: a record linkage study in Northern Ireland. Ophthalmic Physiol Opt.
2020;40(3):365-375.

488.

Central Statistics Office Ireland. National Travel Survey 2019.; 2019.

489.

Harris B, Sampson G. Gender differences in the utilisation of optometric services in Victoria.
Clin Exp Optom. 2005;88(2):109-112.

490.

Eurostat. Majority of transport jobs held by men. European Statistical System. Published
2020. Accessed July 22, 2021. https://ec.europa.eu/eurostat/web/products-eurostat-news//ddn-20200421-1

491.

Loughman J, Moore M, Flitcroft DI. Myopia Progression Centiles from Real World Data: An
Ecologically Valid Tool for Myopia Treatment Efficacy Monitoring? Investig Ophthalmol Vis
Sci. 2020;7(June):2019-2021.

492.

Williams KM, Kraphol E, Yonova-Doing E, Hysi PG, Plomin R, Hammond CJ. Early life factors
for myopia in the British Twins Early Development Study. Br J Ophthalmol. 2019;103(8):10781084.

274

275

12 Appendices
12.1 Appendix 1 – Acuitas Data Extraction Consent Form

Consent to Extraction and Secondary Use of Data from Acuitas
I, _______________________________ (Print Name) confirm that I am the data controller for
_________________________________ (Practice/Company Name). I consent to the anonymised
use of data from my electronic patient record system (Acuitas) by Michael Moore, Ian Flitcroft and
James Loughman for research purposes in accordance with:
1. the best practice guidelines on research in the health sector from the Data Protection
Commissioner 1
2. the approval of the research ethics committee at Technological University Dublin.
The purpose of the use of the extracted data has been explained to me.
I understand that the data extracted will be limited to the dataset outlined in the table below and
will exclude patient names and identification numbers.
I also hereby authorise Ocuco to access my system remotely for the purposes of installing the data
extraction process and allowing it to be run when required for the purposes of the defined research.
Data Category

Data Elements

Demographic Data

•
•
•
•

Gender
Age at exam date
County of residence
Race

Visit Data

•

Date of exam

Clinical data

•

Retinoscopy (sphere & cyl) Right + Left eyes
(R+L)
Autorefractor sphere & cyl (R+L)
Subjective refraction sphere & cyl (R+L)
Prescribed refractive correction sphere & cyl
i.e. Rx Given (R+L)
Refraction Spherical Equivalent R+L
(calculated during extraction)
Unaided vision R+L
Corrected Visual Acuity R+L
Keratometry
IOP
Pathology
History

•
•
•
•
•
•
•
•
•
•
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Signed: ________________________

Date: _________________ (Data Owner)

Signed: ____

Date: _04/12/16_________ (Researcher)

1

____

http://www.dataprotection.ie/documents/guidance/Health_research.pdf
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12.2 Appendix 2 – Practitioner Recruitment Document as Sent to All
AOI Member Optometrists

Dear Practitioner,

Prof. James Loughman and Prof. Ian Flitcroft are leading an international series of trials to
explore myopia development and its control at the Centre for Eye Research Ireland in the new
DIT Grangegorman campus. This will include an upcoming clinical trial involving the use of
atropine to slow down myopia progression. As part of the MOSAIC (Myopia Outcome Study of
Atropine In Children) trial we are seeking additional data through practitioners currently using
the Acuitas patient management system. We are working with Ocuco with the aim of creating a
large set of vision and ocular related data. There is currently very limited data available on the
distribution of refractive error in Europe. We hope to create a database using pre-existing data
to establish any change in distribution of refractive error over the past number of years,
specifically, any change in the level of myopia present. We also want to assess if the age of onset
of myopia has any bearing on the final level of myopia. Such data will help us to inform future
myopia control strategies and is, therefore, a potentially valuable resource.

Ocuco can remotely extract the relevant data from your Acuitas system. As a data controller we
need your permission to pull this data. No patient identifiers will be taken so all patient data will
be completely anonymous. As all patient data is kept anonymous there is no need to inform your
patients. This is in accordance with the current data protection legislation relating to research.
This method of data collection has a significant advantage over other forms of research such as
longitudinal studies, which are expensive and time consuming.
As the data will be extracted remotely by Ocuco staff, this requires no input from the practitioner
for data to be collected other than signed permission.
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The data we are interested in acquiring includes:

•

Gender

•

•
•
•
•
•
•
•

Age at exam date
County of residence
Race
Date of exam
Retinoscopy sphere & cyl (R+L)
Autorefractor sphere & cyl (R+L)
Subjective refraction sphere & cyl
(R+L)
Prescribed refractive correction

•
•
•
•
•
•
•

•

Refraction Spherical Equivalent R+L
(calculated during extraction)
Unaided vision R+L
Corrected Visual Acuity R+L
Keratometry
IOP
Pathology
History
Management

If you are willing to participate in this study or require further information please feel free to
contact me by email at michael.moore@dit.ie. The attached consent form can be signed, scanned
and emailed to me directly, or sent in hard copy to:

Michael Moore
Department of Optometry
Dublin Institute of Technology
Kevin Street
Dublin 8
Regards,

Michael Moore Prof. Ian Flitcroft Prof. James Loughman
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12.3 Appendix 3 – SQLite Code to Join EMR CSV Files

CREATE TABLE Extract(
Customer_number
INT,
PX_ID
INT,
Gender
STRING,
County STRING,
Rx_date STRING,
Age
INT,
RE_SPH
INT,
RE_CYL
INT,
RE_AXIS
INT,
LE_SPH
INT,
LE_CYL
INT,
LE_AXIS
INT,
RE_add
INT,
LE_add
INT,
RE_UVA
STRING,
LE_UVA
STRING,
RE_VA STRING,
LE_VA STRING,
Glasses_sold
STRING,
Contacts_sold
STRING);
/*Get data into extract table, repeat for each DB*/
/*NOC*/
Insert INTO Exports.Extract
SELECT
NOC.Rx_Given.Customer AS Customer_number,
NOC.Patients.Patient_ID AS PX_ID,
NOC.Patients.Gender,
NOC.Patients.County,
strftime ('%Y-%m-%d',datetime (substr(NOC.Rx_Given.Rx_Date, 7, 4) || '-'
|| substr (NOC.Rx_Given.Rx_Date, 4, 2) || '-' ||
substr(NOC.Rx_Given.Rx_Date, 1, 2))) AS Rx_Date,
NOC.Rx_Given.Age,
NOC.Rx_Given.RE_Distance_Sphere AS RE_SPH,
NOC.Rx_Given.RE_Distance_Cylinder AS RE_CYL,
NOC.Rx_Given.RE_Distance_Axis AS RE_AXIS,
NOC.Rx_Given.LE_Distance_Sphere AS LE_SPH,
NOC.Rx_Given.LE_Distance_Cylinder AS LE_CYL,
NOC.Rx_Given.LE_Distance_Axis AS LE_AXIS,
NOC.Rx_Given.RE_near_add AS RE_add,
NOC.Rx_Given.LE_near_add AS LE_add,
NOC.Subjective.RE_distance_unaided_VA AS RE_UVA,
NOC.Subjective.LE_distance_unaided_VA AS LE_UVA,
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NOC.Rx_Given.RE_distance_aided_VA AS RE_VA,
NOC.Rx_Given.LE_distance_aided_VA AS LE_VA,
NOC.Visits.Glasses_sold AS Glasses_sold,
NOC.Visits.Contacts_sold AS Contacts_sold
FROM NOC.Rx_Given
LEFT JOIN NOC.Patients ON NOC.Rx_Given.Patient_ID =
NOC.Patients.Patient_ID
LEFT JOIN NOC.Subjective ON NOC.Rx_Given.Visit_ID =
NOC.Subjective.Visit_ID
LEFT JOIN NOC.Visits ON NOC.Rx_Given.Visit_ID = NOC.Visits.Visit_ID;
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12.4 Appendix 4 – R Code to Convert Snellen Acuity to LogMAR

VA_conv <- function(VA){
inter <- sub("\\-.*", "", VA)
inter2 <- sub("\\+.*", "", inter)
dec <- sapply(inter2, function(x) eval(parse(text = x)))
logMAR <- ((log10(dec) * -1))
return(logMAR)}
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12.5 Appendix 5 – Poster Presentations
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Big Data and Driving: Using pooled prac ce data to guide health policy
Moore, Michaela; Loughman, Jamesa; Flitcro , D. Iana,b
a Centre for Eye esearch reland

u lin ns tute of echnolo y

u lin reland Children s niversity Hospital emple Street

u lin reland.

Introduc on

Methods

A core concept of Big‐Data refers to is the prac ce of re‐analysing large amounts of data for new purposes. 1 In this case we have a empted to
determine the appropriateness of the ages at which visual acuity is screened for driving from a large, anonymized sample (n=115,778) of optometry
prac ce data, pooled across 20 individualsites.
Currently to be licenced to drive in the European Union and in most states in the United States, an individualmust achieve a visual acuity of 20 40 either
with or without an op cal appliance. It is a requirement to have a vision assessment when rst applying for a driving licence and when renewing a driving
licence from the age of 70 and over in Ireland. 2 As most people will apply for their rst licence in their late teens or early twen es, there is a signi cant
period of approximately50 years during which it is possible to con nue holding a driving licence without further vision assessment. Such a signi cant
me period between required vision assessments does not seem appropriate,par cularly,given the myopia epidemic a ec ng young people up to their
late twen es and the well establishedincreasing levels of hyperopiain later life.

Results
shows the distribu on of all of the
pa ents by age. The mean age was 47 21
years. The distribu on peaks in the 46‐50
age group.

Anonymizedelectronic medical records (EMR) were provided by a large so ware developer. This data set comprised of 363,457 refrac ons of 152,164 unique
pa ents and included the date of the visit, subject age, vision and full sphere‐cylindrical refrac on. There were 137,294 pa ents with complete data. Pa ents
under the age of 21 were excluded from the analysis as the majority of these are not eligible to apply for a driving licence. This le 115,778 unique pa ents
that were included in the analysis.
Unaided visual acuity for the right eye was converted to decimal format and categorized as comfortably passing the required standard ( 0.6), as failing the
standard(< 0.4) or as being borderline( = 0.4 <= 0.6). The subjects were grouped according to age in 5‐year intervals from 20 years to 100 years.
The data was collated into histogramdata using the SQLite databaseengine and analyzed using the R programminglanguage.
R

shows the average refrac ve
error for individuals in the borderline
category
The change in refrac ve error with age
shown in Figure 4 indicates that this is
most likely due to increasing levels of
hyperopia as the increasing hyperopia
observed in Figure 4 appears to coincide
with the increasing number of
individuals falling into the borderline
category

EU

20 40

Over 70s only

25%

24.4%

UK

20 40

Not required Over 70s must con rm
they meet vision requirement but no
evidence required

Every 3 years

0%

0%

USA (State
dependant)

20 40‐ varies
from state to
state

Variable Some states require vision Variable 2‐8
assessment at every renewal while
years
some never require vision assessment

0‐100%

0‐100%

Australia

20 40

Over 80s only

7.8%

6.2%

Every year

Discussion
shows the distribu on of unaided
visual acuity at di erent ages when
categorised as comfortably passing,
borderline passing or failing the driving
standard.
The mean unaided visual acuity (expressed
as a decimal) was 0.61 0.38. Overall the
number of individuals comfortably passing
the standard reduces with age while the
number failing the standard increases with
age.
Interes ngly the propor on of those in the
borderline category is fairly sta c un l the
h decade when this also begins to
increase with age.

There is some small variability interna onallyon the level of visual acuity required to drive safely but most
jurisdic ons require visual acuity of approximately 20 40 (or 0.5 in decimal). The frequency with which a
vision assessment is required to renew a driving licence is highly variable. Some jurisdic ons such as Indiana
require a vision assessment at every renewal while other states such as Iowa only require it when a licence is
rst issued3. This research indicates that with increasing age more and more drivers fall below the required
legal visual acuity limits due to increasing levels of hyperopia. A rela onship between reduced visual acuity
and the ability to recognise pedestrians at night has recently been reported,4 giving rise to safety concerns
for those with even mildly reduced acuity. This indicates a possible need for a change in vision assessment
policy in many jurisdic ons.

5 shows the propor on of
individuals in the borderline category
that will be detected if a vision
assessment is required at di erent ages.
At the current requirement of over 70
years old, 24.4% of individuals in the
borderline category are detected. If the
requirement for a vision assessment was
from the age of 50, 69.9% of all
individuals in the borderline category
would be detected.

Conclusions
5

shows the total number of people
in the borderline (blue) and fail (green)
categories. The increase in the number of
individualsfalling into this category is more
obvious in this gure with a drama c
increase during the fourth and
h
decades that starts to fall in the seventh
decade.

A signi cant number of licenced drivers may develop an vision impairment over me that cons tutes a safety
risk for driving if undetected. Policy makers should introduce more frequent vision assessment, ideally when
drivers renew their licence. If vision is not to be assessed at every licence renewal, it should be regularly
assessed from the h decade onwards when increasing levels of hyperopiacombined with presbyopiacause
reducing levels of unaided visual acuity.
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12.6 Appendix 6 – Application of big-data for epidemiological studies
of refractive error. PLoS One publication.
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Structured PhD Programme Modules Completed
It is a requirement by TU Dublin to undertake a number of post-graduate modules (discipline-specific
skills 20 ECTS, and employability skills 20 ECTS).
Modules completed as part of the Structured PhD programme:
Discipline-specific postgraduate modules:
TU Dublin Glaucoma Detection and Decision-making in Optometric Practice – 10 ECTS credits
TU Dublin Authoring Principles – 10 ECTS credits

Employability Skills Training:
University of Limerick Reporting Results in Physical Science – 6 ECTS credits
Datacamp Suite of R Modules – 6 ECTS credtis
TU Dublin Postgraduate Diploma in Third Level Education – 60 ECTS credits (awarded 10 ECTS credits
awarded toward structured PhD programme)

Additional Postgraduate Modules Completed:
University of Cardiff Postgraduate Diploma in Therapeutic Prescribing for Optometrists – 60 ECTS
credits
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